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1 Introduction
1.1 What defines a stem cell?
More than 200 different cell types in the human body are generated by the tightly
orchestrated differentiation of only one cell: the fertilized egg. In order to give
rise to all specialized cell types, the fertilized egg undergoes several rounds of cell
division thereby forming the zygote. The ability of cells to continuously divide
while maintaining an undifferentiated state is called self-renewal and is a defining
hallmark of stem cells. The zygotic cells are considered totipotent (i.e. having the
whole power) because they will later on give rise to all embryonic and extraembry-
onic tissue cells. After some days, the morphology of the zygote changes. For the
first time, different cell types are generated in the so called blastocyst, among them
those which will later give rise to all cells of the embryo. The ability to differentiate,
i.e. to generate at least one other specialized cell type, is defined as the second hall-
mark of stem cells. Thus, the whole organism is built up in a hierarchical fashion
in which cells become more and more specified during development (figure 1.1).
However, not all cells with stem cell character are lost after embryonic develop-
ment. More restricted stem cells can persist throughout adulthood and are called
multipotent, since they are able to generate a variety of cell types from a specific
lineage. For example, multipotent hematopoietic stem cells can give rise to ery-
throcytes, platelets and leukocytes. While during development stem cells initially
specify the different cell types and enable the growth of the organism, the purpose
of adult stem cells is to replenish the pool of effector cells and to enable repair after
tissue damage.
1.2 Embryonic stem cells
Embryonic stem cells (ESCs) are the in vitro equivalent of the cells from the inner
cell mass (ICM) of a blastocyst which can be propagated in culture without losing
their stemness. These cells correspond to a very early stage of embryonic devel-
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Figure 1.1: The process of cell differentiation in mammalian development. Image was
taken from Chaudry (2004) [1]
opment and they retain the ability to differentiate into all cell types of the adult
organism. Because of their enormous potential for clinical applications in the fields
of organ transplantation and tissue engineering, ESCs are currently widely inves-
tigated. However, transplantation of cells generated from conventional ESC lines
could elicit an immune reaction in the patient which limits their application. More-
over, due to the necessity of using human embryo material, ethical implications
need to be considered. Both hurdles were overcome with the development of a
technique which allows the generation of ESC-like cells from adult somatic cells
of mice and humans [2, 3]. These so called induced pluripotent stem cells (iPSCs)
are commonly produced by the overexpression of a set of ESC-typical transcrip-
tion factors. However, alternative reprogramming cocktails have been put forward
(reviewed in [4, 5]). The current clinical research is mainly focusing on the estab-
lishment of efficient differentiation protocols in order to generate specific cell types
which can be transferred back to the patient without the threat of cancer formation.
Apart from this, there is a great interest to use ESCs as tools for the investigation
of general cell biological processes. Interestingly, it was found that stem cells share
certain features with cancer cells, e.g. their ability to proliferate constantly and the
2
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Embryonic stem
cell identity
Transcription 
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Baf250a ...
Figure 1.2: The identity of ESCs is regulated and maintained on epigenetic, transcrip-
tional and posttranscriptional levels.
survival in hypoxic conditions (reviewed in [6, 7, 8]). Techniques which allowed
ESC derivation from genetically modified mice or direct in vitro mutation have led
to substantial advances in the understanding of principal mechanisms underly-
ing cell identity, cell transformation and proliferation. This enabled the identifica-
tion of a complex network governing ESC identity comprising transcription factors,
miRNAs, RNA-binding proteins (RBPs) and epigenetic regulators (figure 1.2).
1.2.1 Transcription factors as master regulators of pluripotency
Transcription factors were the first components of the mESC network that were
identified as pivotal regulators of pluripotency. There is a plethora of transcription
factors that are constantly expressed in ESC, but only a handful of them were found
to be acting as master regulators. The key to this finding was the development
of iPSCs from murine somatic cells by overexpression of just four trasncription
factors: Oct4, Sox2, Klf4 and c-Myc [2]. An independent study performed in hu-
man ESCs revealed a similar set of the transcription factors, namely Oct4, Sox2 and
Nanog with the addition of the RNA-binding protein Lin28a [3]. These and other
studies showed that Sox2 and Oct4 are indispensable for establishing pluripotency
whereas other transcription factors such as Nanog, Esrrb, Klf4 and Tcf2l1 mainly
support self-renewal [9, 10, 11]. They may bind to hundreds of genomic loci, lead-
ing to both activation and suppression of gene transcription [12, 13]. The efficient
suppression of specific transcriptional programs is essential for the maintenance of
pluripotency and should not be underestimated. This is the reason why the inhi-
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bition of glycogen synthase kinase 3 (Gsk3) and mitogen-activated protein kinase
kinase (Mek) signaling further promotes the derivation of mESCs [10, 14].
Master regulatory transcription factors in turn upregulate other transcriptions
factors and this transcription factor hierarchy exerts far-reaching effects on the
whole transcriptional landscape. Thereby, they stabilize the ground state of pluripo-
tency and efficiently repress differentiation and somatic cell programs. A recent
study found that a transcription factor set of just 12 components establishes the
whole ESC network [15]. ESC transcription factors usually work cooperatively for
efficient gene expression regulation and enforce their own transcription, thus es-
tablishing positive-feedback-loops [16, 17, 13, 12].
When ESCs start to differentiate some transcription factors are downregulated
whereas others remain expressed depending on the stimulus. This creates an im-
balance that will influence the germ layer formation. For example, it was found that
during neuroectodermal cell commitment Sox2 remains highly expressed, while
Oct4 becomes downregulated [18]. A similar mechanism was identified for Klf4
and Klf5 which differentially inhibit mesoderm and endoderm formation [19]. Ac-
cordingly, the reprogramming of adult stem cells to iPSCs usually requires less
additional factors than are needed for fully differentiated cells [20] .
1.2.2 The chromatin landscape of the pluripotent genome is maintained
by epigenetic regulators
While it is widely recognized that transcription factors play a major role in the
global execution of specific gene programs, chromatin regulators are also essential
for the organization of the genome and the stabilization of the uncommitted ESC
state. The basic module of genome organization is the nucleosome; a 147 nucleotide
stretch wrapped around an octamer protein complex consisting of two copies of
H2A, H2B, H3 and H4 histones [21]. The modification of the nucleosomes can alter
gene expression by making certain gene regions more or less accessible for DNA
binding proteins. The nucleosome can be modified by site-specific incorporation
of histone variants as well as histone-modifying enzymes and ATP-dependent re-
modeling complexes (reviewed in [22, 23, 24]). The best studied pathways leading
to epigenetic regulation are histone modifications including acetylation, methyla-
tion, phosphorylation, ubiquitination, and ribosylation [25]. Indeed, it has been
reported that the process of reprogramming adult tissue cells to iPSC is always ac-
companied by remodeling of the epigenome [2, 26, 27]. However the outcome of
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specific modification patterns is context-dependent, hence the result of the same
modification can be different depending on the gene and cell type.
Generally, it is thought that ESCs have a more open (meaning easily accessi-
ble) chromatin than differentiated cells [28]. Moreover, there is an unusually high
prevalence of bivalent histone marks, allowing for pervasive gene transcription
[29, 30]. Hence, many genes that are actually characteristic for differentiated cells
are continuously expressed at low levels in ESCs, prompting the speculation that
the expression of these developmental genes is maintained in a poised state in or-
der to prime ESCs to rapidly induce differentiation. This may contribute to the
general plasticity of the ESC genome. Induction of differentiation then leads to a
dramatic reduction of the actively transcribed genome [31].
1.2.3 microRNAs regulate the balance between stemness and
differentiation
microRNAs (miRNAs) constitute another level of protein expression regulation in
cells downstream of gene transcription. miRNAs are short, about 22 nucleotide
long, single-stranded RNA molecules which can repress protein expression of spe-
cific target genes by imperfect binding to the mRNA. Until today, more than 1,500
miRNAs have been identified in the human genome and it was estimated that
about one third of all genes show conserved posttranscriptionally regulation by
miRNAs [32].
The biogenesis of miRNAs is a multi-step process involving several protein com-
plexes (figure 1.3). All miRNAs originate from Polymerase-II/III transcripts un-
dergoing conventional capping and poly-A-tailing. In the canonical pathway from
which most cellular miRNAs are produced, a stem loop structure within this pri-
mary transcript (pri-miRNA) is recognized by the so called microprocessor com-
plex consisting of the proteins Dgcr8 and Drosha [34, 35]. The RNA-hairpin is cut
out resulting in a pre-miRNA intermediate of about 70 nucleotides length, which
is subsequently transported into the cytoplasm with the help of the shuttle pro-
tein Exportin-5 [36, 37]. There, the RNaseIII enzyme Dicer binds to the precursor
and cleaves off the stem loop, generating an imperfect double strand RNA with
a length of about 22 nucleotides [38, 39]. Usually only one of the two generated
miRNAs is biologically active and loaded into the RNA-induced silencing complex
(RISC), whereas the other one, known as the passenger strand, is rapidly degraded
[40, 41]. A key component of the RISC is the protein Argonaute-2 (Ago2) which
directly binds the miRNA and orients it for interaction with the target mRNA.
5
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Figure 1.3: The canonical miRNA processing pathway. Figure taken from Winter et al.
(2009)[33]
Upon binding of the miRISC, the initiation of translation is blocked [42]. Further-
more, miRNA induced deadenylation and decapping leads to decreased stability
of the mRNA. However, other mechanims including mRNA sequestration, mRNA
restriction and premature termination of translation were shown to contribute to
miRNA-mediated effects (reviewed in [43]).
Essential for the miRNA activity on target mRNA regulation is the perfect pair-
ing in the region of the nucleotides 2-8, also referred to as the seed sequence. This
region is usually especially highly conserved and identical among the members of
a miRNA family. The other parts of the miRNA confer further target specificity and
stabilize the interaction [32, 44]. miRNAs are, like transcription factors, tightly reg-
ulated in their expression and the miRNome is very characteristic for a certain cell
type. Hence, it is understandable that mESCs also have a unique expression pat-
tern of miRNAs. The importance of miRNAs for governing ESC maintenance and
differentiation has been demonstrated by the generation of Dgcr8 and Dicer KO
mESCs which lack nearly all mature miRNAs. In the undifferentiated cell state,
these cells exhibit a significantly prolonged cell cycle and G1 transit, which can be
rescued by reintroduction of the stem-cell specific 290-miRNA family [45]. More-
over, upon induction of differentiation, Dicer and Dgcr8 knockout mESCs fail to
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upregulate differentiation genes such as Hnf4a, Brachyury and Gata-1, which pre-
cludes the exit of the stem cell maintenance program [46, 47, 48]. However, over-
expression of miRNAs of the let-7 family is able to overcome the inability to dif-
ferentiate. These findings illustrate that the balance between miRNAs supporting
stem cell maintenance and those promoting differentiation is critical for the full
functionality of mESCs [49].
miRNAs that are important for the stem cell functions are summarized as ESC-
specific cell cycle regulating (ESCC) miRNAs and comprise the related families
of the miR-290 cluster, the miR-302/367 cluster and the miR-17/20/106 miRNAs
which together constitute the majority of miRNAs expressed in the human and
murine ESCs. These miRNAs support the unique ESC cycle as they lower the
G1-S-checkpoint barrier by promoting both hyperphosphorylation of Rb proteins
and suppression of miRNAs that antagonize rapid cell-cycling [50]. Furthermore,
miRNAs indirectly promote the expression of factors and epigenetic modulators
that enhance stem cell maintenance (e.g. Sall4, Lin28, Dnmt3a/b) [49, 51].
On the other hand, there are miRNAs which are functionally counteracting the
ESCC miRNAs and which are upregulated upon induction of differentiation. Those
miRNAs target the central ESC transcriptional network, help to stabilize the differ-
entiated cell state and establish a somatic cell cycle. Those can be categorized as
”pro-differentiation” miRNAs [52, 53, 54].
The let-7 miRNA, in particular, is a widely investigated miRNA since it has a
central role in the regulation of differentiation and proliferation. let-7 was shown
to be rapidly upregulated upon differentiation in different species [55, 56, 57, 58].
Furthermore, let-7 was one of the first miRNAs identified and let-7 target regu-
lation is highly conserved during evolution [59]. Important target mRNAs of the
let-7 miRNA family in mESCs are for example c-Myc Sall4, Lin28 and Trim71 [49].
In mouse and human there are 9 different let-7 members originating from 14 and
13 genes, respectively [60]. Surprisingly, the transcription of the let-7 primary tran-
script is already quite high in the undifferentiated state, although the mature let-7
miRNA is almost undetectable [61, 58]. This discrepancy could be explained by
the discovery of a negative regulation exerted by the RNA binding protein Lin28
which recognizes a specific conserved sequence in the loop structure of pre-let-
7 molecules. Binding of the precursor by the stemness factor Lin28a leads to se-
questration from the Dicer complex and to the recruitment of the terminal-uridyl
transferase Tut4 which tags the let-7 miRNA precursor for degradation by the exo-
nuclease Dis3l2 [62, 63, 64, 65]. In addition, the Lin28b protein variant was shown
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to induce pri-let-7 degradation already in the nucleus [66]. This mechanism en-
ables fast upregulation of the mature miRNA upon differentiation since transcrip-
tion must not be altered and posttranscriptional processing is directly linked to the
expression of Lin28.
Transcription of miRNAs is majorly regulated by some master transcription fac-
tors like Oct4, Sox2, Nanog and Tcf3. They induce efficient expression of mESC
specific miRNAs such as the miR-290 family. On the other hand, the promoter sites
of pro-differentiation miRNAs are also bound by ESC transcription factors but they
are at the same time repressed by Polycomb group complexes [67]. This indicates
that these miRNAs are constantly kept in a poised state.
1.2.4 RNA binding proteins in stemness regulation
Like miRNAs, RNA-binding proteins (RBPs) act posttranscriptionally to regulate
protein output. RBPs can regulate the localization, maturation, transport, stabil-
ity and translational efficiency of specific coding and non-coding-RNAs. A recent
estimation yielded a total of 1,500 RBPs in the human genome, equivalent to 7.5%
of all human genes [68]. The largest class of them constitute the mRNA-binding
proteins (mRBPs) with about 700 members. Concomitantly with extensive post-
transcriptional mRNA regulation in higher eucaryotes, such as alternative splicing
and polyadenylation, the class of mRBPs increased substantially during evolution.
On the other hand, the actual binding units of RBPs seem to be highly conserved
[68]. Especially the RBDs of ribosomal proteins show the highest conservation and
can be structurally differentiated from mRBPs which mostly contain a limited set
of RBDs such as an RNA recognition motif (RRM), a DEAD-motif, a K-homology
(KH) domain or a zinc-finger domain. RBDs often occur in multiple repeats or
in combination with other RBDs to increase sequence specificity and affinity [69].
Currently, the RNA target sequence cannot be predicted from the structure. Hence,
the vast amount of RBPs need to be individually investigated to uncover their tar-
get spectrum and function. Moreover, the specificity of the interaction of an RBP
with its target RNA can be sequence- as well as structure-mediated and regulatory
posttranslational modifications of the RBP create an additional layer of complexity.
Recently, it was found that a number of RBPs are dynamically regulated in iPSC
reprogramming and differentiation [70], suggesting an active contribution of these
proteins in stem cell maintenance. In comparison to transcription factors our cur-
rent understanding of RBPs in mESCs biology is limited. Some examples will be
explained here in more detail.
8
1.2. Embryonic stem cells
Although they are not only expressed in stem cells, proteins of the PAZ (Piwi/
Argonaute/ Zwille) domain family are of significant importance to stem cells since
they are majorly involved in post-transcriptional gene silencing. Argonaute pro-
teins and Dicer are essential components of the RNA-silencing pathway. Argonaute
proteins interact with miRNAs as well as their mRNA targets and they are impor-
tant for both miRNA biogenesis and activity. Deficiency of all four Argonaute pro-
teins was reported to induce apoptosis in mESC [71]. However, the single knock-
out of Argonaute-2 (the catalytic subunit of the RISC) in mESC leads to delayed
differentiation and decreased proliferation [72], suggesting that the other Argonu-
ate proteins may exert further functions that go beyond miRNA biogenesis and
activity regulation.
A specific class of RBPs regulates alternative splicing of the primary mRNA tran-
script in the nucleus. Since more than half of the mouse and human genes have
at least one alternative transcript, among them many pluripotency factors, RBPs
are required for differential expression regulation of splicing variants. A couple
of splicing factors have been identified to regulate the alternative expression of
pluripotency factors. For example, in undifferentiated mESCs the Oct4a variant
which supports self-renewal is primarily expressed at the expense of the Oct4b
[73], a process that is regulated by Tip110 [74]. On the other hand, RBPs like Mbnl1
and Rbfox2 specifically induce the switch to differentiation promoting transcript
variants and thus counteract stem cell maintenance [75, 76].
One of the best studied RBPs in ESC is Lin28. Lin28 was shown to bind to differ-
ent classes of RNAs, namely let-7 pre-miRNA, mRNAs and snoRNAs [63, 77, 78].
Lin28 was first discovered as a heterochronic gene in the model organism C. elegans
[79] where mutation of the lin-28 gene leads to accelerated differentiation of the hy-
podermal seam cells. Its stem cell-specific expression pattern seems to be conserved
in humans, where it was functionally associated with processes such as develop-
ment, glucose metabolism, pluripotency and differentiation [3, 80, 81, 82, 83, 84, 85].
The overexpression of Lin28a together with Nanog, Oct4 and Sox2 was shown to
reprogram human fibroblasts [27]. Moreover, some cancers were found to regain
Lin28 protein expression. Lin28 overexpression in tumors was found to have a pos-
itive impact on tumor development and growth, for instance in germ cell tumors
[86, 87], breast cancer [88], hepatocellular carcinoma [89] and Wilms tumor [84].
These findings further support the idea of a close relationship between stem cell
biology and cancer.
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In humans and mice, two isoforms of Lin28, called Lin28a and Lin28b, are ex-
pressed from two distinct genes. Structurally, both proteins are very similar. At
the N-terminus there is a cold-shock domain (CSD) followed by a C-terminal Zinc-
knuckle domain (ZKD) comprising two retroviral-type CHCC Zn-knuckles. Lin28b
possesses a nuclear localization sequence allowing the protein to shuttle between
cytoplasm and nucleus, whereas Lin28a can be mainly found in the cytoplasm, i.e.
in P-bodies, ER-structures and stress granules [66, 90].
1.3 Germline stem cells
A specific type of adult stem cells are the germ stem cells. Germ cells give rise to
gametes (sperm and eggs) in sexually reproducing species. While female mam-
mals do not produce oocytes (precursors of eggs) after birth [91, 92, 93], a stem
cell population constantly replenishes the sperm cell pool in males. The so called
spermatogonial stem cells (SSCs) provide a bona fide example for the tightly regu-
lated balance of stemness versus differentiation. Moreover, germ cells are unique
in that their normal end product is again a totipotent zygote and they provide the
enduring link between the generations [94]. It was found that embryonic germ
cells (EGCs) when taken into culture, can reactivate cellular programs that closely
resemble those of embryonic stem cells [95, 96]. Those cells can form tissues from
all three germ layers when transferred into donor animals. Additionally, germ cell
tumors have long been used as surrogate for embryonic stem cells for the investi-
gation for stemness and differentiation [97].
The specification of primordial germ cells (PGCs) happens very early during em-
bryonic development at around stage E6.5 by instructive signaling from neighbor-
ing yolk sac cells which secrete BMPs [98, 99] (see figure 1.4). This induces ex-
pression of early germ cell markers such as Blimp1/PRDM1 and Stella/Dppa3. In
turn, Blimp-1 actively suppresses somatic cell fates (i.e. homeobox genes) [100]. In
mice, a founder population of about 50 cells starts to migrate along the hindgut at
E8.5 undergoing several rounds of mitosis before reaching the genital ridges. Upon
arrival, the cells, about 5,000, start to express Vasa and germ cell nuclear antigen
(Gcna). During germline development, an extensive remodeling of the epigenetic
landscape occurs involving erasure of DNA methylation patterns and posttrans-
lational histone modifications [101, 102]. PGCs are the only lineage that retains
the expression of pluripotency-associated genes after gastrulation, such as Oct4,
Nanog, Sall4 and Sox2. The Sry ((sex-determining region of Y)) gene is essential
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Figure 1.4: The specification of the germ cell lineage during embryonic development.
Modified from Bikoff & Robertson (2008) [104].
for the sex-specific germ cell development starting at E10.5. In female embryos,
meiosis starts already in the devolving embryo and arrests during Meiosis I. Meio-
sis II is then induced under the influence of hormones during puberty [103]. In
contrast, in males meiosis is part of spermatogenesis which is actively suppressed
until puberty.
1.4 The TRIM protein family
The TRIM protein family is characterized by the tripartite motif consisting of an
N-terminal RING finger domain in conjunction with one or two B-box motifs and
a coiled-coil region [105, 106, 107]. The C-terminal domains following the tripartite
motif can be diverse and define further subgroups within the TRIM protein family
[108]. Two thirds of the human and mouse TRIM proteins contain a B30.2 domain
at the C-terminus (also called PRY-SPRY-domain). This subfamily of TRIM proteins
is evolutionary relatively young and mainly involved in immunological processes
[109]. Other prevalent C-terminal domains are for instance the PHD-BROMO do-
main, the MATH domain or the Filamin-NHL domain [109] which show high con-
servation from invertebrates to humans (figure 1.5).
Due to their structural diversity, TRIM proteins are implicated in a plethora of
processes including apoptosis regulation [111, 112, 113], autophagy [114], cell dif-
ferentiation [115, 116, 117] and antiviral defense [118, 119]. Likewise, TRIM proteins
are also playing a role in pathophysiological conditions, such as muscular dystro-
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TRIM54, TRIM55, TRIM63
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TRIM1, TRIM5a, TRIM6, TRIM7, TRIM10, TRIM11, TRIM15, TRIM17, TRIM21, 
TRIM22, TRIM25, TRIM26,TRIM27, TRIM34, TRIM35, TRIM38, TRIM39, 
TRIM41, TRIM43, TRIM47, TRIM48, TRIM49, TRIM50, TRIM53, TRIM58 
TRIM60, TRIM62, TRIM64, TRIM65, TRIM68, TRIM69, TRIM72, TRIM75
TRIM24, TRIM28, TRIM33
TRIM2, TRIM3, TRIM32, TRIM71
TRIM37
TRIM23
TRIM45
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Figure 1.5: Overview on the domain structure and composition of the TRIM protein fam-
ily. Definition of subgroups according to Ozato et al. (2008) [110] COS, C-terminal sub-
group one signal; FN3, Fibronectin type 3; PHD, plant homeodomain, MATH, meprin and
meprin and TRAF-homology domain; NHL, NCL1, HT2A and LIN41 domain; ARF, ADP-
ribosylation factor-like; TM, transmembrane, PML, Promyelocytic leucemia; MID, midline
phy [115, 120], X-linked Opitz syndrome [121, 122], familial Mediterranean fever
[123, 124] and also different types of cancers [113, 125, 126].
The RING finger domain is characterized by a series of cystedine and histidine
residues forming a “cross-brace” to bind two zinc ions [127, 128]. RING domains
are besides HECT domain-bearing proteins the largest class of E3-ubiquitin ligases.
Many studies have shown that TRIM proteins can act as E3-ubiquitin ligases by
adding ubiquitin residues to specific protein substrates (reviewed in [129]). The
ubiquitination process begins with the ATP-dependent coupling of the 8.5 kDa
Ubiquitin protein to the E1 ubiquitin-activating enzyme (see figure 1.6).. Next, the
ubiquitin is transferred to one of several E2 ubiquitin-conjugating enzymes. Fi-
nally, E3 ubiquitin ligases mediate the transfer of the ubiquitin molecule from an
E2 enzyme to a specific substrate. After attachment of a single ubiquitin moiety
to a protein substrate, further ubiquitin molecules can be added to the first, yield-
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Figure 1.6: Illustration showing the ubiquitination pathway leading to substrate degra-
dation. The figure was taken from Hatakeyama and Shigetsugu (2011)[135].
ing a poly-ubiquitin chain. In most cases ubiquitin-tagging induces degradation of
the protein by the 26S proteasomal pathway. However, there are also examples in
which ubiquitination plays a role as a signaling molecule for the activation or inac-
tivation of a target protein (reviewed in [130]). It was found that ubiquitin modifi-
cations that are involved in signaling are mainly coupled via other than the classical
Lys-48 bond [131] (e.g. Lys-63) and thus do not lead to formation of poly-ubiquitin
chains. In addition, some TRIM proteins such as Trim27 or Trim40 were also found
to catalyze the attachment of ubiquitin-like modifiers including SUMO proteins
[132] IFN-stimulated gene 15 (ISG15) [133] and NEDD8 [134]. Hence, TRIM pro-
teins are more than simple signaling mediators for protein degradation.
Less is known about the function of the B-boxes, which rarely appear outside of
TRIM proteins. However, it is speculated that they contribute to E3-ligase activity
[136, 137]. The coiled-coil domain on the other hand is a very generally occurring
motif and is responsible for the ability of many TRIM proteins to form homo- and
hetero-multimers with other TRIM proteins. In addition, the coiled-coil domain
seems to be the guiding structure for proper intracellular TRIM protein localization
[106].
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1.4.1 The TRIM-NHL proteins
As mentioned before, the large family of TRIM proteins is further subdivided ac-
cording to their C-terminal domains, one of them being the TRIM-NHL proteins. In
mammals the TRIM-NHL family consists of four members: Trim2, Trim3, Trim32
and Trim71 [138], however TRIM-NHL proteins can also be found in invertebrates
(see figure ??). The name “NHL” was derived from the first three proteins identified
in C. elegans harboring this domain feature: NCL-1, HT2A and Lin-41 [107]. The
NHL domain consists of 5-6 repeats of a 44 amino acid stretch, resembling WD40
repeats. Together the repeats form a tight beta-propeller structure which builds an
interaction surface for other proteins as well as RNAs. The NHL repeat structure
can also be found in a variety of prokaryotic proteins which can act as monooxy-
genases [139]. On the other hand, brat, a Trim-NHL protein from D. melanogaster,
is a well characterized RNA binding protein which acts in concert with other post-
transcriptional regulators to repress protein expression of target genes [140, 141].
The NHL domain may thus be able to interact with both proteins and RNA. In line
with this it was found that the surface of those NHL proteins that interact with
RNA is positively charged which enables more efficient interaction with negatively
charged RNA molecules. This is particularly true for the human TRIM-NHL pro-
teins TRIM71 and TRIM3 [141]. Nevertheless, the identification of concrete binding
sites remains a challenging task. Surprisingly, several TRIM-NHL have further-
more been found to regulate the expression of miRNAs [142, 143, 144, 145]. Until
now it is unclear whether they all use a common mechanism and if this is based
on an interaction with the RNA itself or via regulation of proteins that regulate
miRNA biogenesis and function.
1.4.2 Trim71 as a conserved regulator of embryonic development
Trim71 was first discovered as a heterochronic gene in the model organism C. ele-
gans where it was named lin-41 (lineage variant 41) [146]. In the same study, the
authors found a reciprocal relationship between the protein expression of lin-41 and
the expression of a newly identified short non-coding RNA, named let-7 (lethal 7).
Accordingly, LIN-41 is downregulated when let-7 miRNA is upregulated precisely
at the switch between larval stages 3 and 4 [146]. Interestingly, mutation of the
lin-41 gene resulted in precocious differentiation of the hypodermal seam cells, a
stem cell compartment at the lateral sites of the nematode. In contrast, overpro-
duction of LIN-41 leads to reiteration of larval cell states instead of terminal dif-
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Figure 1.7: Phylogenetic tree of TRIM-NHL proteins from mouse, fly and nematode
shows high conservation of protein domain structures. C. elegans proteins are in light
green, D. melanogaster in red, M. musculus in blue type. The figure was taken from Wulczyn
et al. (2010)[138].
ferentiation [147]. Thus, the lin-41 -deficient mutants behaved exactly opposite to
the mutants of the miRNA let-7. Indeed, the lin-41 mRNA harbors two partially
complementary let-7 binding sites which were later found to be conserved in many
other Trim71/lin-41 homologs [57, 59]. miRNA-dependent gene regulation could
also be shown for other heterochronic genes identified in C. elegans at the same time
(lin-14, lin-28, lin-42) which established a new mechanism used for rapid cell fate
changes as required during embryonic development [148]. Furthermore, the tran-
scription factor lin-29 was identified as major downstream target of lin-41, since
the lin-41 knockout phenotype could be reverted by simultaneous deletion of lin-
29 [147].
As in the nematode, the phenotype of the homozygous knockout of Trim71 in
the mouse results in embryonic death at around midgestation. Most strikingly, the
neural folds, precursor structures of the central nervous system, fail to fuse leading
to an exencephalus phenotype [131]. However, the malformations in the central
nervous system are likely not solely responsible for the embryonic death of the
mutant animals, suggesting that other so far unknown phenotypes play a role dur-
ing embryonic development. Interestingly, it was found that ablation of the last
24 amino acids was already enough to induce the exencephalous phenotype in the
majority of the homozygous offspring. Independently of that, other studies in the
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model organisms D. melanogaster and D. rerio showed that the respective Trim71 ho-
mologs are required for proper embryonic development [149, 150]. However, there
still seem to be differences between the species with regards to Trim71-dependent
cellular functions. For example, the lethal mutant phenotype of the D. melanogaster
homolog of Trim71, wech, is caused by a general muscle detachment in the fly lar-
vae. It was therefore postulated that the wech protein functions as an adapter pro-
tein for the cytoskeletal network and is a regulator of cell adhesion [150]. Until this
day, there are no matching observations for other Trim71 homologs and it remains
uncertain in how far this protein function is conserved in mammals.
On the molecular level, the mechanism of Trim71 functionalities are still poorly
understood. Several studies have addressed the question whether Trim71 acts as
a conventional E3-ligase and tried to identify putative protein substrates. Trim71
localizes to so called P-bodies where Ago2, the catalytic component of the RISC
complex, can be found as well. Both proteins were shown to interact and it was pos-
tulated that Ago2 is a substrate for Trim71-mediated ubiquitination. This ubiqui-
tination would result in the degradation of Ago2, thus influencing global miRNA-
biogenesis and activity [145]. In line with this hypothesis, an altered expression
of the miRNA let-7 was observed. However, other groups could not confirm this
regulatory mechanism [151, 152, 153], whereas one study in the model organism C.
elegans argues that Ago2 regulation only takes place in a timely restricted manner
during development [154].
Another proposed substrate for Trim71-dependent ubiquitination was identified
by Chen et al. [151]. This study links Trim71 to FGF signaling and postulated that
Trim71 is a positive regulator of FGF signaling by the stabilization of the adapter
protein Shcbp1 [151]. FGF signaling is very important during the formation of
the central nervous system and could contribute to the morphological aberrations
observed in Trim71-deficient embryos.
Finally, a very recent publication suggested that Trim71 could act as a negative
regulator of LIN28b [155]. Interestingly, this again links Trim71 to the miRNA let-7,
since Lin28a and Lin28b are the main posttranscriptional suppressors of let-7 ex-
pression. However, in contrast to other findings [145, 154], in this case an enhanced
let-7 expression is expected when Trim71 is present.
Other studies mainly concentrated on the putative role of Trim71 as an RNA-
binding protein (RBP). In a global screening approach, Trim71 was recently iden-
tified as an RBP in mESCs [70]. Moreover, when transfected together with Oct4,
Sox2 and Klf4, Trim71 overexpression can enhance the reprogramming efficiency of
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MEFs, presumably by suppression of pro-differentiation genes [156]. This suggests
that there might be a specific role of Trim71 in the regulation of the balance between
stemness and differentiation in ESCs. A couple of gene candidates have been pro-
posed to be regulated in a Trim71-dependent fashion [152, 153, 156]. However, it
is still unclear whether the NHL domain of Trim71 recognizes a specific sequence
motif of a RNA structure. Accordingly, it is until now impossible to predict target
genes.
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1.5 Aim and objectives of this study
Trim71 is a highly conserved protein involved in the regulation of embryonic de-
velopment, which was identified about 15 years ago in the nematode C. elegans.
Since then, many studies have investigated the effect of Trim71 ablation in differ-
ent model organisms, revealing striking effects on embryonic development in ze-
brafish, chicken, fruit fly and mouse. However, apart from these phenotypic anal-
yses, very little mechanistic insight was gained regarding the function of Trim71.
Instead, there are a variety of inconsistent reports describing a presumptive role
of Trim71 in diverse processes such as ubiquitination, mRNA stability and miRNA
expression regulation. Its stem cell restricted expression and the fact that Trim71
might be able to regulate target genes and proteins involved in various pathways,
make this gene a putative master regulator for the balance between stemness and
differentiation.
The aim of this study is to investigate the implications of Trim71 deficiency in a
defined and relevant cell model. Since an early contribution of Trim71 in develop-
ment was postulated, mESCs derived from conditional Trim71 knockout animals
were used as a tool to investigate the effect of Trim71 on stemness and differentia-
tion. In addition, this cell system could be used to validate proposed protein ubiq-
uitination targets as well as Trim71-dependent regulation of mRNA and miRNA
expression. Furthermore, we wanted to relate our findings to in vivo conditions
for which a new conditional knockout mouse model was generated. A new condi-
tional mouse line will overcome major drawbacks of all previous studies in mice us-
ing Trim71 knockout alleles for constitutive deletion. Until today, the relevance of
Trim71 expression in adult tissues is completely unknown and a conditional knock-
out mouse might be used to analyze the effect of Trim71 deficiency in adult organs.
Based on the finding that Trim71 expression can be detected in the testes of adult
wildtype mice, and the fact that germ cells share some defining features with ESCs,
we aim to investigate the role of Trim71 in the germ cell compartment in more de-
tail. By crossing Trim71 conditional animals with a germ cell-specific Cre driver line
we generated the first tissue specific Trim71 knockout and analyzed its phenotype
with regards to fertility in males and females. In combination with in vitro data this
might lead to better understanding of the principal biology of Trim71, potentially
leading to valuable insights into the biology of stem cells, cell type specification
and fertility.
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2.1 Materials
2.1.1 Technical devices
Autoclave 135T, HP Medizintechnik (Oberschleißheim)
Automatic cell separator Automacs pro, Miltenyi (Bergisch Gladbach)
Binocular Wild Herrbrugg (Bad Dürkheim)
Blotting equipment Mini Trans-Blot Cell, Bio-Rad Laboratories
(Munich)
Centrifuge 5810R, Eppendorf (Hamburg)
Centrifuge 5415R, Eppendorf (Hamburg)
Centrifuge Avanti J-20XP, Beckman Coulter (Munich)
CO2 incubator Labotect (Göttingen)
Developing machine SRX-101A, Konica Minolta (Langenhagen)
Electropheresis chamber
(agarose gels)
Polymehr (Paderborn)
Electropheresis chamber
(SDS-PAGE)
Mini Trans-Blot Cell, Bio-Rad Laboratories
(Munich)
Flow cytometer Canto II, BD Bioscience (Heidelberg)
Gel documentation device Gel Max, Intas (Göttingen)
Heat block Thermomixer compact, Eppendorf
(Hamburg)
Heating cabinet EcoCell 55, MMM Medcenter (Munich)
Laminar flow hood BioFlow, BDK (Sonnenbühl-Genkingen)
Luminometer MicroLumat Plus LB96V, Berthold (Cologne)
Magnetic rack DynaMag-2 magnet, Invitrogen/ Life
Technologies (Carlsbad, USA)
Magnetic stirrer Combimac RCT, IKA (Staufen)
Microplate reader infinite M200, Tecan (Männedorf,
Switzerland)
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Microplate reader Synergy HT, Biotek (Bad Friedrichshall)
Microscope Axiovert 100, Zeiss (Jena)
Microscope Digital sight ds-1, Nikon (Tokyo, Japan)
Microscope LSM FV-1000, Olympus (Tokyo, Japan)
Orbital shaker innova44, New Brunswick, Eppendorf
(Hamburg)
PCR cycler MyCycler, Bio-Rad Laboratories (Munich)
PH meter MP220, Mettler Toledo
(Greifensee,Switzerland)
Power supply EV-243, Consort (Turnhout, Belgium)
Real-time PCR cycler iCycler iQ5, Bio-Rad Laboratories (Munich)
Rocker WS-10, Edmund Bühler (Hechingen)
Roller mixer RS-TR05, Phoenix Instrument (Garbsen)
Rotation wheel Neolab Rotator, Neolab (Heidelberg)
Scale JB2002-G/FACT, Mettler Toledo (Greifensee,
Switzerland)
Scanner Scan Maker 8700, Mikrotek (Hsinchu,
Taiwan)
Special accuracy weighing
machine
AG285, Mettler Toledo (Greifensee,
Switzerland)
Spectrophotometer NanoDrop 2000, Thermo Scientific
(Waltham, USA)
Suction pump AC, HLC BioTech (Bovenden)
Ultracentrifuge Optima LE-80K Ultracentrifuge, Beckman
Coulter (Munich)
Vortex mixer UNIMAG ZX3, VELP scientica (Milan, Italy)
Water bath WNE, Memmert (Schwabach)
2.1.2 Chemicals and Reagents
1-Butanol Merck (Darmstadt)
2-Mercaptoethanol Carl Roth (Karlsruhe)
2-Propanol Merck (Darmstadt)
Acetic acid Carl Roth (Karlsruhe)
Aceton Carl Roth (Karlsruhe)
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Acrylamide/Bisacrylamide solution
(30%)
Carl Roth (Karlsruhe)
Agar BD (Heidelberg)
Agarose Invitrogen/Life Technologies (Carlsbad, USA)
Ammonium acetate Carl Roth (Karlsruhe)
Ammonium persulfate (APS) Carl Roth (Karlsruhe)
Antipain Sigma-Aldrich (St. Louis, USA)
Aprotinin Sigma-Aldrich (St. Louis, USA)
Benzamidin Carl Roth (Karlsruhe)
Bovine serum albumin (BSA) Carl Roth (Karlsruhe)
Bromodeoxyuridine (BrdU) labeling
reagent
Roche (Mannheim)
Bromphenolblau Carl Roth (Karlsruhe)
Caesium chloride (CsCl) Carl Roth (Karlsruhe)
Chloroform Carl Roth (Karlsruhe)
collagenase (Type IV) Sigma-Aldrich (St. Louis, USA)
Diazabicyclooctan (DABCO) Sigma-Aldrich (St. Louis, USA)
Dimethyl sulfoxide (DMSO) Carl Roth (Karlsruhe)
Disodium phosphate (Na2HPO4) Carl Roth (Karlsruhe)
Dithiothreitol (DTT) Applichem (Gatersleben)
DNA loading Dye (6x) Fermentas (St. Leon-Rot)
Dynabeads Protein G Invitrogen/Life Technologies (Carlsbad, USA)
Ethanol VWR (France)
Ethidium bromide (EtBr) Carl Roth (Karlsruhe)
Ethylenediaminetetraacetic acid Carl Roth (Karlsruhe)
Gelatin, from porcine scin Sigma-Aldrich (St. Louis, USA)
Glucose Carl Roth (Karlsruhe)
Glycogen Roche (Mannheim)
HEPES Carl Roth (Karlsruhe)
Hydrochloric acid (HCl) Carl Roth (Karlsruhe)
Hydrogen peroxide (H2O2) Merck (Darmstadt)
Igepal CA-630 Sigma-Aldrich (St. Louis, USA)
LB-Agar GIBCO/Life Technologies (Carlsbad, USA)
Leupeptin Sigma-Aldrich (St. Louis, USA)
Magnesium chloride (MgCl2) Carl Roth (Karlsruhe)
Methanol Carl Roth (Karlsruhe)
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Milk powder Carl Roth (Karlsruhe)
Mounting medium (IF), Fluoroshield Immuno Bioscience (Burlington, USA)
Paraformaldehyde (PFA) Merck (Darmstadt)
Phenol Carl Roth (Karlsruhe)
Phenylmethanesulfonylfluoride
(PMSF)
Sigma-Aldrich (St. Louis, USA)
Poly-L-lysine (PLL) Sigma-Aldrich (St. Louis, USA)
Ponceau S Carl Roth (Karlsruhe)
Potassium chloride (KCl) Carl Roth (Karlsruhe)
Sodium azide (NaN3) Carl Roth (Karlsruhe)
Sodium chloride (NaCl) Carl Roth (Karlsruhe)
Sodium deoxycholate (SDS) Sigma-Aldrich (St. Louis, USA)
Sodium fluoride (NaF) Carl Roth (Karlsruhe)
Sodium hydroxide (NaOH) Carl Roth (Karlsruhe)
Tetramethylethylenediamine
(TEMED)
Sigma-Aldrich (St. Louis, USA)
Tris(hydroxymethyl)aminomethane)
(TRIS)
Carl Roth (Karlsruhe)
Triton X-100 Carl Roth (Karlsruhe)
TRIzol Reagent Invitrogen/ Life Technologies (Carlsbad, USA)
Trypsin, 2.5 % GIBCO/ Life Technologies (Carlsbad, USA)
Tween 20 Carl Roth (Karlsruhe)
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2.1.3 Kits
Anti-SSEA-1 MicroBeads Miltenyi Biotec (Bergisch Gladbach)
BCA Protein Assay Reagent Thermo Scientific (Waltham, USA)
Alkaline Phosphatase detection kit Sigma-Aldrich (St. Louis, USA)
anti-FITC microbeads Miltenyi Biotec (Bergisch Gladbach)
Anti-FITC MicroBeads Miltenyi Biotec (Bergisch Gladbach)
anti-FLAG M2 Magnetic Beads Sigma-Aldrich
DIG-RNA Labeling Mix Roche (Mannheim)
DNase I (RNase-free) Life Technologies (Carlsbad, USA)
Dual-Luciferase Reporter Assay System Promega (Fitchburg, USA)
ECL Plus Western-Blotting Substrate Thermo Scientific (Waltham, USA)
Fugene HD Roche (Mannheim)
High-Capacity cDNA Reverse Transcription
Kit
Applied Biosystems/ Life Technologies
(Carlsbad, USA)
In-Fusion HD Cloning Kit Clontech Laboratories
(Mountain View, USA)
Kapa Sybr Fast qPCR Mastermix for
Bio-Rad iCycler
Peqlab (Erlangen)
Lipofectamine 2000 Transfection Reagent Invitrogen/Life Technologies
(Carlsbad, USA)
Lipofectamine RNAiMAX Transfection
Reagent
Life Technologies (Carlsbad, USA)
miScript II RT Kit Quiagen (Hilden)
NucleoSpin Gel and PCR Clean-up kit Macherey-Nagel (Düren)
PeqGold Hot Start Mix Real-Time Peqlab (Erlangen)
Riboprobe® Combination System-SP6/T7
RNA Polymerase
Promega (Madison, USA)
Xfect mESC Transfection reagent Clontech Laboratories
(Mountain View, USA)
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2.1.4 Antibodies
2.1.4.1 Primary antibodies
Target protein Host species Application Supplier
CD90.2-FITC mouse FACS (0.25 µg/
1x106 cells)
BioLegend
Actin rabbit WB (1:2000) Sigma-Aldrich
Ago2 (C34C6) rabbit WB (1:1000) Cell Signaling
CD133-PE (13A4) rat FACS (0.4 µg/
1x106 cells)
eBiosciences
CD15 (SSEA-1)
(MC-480) Alexa
Fluor 647
mouse FACS (0.2 µg/
1x106 cells)
BioLegend
c-Myc (9E10) mouse WB 1:400) Santa Cruz
Biotechnology
c-Myc (D84C12) rabbit WB 1:1000) Cell Signaling
Digoxigenin-AP
(Fab-fragments)
sheep ISH (5 U/ml) Roche
Flag mouse WB (1:1000) Sigma-Aldrich
GFP (B-2) mouse WB (1:1000),
IP (4 µg/mg)
Santa Cruz
Biotechnology
Hmga2 rabbit WB (1:1000) Cell Signaling
Lin28a/LIN28A
(D1A1A)
rabbit WB (1:1000),
FACS (1:200)
Cell Signaling
LIN28B human rabbit WB (1:1000) Cell Signaling
Lin28b mouse rabbit WB (1:1000) Cell Signaling
Oct4 rabbit WB (1:1000) Abcam
p21 (F-5) mouse WB (1:250) Santa Cruz
Biotechnology
p27 rabbit WB (1:1000) Cell Signaling
p53 rabbit WB (1:1000) Cell Signaling
PABP (H-300) rabbit WB (1:400) Santa Cruz
Biotechnology
Plexin B2 PE (3E7) armenian hamster FACS (0.8 µg/
1x106 cells)
Novus Biologicals
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Target protein Host species Application Supplier
Sall4 (6E3) mouse WB (1:500) Sigma-Aldrich
Sox2 mouse WB (1:500) R&D Systems
Trim71 sheep WB (1:1000) R&D Systems
Trim71 rabbit WB (1:1000) Sigma-Aldrich
Tubulin mouse WB (1:1000) Sigma-Aldrich
Vasa (N-14) goat WB (1:400) Santa Cruz
Biotechnology
2.1.4.2 Secondary antibodies
Target species Modification Host
species
Application Supplier
α-mouse HRP goat WB (1:5000) Santa Cruz
α-rabbit HRP goat WB (1:5000) Santa Cruz
α-rat HRP goat WB (1:5000) Santa Cruz
α-goat HRP donkey WB (1:5000) Santa Cruz
α-sheep HRP donkey WB (1:5000) Santa Cruz
α-mouse Alexa-Fluor 647 goat IF (1:400) Jackson
ImmunoResearch
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2.2 Methods
2.2.1 Animal experiment techniques
2.2.1.1 The generation of a new conditional Trim71 targeting allele
At the beginning of this study only two Trim71 transgenic mouse lines have been
described [131]. Both of them were based on gene trap insertions leading to a pre-
mature stop within the Trim71 gene. However, the lethal phenotype of the Trim71
full knockout is fatal for any investigations on the protein function that go beyond
embryogenesis. Therefore, the new conditional Trim71 mouse allele with the name
Trim71tm1695Arte was created. The genetic engineering was planned and realized by
the biotechnology company Taconic Artemis (Cologne).
The Trim71 gene has four exons gene which are located on Chromosome 9, about
15 kbp apart from the neighboring Ccr4 gene. According to the common databases,
the coding sequence is spread over all four exons and there are no indications for al-
ternative splicing products. For the targeting vector, the sequence of exon four from
the Trim71 genomic locus, coding for the largest part of the protein, was flanked by
unidirectional loxP sites (figure 1.5). Furthermore, two positive selection markers
were inserted at both sites of the homology region in order to increase the chances
for recombination events of both LoxP sites. These selection cassettes were flanked
by FRT and F3-sites. A translational stop cassette was located downstream of the
distal LoxP site and a mini-gene coding for thymidine kinase (Tk) was inserted in
the targeting vector to ensure that the insertion into the genome is primarily facili-
tated via homologous recombination.
A first heterozygous mouse breeding pair containing the targeted Trim71 allele
was crossed with a FLP-deleter strain to eliminate the neomycin and the puromycin
resistance cassettes [157]. Subsequently, a constitutive Trim71 knockout allele mouse
line was generated by crossing with PGK-Cre mice resulting in ubiquitious Cre acti-
vation [158]. Furthermore, in this study two additional mouse lines were generated
with the floxed Trim71 allele allowing for temporally and spatially defined deletion
of the gene. On the one hand, mice with the floxed allele were crossed with mice in
which Cre expression is regulated by the germ cell specific Nanos3 gene resulting
in a tissue specific knockout of Trim71 [159]. On the other hand, for the generation
of inducible MEFs, ESCs and RG-like cells where the mutation can be induced by
the application of the drug tamoxifen, conditional Trim71 mice were crossed with
Rosa26-CreERT2 mice [160]. All mice used for the experiments had the C57BL/6J
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5’ UTR 3’ UTRExon1 Exon2 Exon3 Exon4
Wildtype Trim71 allele
5’ UTR Exon1 Exon2 Exon3 3’ UTRExon4Neo Puro
Targeted allele
5’ UTR Exon1 Exon2 Exon3 3’ UTRExon4
Conditional knockout allele (after Flp recombination)
5’ UTR Exon1 Exon2 Exon3
Knockout allele
Exon3 3’ UTRExon4Neo Puro Tk
Targeting vector
LoxP site
FRT site F3 site
Genotyping primer
Exon Stop
Figure 2.1: Overview of the targeting strategy for the generation of a conditional Trim71
knockout allele in mice. The last of four exons was flanked by unidirectional LoxP sites
which allows for the excision of this exon after Cre activation.
genetic background. Breeding and maintaining of experimental animals was done
in the LIMES Genetic Resources Center (GRC) as well as in the animal facility of the
Department of Developmental Pathology in Bonn according to the German Animal
Welfare Act.
2.2.1.2 Genotyping of mice
For genotyping of the mice, genomic DNA was extracted from tail tip biopsies.
Therefore, the tail tips were cooked for 20 min at 95°C in 200 µl 50 mM NaOH
solution. Afterwards, the solution was neutralized again by the addition of 50 µl
1M Tris (pH 8). 2 µl of the supernatant was used for the genotyping PCR. For the
genotyping of cultured cells the DNA was extracted as described in section 2.2.2.7.
Genotyping PCRs were performed with the DreamTaq polymerase (Thermo Sci-
entific) according to the manufacturer’s recommendations using 15 pmol of each
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primer. For Trim71, Rosa26-Cre and Nanos3-Cre a three primer strategy was ap-
plied resulting in multiple possible bands (see below).
Trim71
Trim71-206 GAA AGG AGG CTA GCC AAA GG WT 242 pb
Trim71-207 ATG CTG TAC GGT AGG AGT CTT CC KO 322 bp
Trim71-209 CAC ACA AAA AAC CAA CAC ACA G FL 361 bp
Rosa26-Cre
Rosa26 for AAA GTC GCT CTG AGT TGT TAT C WT 603 bp
Rosa26 rev2 GGA GCG GGA GAA ATG GAT ATG TG 397 bp
Cre-rev CAT CAC TCG TTG CAT CGA CC
Nanos3-Cre
nos3-F1 CAG AGG CCA CTT GTG TAG CG WT 220 bp
nos3-R1 GGG ACT GAT AGA TGG CAC TG 270 bp
PGK-neo-R2a CAG AGG CCA CTT GTG TAG CG
Y-chromosome
Sry Mm for TGG GAC TGG TGA CAA TTG TC 406 bp
Sry Mm rev GAG TAC AGG TGT GCA GCT CT
X chromosome
Xist Mm for GCT TTG TTT CAC TTT CTC TGG TGC 566 bp
Xist Mm rev ATT CTG GAC CTA TTG GGA AGG G
2.2.1.3 Isolation of spermatogonia from mouse testes
Testes were isolated from male mice between 50-60 days of age. The cell isola-
tion protocol was modified from Ogawa et al. (1997)[161]. First, the tunica albug-
inea was removed from the testis, thereby exposing the seminiferous tubules. The
tubules of several organs were pooled and then incubated in approximately 10 vol-
umes of HBSS with calcium and magnesium containing 1 mg/ml collagenase (Type
IV) and DNAse I (200 to 500 µg/ml). The tissue was incubated at 37°C with gentle
agitation for 15 min or until the tubules separated. Dispersion of the tubules can
be hastened by careful dissection and spreading of the tubules. The testis tubules
were then washed three times in 10 volumes of HBSS, followed by incubation at
37°C for 5 min in HBSS containing 0.25% trypsin and 150 µg/ml DNAse I with
occasional gentle agitation. The trypsin treatment was terminated by adding 20%
volume of FBS. Following digestion, the cell suspension is filtered through a ny-
lon filter with 40 µm pore size to remove large clumps of cells. The filtrate was
centrifuged at 1000 rpm for 5 min at 4°C and the supernatant carefully removed
from the pellet. The cells were then resuspended in PBS for counting. Magnetic-
activated cell sorting (MACS) for CD90 positive cells was used to enrich SSCs from
the total cell population. Therefore, 1·106 cells were stained with 0.2 µg FITC anti-
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CD90.2 antibody (BioLegend) for 15 min at 4°C. The cells were then washed in
MACS-buffer and incubated in a 1:5 dilution of anti-FITC microbeads (Miltenyi)
and incubated for another 15 min at 4°C before final washing in MACS buffer. The
pellet was resuspended in 500 µl MACS buffer and loaded on AutoMACS device
with the program setting positive selection. The efficiency of enrichment was later
controlled by FACS.
MACS-buffer 2 mM EDTA
0.5% (v/v) FBS
ad 100% (v/v) PBS
2.2.1.4 PGC detection in embryos by alkaline phosphatase
Embryos were obtained from pregnant females 8.5 with the first day of vaginal
plug identification defined as 0.5 dpc. Embryos were dissected in PBS and the
upper part of the embryo was cut off and used for genotyping. The lower parts
were fixed in 4% PFA for 3 h, followed by washing in PBS. Embryos were placed
in 70% ethanol at 4°C for 1 hour, then washed once in PBS and stained with Fast
Red TR and α-naphthyl phosphate (Sigma) to detect alkaline phosphatase-positive
cells.
2.2.2 Molecular biological methods
2.2.2.1 PCR for the amplification of cDNAs
In order to clone new cDNAs in a eukaryotic expression vector, a PCR was set up
using sequence specific primers containing restriction sites for subsequent enzy-
matic digest. A mouse E19 embryonic library (Origene) and a homemade human
NK cell library were used as template DNA pool for mouse and human cDNAs,
respectively. The standard PCR reaction was set up as described below:
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Standard PCR reaction 10 µl 5x Phusion GC buffer
200 mM 10 mM dNTPs
15 pmol Forward primer
15 pmol Reverse primer
100 ng Template DNA
0-2 µl DMSO
1 unit Phusion DNA polymerase
ad 50 µl ddH2O
Cycle number Denature Anneal Extend Hold
1 98°C, 2 min
2-31 98°C, 30 s 55-62°C, 20 s 72°C, 30 s/kbp
32 72°C, 3 min 4°C
2.2.2.2 Primers for the amplification of cDNAs
TRIM constructs
Trim71 mm fo mlu GCG GGG ACG CGT ATG GCT TCG TTC CCG GAG ACC GAC TT
Trim71 mm re not GCG GGG GCG GCC GCT TAA GAT GAG GAT TCG ATT GTT GCC AAA
Trim71 C12L/C15A
mm/hs fo mlu
GCG GGG ACG CGT ATG GCT TCG TTC CCG GAG ACC GAC TTC CAG ATA
TTA CTG CTG GCC AAG GAG ATG TGC GGC T
Trim71 mmΔRBCC fo mlu GCG GGG ACG CGT TTC GGC AGT GAA GGT GAC GGG
Trim71 mmΔNHL re not GCG GGG GCG GCC GCT TTA GCT CTC CAG CTT GCT GAG ACT
Trim32 mm fo mlu GCG CCC ACG CGT ATG GCT GCG GCT GCA GCA GCT TCT
Trim32 mm re not GCG CCC GCG GCC GCT TAA GGG GTG GAA TAT CTT CTC
TRIM71 hs fo mlu TCC ACA TCT ACC GGG ATG GCT TCG TTC CCC GAG
TRIM71 hs rev CTC CTC CAC TCC CAA GGG AGA AGA CGA GGA TTC GAT TGT TGC
TRIM71 hsΔRBCC fo mlu GCG GGG GCG GCC GCT TTA GAT GTC TAG CGC TCT ACC CTC C
TRIM71 hsΔNHL re not TCC ACA TCT ACC GGG ATG AGC AGC GGG GCC TTT G
TRIM32 hs fo mlu GCG GGG ACG CGT ATG GCT GCA GCA GCA GCT TC
TRIM32 hs re not GCG GGG GCG GCC GC CTA TGG GGT GGA ATA TCT TCT CAG ATG G
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Lin28 constructs
Lin28a mm fo mlu GCG CCC ACG CGT ATG GGC TCG GTG TCC AAC CAG CAG
Lin28a mm re not GCG CCC GCG GCC GCT CAA TTC TGG GCT TCT GGG AGC AG
Lin28a mmΔCHCC re not GGG GCG GCG GCC GCT CCT TTG GAT CTT CGC TTC TGC
Lin28 mmΔCSD fo mlu GGG GCG ACG CGT GGT GGT GTG TTC TGT ATT GGG A
Lin28a mm H165A fo GCT ATG GTG GCC TCG TGT CCA C
Lin28a mm H165A re CGA GGC CAC CAT AGC GTT GAT GCT TTG GC
Lin28a mm H147A fo CGC TCA TGC CAA GGA ATG C
Lin28a mmH147A re GCA TTC CTT GGC ATG AGC GTC TAG CCC ACC GCA GTT GTA G
LIN28A hs fo mlu GCG GGG ACG CGT ATG GGC TCC GTG TCC AAC C
LIN28A hs re not GCG GGG GCG GCC GCT CAA TTC TGT GCC TCC GGG AG
LIN28B hs fo mlu GGG GCG ACG CGT ATG GCC GAA GGC GGG GCT AG
LIN28B hs re not GGG GCG GCG GCC GCT TAT GTC TTT TTC CTT TTT TGA ACT GAA GGC C
Luciferase constructs
Foxj1 mm fo xho GCG GGG CTC GAG AAG GTC AGG CCC CAC CCC ATC TCC
Foxj1 mm F1 xho GCG GGG CTC GAG CAT ATC CAA GCC CAG AAG ACT GG
Foxj1 mm F2 xho GCG GGG CTC GAG GCA CTC TGA GAG CTG AAG CCC
Foxj1 mm F3 xho GCG GGG CTC GAG GAT GAT AAC AAA TTA ATT CCC AGG AGG C
Foxj1 mm F4 xho GCG GGG CTC GAG CGA AAT GGT CTC TAA GCC CGC TAG
Foxj1 mm F5 xho GCG GGG CTC GAG GTG AAT GTA GTT ATA GCT AAG ACT TAA CTG GG
Foxj1 mm re not GCG GGG CGG CCG CCT TTA CAT GAA AAA GGT TAA ATT GCT CCA CG
Inhbb mm fo xho GCG GGG CTC GAG CAG AGG CAA CGG GGG CGG AGC
Inhbb mm re not GCG GGG CGG CCG CCC GTG GCA CTC CAT CTT TTA TTG TC
Mras mm fo xho GCG GGG CTC GAG CAG CCT GAA GCC CTG GGC ATA GC
Mras mm re not GCG GGG CGG CCG CCT CTG ATT GTT TCT TTA TTA ATA AGT AGA GAT ACA C
Nanos3 mm fo xho GCG GGG CTC GAG GAG CTT GGA GTG GGG AGG AC
Nanos3 mm re not GCG GGG CGG CCG CCC ACT CCT TAG CAT TTA TTG GAT GTT G
Obscn mm fo xho GCG GGG CTC GAG TGC CAC ACA TTG GAG ATA AGG GTA AG
Obscn mm re not GCG GGG CGG CCG CGA GGG TTT GGG ACT TGA TTT ATT GTT CTC ATC
Pou5f1 mm fo xho GCG GGG CTC GAG CTG AGG CAC CAG CCC TCC
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Pou5f1 mm re not GCG GGG CGG CCG CAG CTA TCT ACT GTG TGT CCC AGT C
Prom1 mm fo xho GCG GGG CTC GAG CAA CTG GAG TTG AAG CTG CTT GAA CAA C
Prom1 mm re not GCG GGG CGG CCG CGT TCA TTC ATG CTT TAT TTT AAA TCT CAA CAT CAG G
Plxnb2 mm fo xho GCG GGG CTC GAG CCG TCA ATG CCG CCT CAG GAT G
Plxnb2 mm F1 xho GCG GGG CTC GAG CCT CTT GTA GAC TGT AGC GTC TTT CTC
Plxnb2 mm F2 xho GCG GGG CTC GAG GGC GGT GGA GGC ATG GCC
Plxnb2 mm F3 xho GCG GGG CTC GAG CAA TGC CTT CCT GAC CTC ACC
Plxnb2 mm F4 xho GCG GGG CTC GAG AGG TCC TTG TCT CAG CTG TTA AAC
Plxnb2 mm re not GCG GGG CGG CCG CCC AGA GAG TGA AAA AGA CAA CTG TAT TG
Plxnb2 mm F4a xho CCT GAC TCG AGA CCC AGA AAA CTG AGG TCC TTG TCT CAG CT
Plxnb2 mm F4a not GGA CTC GCC GGC GCC TGT TTA ACA GCT GAG ACA AGG ACC TCA G
Plxnb2 mm F4b xho CCT GAC TCG AGC TGT CCT GGA GGC CCT GCC TGG ATC TGG GG
Plxnb2 mm F4b not GGA CTC GCC GGC GGC TCC AGC ACC CCC AGA TCC AGG CAG GGC C
Plxnb2 mm F4c xho CCT GAC TCG AGA GCA TCT CCC CCC AGG ACC ACC CAC CCT TT
Plxnb2 mm F4c not GGA CTC GCC GGC GCG ATT TAC AAA AAG GGT GGG TGG TCC TGGG
Plxnb2 mm F4d xho CCT GAC TCG AGT GAT TGT AAA TCC AAT ACA GTT GTC TTT TT
Plxnb2 mm F4d not GGA CTC GCC GGC GCC AGA GAG TGA AAA AGA CAA CTG TAT TGG A
Tcf15 mm fo xho GCG GGG CTC GAG ACC TGG ATC CCT GGT TTT CTC C
Tcf15 mm re not GCG GGG CGG CCG CAT ACC TTT ATT TTG ACC CCC TCC C
Trim54 mm fo xho GCG GGG CTC GAG CCC GAC TCT GAT CCA GAG CGC ACA C
Trim54 mm re not GCG GGG CGG CCG CGG GAC ACT TGA GTC CTT TAT TGA GAA C
2.2.2.3 Enzymatic DNA digest and ligation
The PCR products were cleaned by phenol extraction and then precipitated using
LiCl and 96% ethanol. The pellet was washed once and air-dried before resuspend-
ing in ddH2O. The extracted DNA was then subjected to enzymatic digest with the
appropriate buffer conditions (enzymes and buffers from Thermo Scientific). The
restriction digest was incubated for 2 h at 37°C. Vector backbones were addition-
ally treated with alkaline phosphatase for 10 min. Then, DNA loading buffer was
added and the whole reaction was loaded on an agarose gel and run to separate
the digestion products. The DNA gel bands of interest were cut out using a scalpel.
The DNA was extracted from the gel using the NucleoSpin Gel and PCR Clean-up
kit (Macherey-Nagel) according to the manufacturer’s instructions. The concentra-
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tions of the gel-purified DNA were measured and the ligation set up with a 1:3
molar ratio of vector to insert DNA in a final volume of 20 µl containing 2 µl ligase
buffer and 0.5 units T4 DNA ligase. The ligation reaction was incubated either for
2 h at RT or at 16°C overnight.
2.2.2.4 Transformation of chemically competent E. coli bacteria
For transformation of plasmid DNA chemically competent E. coli bacteria of the
strains DH5α, MC1061 and Stbl3 were used. The bacteria were thawed on ice and
60 µl of the cell suspension were mixed with either 7 µl of the ligation reaction (see
above) or 50 ng of plasmid DNA for retransformation. After 10 min incubation on
ice, the caps were placed in a 42°C water bath for 45 s and subsequently put back
on ice 1 min. 1ml LB0 medium was added to the bacteria which were then incu-
bated on a shaker at 37°C for another 45 min. The cells were briefly centrifuged
and resuspended in 150 µl LB0 before plating on LB agar plates containing a se-
lective antibiotic corresponding to the resistance cassette on the plasmid (30 µg/ml
kanamycin or 100 µg/ml ampicillin). The plated bacteria were incubated overnight
at 37°C.
2.2.2.5 Mini-preparation of plasmid DNA
After an overnight culture at 37°C, the colonies grown on the plate were individ-
ually picked using a pipet tip for inoculation of mini-preparation cultures. Picked
bacteria were cultured in 4 ml LB medium with antibiotics overnight. The bacteria
were spun down by centrifugation for 2 min at 5000 rpm. The pellet was resus-
pended in 200 μl solution I. 400 μl solution II was added to facilitate bacterial lysis
and the solution was mixed by inversion of the caps and incubated for 3 min at
RT. For neutralization, 300 μl solution III was added resulting in precipitation of
bacterial proteins and genomic DNA. The crude precipitate was separated by cen-
trifugation for 12 min at 13,000 rpm. The supernatant was transferred to a new cap
and 400 μl phenol-chloroform (1:1) was added and the cap was shortly vortexed.
After centrifugation for 5 min at 13,000 rpm, the upper aqueous phase containing
the plasmid DNA was transferred to a new cap and 0.6 ml 2-propanol was added
for DNA precipitation. The DNA was spun down for 12 min at 13,000 rpm and the
pellet was washed once with 70% ethanol. The DNA was dried at 37°C and then
resuspended in 50 μl water containing 5 μg RNAseA.
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Solution I (pH 8) Solution II (pH 13) Solution III (pH 5)
10 mM EDTA 0.2 M NaOH 3 M KAc
25 mM Tris 1% SDS (w/v) 2 M HAc
50 mM Glucose
2.2.2.6 Maxi-preparation of plasmid DNA
For maxi-preparations 1 l of an overnight bacterial culture was centrifuged for
20 min at 4,200 rpm. The resulting pellet was thoroughly resuspended in 40 ml
solution I (see table in 2.2.2.5). Then, 80 ml of solution II was added to enable
bacterial lysis. In order to neutralize the suspension another 40 ml of solution III
was carefully mixed in resulting in precipitation of cellular material including ge-
nomic DNA. The mixture was spun down for 20 at 4,200 rpm and the supernatant
transferred into a new vessel together with 100 ml of 2-propanol. The solutions
were mixed and the plasmid-containing precipitate was spun down for 12 min at
5,000 rpm and the supernatant decanted. For further purification, the crude DNA
was subjected to caesium chloride gradient-centrifugation according to Glisin et al.
(1974) [162]. In short, the pellet was resuspended again in 3.5 ml solution I, then
5.5 g CsCl and 0.5 ml EtBr (2% solution) was added. The clear supernatant was
filled in ultra-centrifugation tubes and sealed. the samples were centrifuged for 4
h at 80,000 rpm in which time a continuous gradient of salt density is build up.
the plasmid DNA accumulates in the specific isopycnic layer. After centrifugation
the visible EtBr-containing DNA layer can be collected using a syringe. The EtBr is
subsequently removed by several washing steps with butanol. Finally, the plasmid-
DNA was precipitated by adding 1 volume of sodium acetate (1M) and 3 volumes
of 96% ethanol. The precipitate was pelleted by centrifugation (5 min; 5,000 rpm)
and washed once with 70% ethanol before drying. The DNA was solved in suf-
ficient ultra-pure water and the concentration was measured using a spectropho-
tometer.
2.2.2.7 Extraction of genomic DNA from cells
For preparation of genomic DNA, the cell pellet was dissolved in 200 µl of genomic
DNA cell lysis buffer to which proteinase K was freshly added. The samples were
incubated overnight at 56°C under constant agitation. Then 600 µl ethanol was
added resulting in the precipitation of genomic DNA. The DNA was centrifuged
and the pellet washed once with 75% ethanol. The pellet was dried and resus-
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pended in 50 µl ddH2O and further on stored at 4°C. The concentration of the DNA
was measured using a spectrophotometer and about 100 ng DNA was used per
PCR reaction (e.g. for genotyping). For large scale genomic DNA preparation in
96 well plates, cells were directly lysed in the plate with 50 µl lysis buffer applied
per well. Accordingly, 100 µl ethanol was added for DNA precipitation and the
supernatant was carefully tilted instead of centrifugation.
genomic DNA cell lysis buffer 10 mM NaCl
pH 7.5 10 mM Tris
10 mM EDTA
0.5% Sarkosyl
80 units/ml Proteinase K (freshly added)
2.2.2.8 RNA isolation
For RNA isolation from cells and tissues TRIzol reagent (Life Technologies) was
used according to the manufacturer’s instructions. In short, 1·105-1·107 cells or 5-20
mg of ground tissue were resuspended in 1 ml of TRIzol reagent and either pre-
pared directly or stored at -80°C for later preparation. 0.2 ml of chloroform was
added and the sample thoroughly vortexed. To support phase separation, the sam-
ples were centrifuged at 10,000 rpm for 8 min at 4°C. The upper aqueous phase was
transferred to a new cap and 0.5 ml 2-propanol was added. The RNA was precipi-
tated by centrifugation at 13,000 rpm for 12 min at 4°C. The pellet was washed once
with 70% ethanol and air-dried before resuspending in ddH2O containing DNAseI
(1 unit/25 µl). The DNA was digested for 30 min at 37°C and the enzyme then
heat-inactivated for 30 min at 75°C.
2.2.2.9 cDNA synthesis for real-time PCR
The concentration of the RNA solution was measured using a spectrophotometer.
Depending on the downstream application different protocols for reverse transcrip-
tion were applied according to the manufacturer’s recommendations.
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Reverse
Transcription
Application Input Method Protocol
High-Capacity cDNA
Reverse Transcription
Kit (Applied
Biosystems)
mRNA and
pri-miRNA
quantification
500 ng
total
RNA
random
hexamer
primers
37°C, 2 h
85°C, 5 min
TaqMan miRNA Assays
plus TaqMan
MicroRNA Reverse
Transcription Kit
(Applied Biosystems)
mature
miRNAs and
non-coding
RNAs
100 ng
total
RNA
sequence-
specific
primers
16°C, 30 min
42°C, 30 min
85°C, 5 min
miScript II RT kit
(Quiagen)
mature and
pre-miRNAs
200 ng
total
RNA
oligo-ligation to
all RNAs
37°C, 60 min
95°C, 5 min
2.2.2.10 Real-time qPCR
Two different 2x master mixes were used for the real-time analyses. On the one
hand, gene specific TaqMan assays (Applied Biosystems) were used in combina-
tion with the Hot Start Mix Real-Time (Peqlab). This method works with a fluores-
cently labeled DNA probe which is binding to the amplified PCR product. With ev-
ery amplification step more dye-molecules are degraded leading to increased light
emission. The system has the advantage of high specificity since the light emission
requires concurrent binding of both primers and the probe. For some experiments
however, conventional primers in combination with a SYBR-green containing real
time master-mix were used. SYBR-green induced fluorescence will occur as long
as double stranded DNA is generated and does not require sequence specificity.
Therefore, the PCR products were afterwards checked by gel electrophoresis and
sequencing. For both applications the following PCR program was used:
Cycle number Denature Anneal Extend measure
1 95°C, 3 min
2-46 95°C, 10 s 58°C, 30 s 72°C, 30 s x
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2.2.2.11 Preparation of RNA probes for in situ hybridization
A part of the murine Trim71 cDNA referring to nt 1999-2970 (NM_001042503.2)
was synthesized by PCR using a stage E19 whole embryo cDNA library (Origene).
After PCR amplification, the cDNA fragment was cloned into the pGEM-T cloning
vector (Promega). This plasmid was linearized with a restriction enzyme and used
as a template for in vitro transcription. For in vitro transcription the linearized tem-
plate DNA was incubated together with DIG-RNA Labeling Mix (Roche) and the
Riboprobe® Combination System-SP6/T7 RNA Polymerase (Promega) according
to the manufacturer’s recommendations. The remaining plasmid DNA was di-
gested with 1U DNAseI and the integrity of the RNA was controlled on an agarose
gel.
2.2.2.12 Whole mount in situ hybridization
Whole-mount in situ hybridization procedures were performed according to Wilkin-
son (1992) [163] with some modifications. Briefly, after rehydration with a grad-
uated MetOH/PBT series, embryos were bleached with 6% H2O2 in PBT for 15
min and treated with 10 μg/ml Protease K (Roche) for 8-15 min at RT depend-
ing on the stage, stopped with 0.2% glycine and the embryos were then re-fixed
with 4% PFA, 0.2% glutaraldehyde in PBT for 20 min at RT. Pre- hybridization
(in 5× SSC (pH 4.5), 50% formamide, 1% SDS, 50 μg/ml yeast tRNA (Roche), and
0.5 μg/ml heparin (Sigma-Aldrich)) was performed at 67 °C for 1 h, then a DIG-
RNA probe (about 500 ng/ml) was added and hybridized for over 14 h at 70 °C.
Subsequently, embryos were subjected to a series of post-hybridization washes in
wash buffers containing formamide, SSC and SDS. After blocking with 10% sheep
serum (Jackson ImmunoResearch) in TBS containing 0.1% Tween 20 (TBST) for 1
h at RT, embryos were incubated overnight with anti-DIG-AP Fab fragments anti-
body (Roche) and 1% sheep serum in TBST at 4 °C. After a series of washes with
TBST, embryos were equilibrated with NTMT (5 M NaCl, 1 M Tris-HCl (pH 9.5),
1 M MgCl2, and 0.1% Tween 20). Color reaction was performed at 4 °C or RT
with nitro blue tetrazolium/5-bromo-4-chloro-3- indolyl phosphate (NBT/BCIP)
(Roche), then embryos were stored in 4% PFA in PBT at 4 ° C. Stained samples
were photographed with a SZX10 microscope and Colorview Soft Imaging system
(Olympus).
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2.2.3 The generation of homozygous Lin28a knockout mESC lines
In the course of the studies, Lin28a knockout mESCs were generated in the Trim71fl/fl
#1 cell line. This would in principle allow the investigation of all combinations of
Trim71 and Lin28a knockouts in the same cellular background. Whereas most con-
ventional knockout cell lines are generated from homozygous mice we wanted to
generate a homozygous Lin28a knockout directly in our in vitro cell system. How-
ever, using a targeting vector for homologous recombination does not result in ho-
mozygously targeted clone because the chances for such a event are very low. Re-
cent advances in the field of reverse genetic engineering has offered new tools for
the generation of genetically modified organisms. Both, zinc finger nucleases and
Transcription activator-like effectors nucleases (TALENs) enable costum-designed
DNA binding and restriction. For this approach, the TALENs are co-transfected
with a partially homologous targeting plasmid which will be used during DNA re-
pair by the cell intrinsic repair machinery.For the construction of the Lin28a knock-
out, a strategy was chosen that would insert a targeting cassette with a G-418 cas-
sette with a transcriptional stop in close proximity of the translational start site of
Lin28a. Due to this, the TALEN technique was combined with a Lin28a targeting
vector which will allow the pre-selection with an antibiotic and thus increase the
chance to yield homozygously targeted clones. The following sections will describe
the specificities of the generation of the Lin28a KO cell lines, especially the cloning
of the TALENs and the targeting construct. Both, the targeting construct and the
TALENs require the assembly of several DNA fragments within one vector. There-
fore, ligation independent cloning (LIC) techniques were applied to generate the
constructs. LIC does not depend on the usage of unique restriction sites and is thus
less limited in its application. Moreover, several DNA fragments can be assem-
bled simultaneously. For the TALEN cloning the Golden Gate Assembly was used,
whereas for the targeting vector the commercial In-Fusion system was used.
2.2.3.1 Construction of Lin28a-specific TALENs by hierarchical “Golden Gate
Assembly”
The deciphering of the TALE code has enabled the generation of custom-designed
binding domains[164]. TALEs are DNA bacterial binding proteins from Xanthomonas
sp. consisting of 34 amino acid long tandem repeat modules which are binding to
a specific DNA nucleotide[165, 166]. The repeats are highly conserved differing
only in two amino acid positions, called the repeat variable diresidues (RVD), that
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specify the targeted nucleotide. Via stringing together several monomers in a row,
a target sequence from 5’ to 3’ can be defined (figure 2.2a). Linked to other effector
domains TALEs can guide transcription activators or nucleases to a specific loca-
tion in the genome[167, 168, 169]. For example, by pairwise binding of two TALE
binding domains fused to the unspecific FokI endonuclease catalytic domain (TAL-
ENs) a molecular scissor can be build, generating a double strand break at a desired
location in the genome (figure 2.2b). The error-prone DNA repair will eventually
lead to insertion or deletions (indels) at the site of the strand break. If the targeted
site is located within the coding region, there is a high chance to generate a frame
sift mutation within the translational code. This will result in a premature stop of
the translation. However, TALENs can also be used to facilitate the integration of
a targeting construct. This method has the advantage that the mutation is clearly
defined and moreover it allows the insertion of an antibiotic resistance cassette.
Two independent TALEN pairs were cloned, one of them cutting at 8 bp up-
stream, the other one 26 bp downstream of the start codon.
TALENs 1+2: Mus musculus lin-28 homolog A (C. elegans) (Lin28a), mRNA:
ref|NM_145833.1|
43 T GGGGCCCGGGGCCACGGGC tcagcagacgaccatg GGCTCGGTGTCCAACCAGC A 98
TALEN 1 NH NH NH NH HD HD HD NH NH NH NH HD HD NI HD NH NH NH HD
TALEN 2 NH HD NG NH NH NG NG NH NH NI HD NI HD HD NH NI NH HD HD
TALENs 3+4: Mouse DNA sequence from clone RP23-314D24 on chromosome 4,
complete sequence
39499 T GGGCTCGGTGTCCAACCAG cagtttgcaggttcg AGCTTGCGATTCAGCGGGC A 39445
TALEN 3 NH NH NH HD NG HC NH NH NG NH NG HD HD NI NI HD HD NI NH
TALEN 4 NH HD HD HD NH HD NG NH NI NI NG HD NH HD NI NI NH HD NG
For the cloning of the TALEN vectors, a hierarchical ligation strategy as described
by Sanjana et al. [170]was used. First, the TALE monomers were PCR-amplified
with primers (please see ref. [170] for primer sequences) that will later on de-
fine the position of the TALE within the TALEN. For this step the primers were
used as described in the protocol and the PCR was performed on TALE plasmids
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Figure 2.2: Constructing customized TALENs for genome engineering (a) The modular
structure of the TALENs can be designed for binding a specific target sequence. Each
monomer comprises 34 amino acids of which position 12 and 13, termed the repeat vari-
able diresidues (RVD), specifies the bound nucleotide (NG=T, NI=A, NH=G, HD=C). In
addition, a nuclear localization signal (NLS) and a FokI endonuclease catalytic domain are
fused the N-terminus and C-terminus, respectively. (b) Pairwise binding of two TALENs
at a target sequence will lead to a double strand break. Error-prone re-ligation of the two
end will lead to indel mutations. However, co-transfection with a partially homologous
donor DNA can be used to insert larger DNA fragments into the endogenous DNA locus
by homologous recombination.
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obtained as a gift from Feng Zheng (Addgene plasmids #32180, #32181, #32183,
#375271) In a first round, a combinatorial DNA assembly is used to generate 3 hex-
amers of TALE monomers (see figure 2.3). In this so called Golden Gate assembly
PCR-products from a TALE monomer library are combined in a restriction ligation
reaction. Thereby, the primers used for monomer PCRs code for the position of
the different monomers within the hexamer, since they harbor restriction sites for
type IIS endonucleases that will generate unique overhangs used for sequential lig-
ation. Moreover, the last hexamer will ligate to the first one resulting in a circular
DNA product that is protected against the following DNA digest. This reduces the
occurrences of not completely assembled hexamers which can be isolated by gel
extraction.
Golden Gate reaction I 1 µl Tango buffer (10x)
7.5 units Esp3I (BsmBI)
1 mM DTT
750 units T7 ligase
1 mM ATP
15-18 ng 6 different monomer PCR products (each)
ad 10 µl ddH2O
Cycle number Digest Ligate hold
1-15 37°C, 5 min 20°C, 5 min 4°C
DNA digest 1 µl PlasmidSafe reaction buffer (10x)
10 units PlasmidSafe DNAse
1 mM ATP
7 µl Golden Gate reaction
ad 10 µl ddH2O
The DNA digest was performed for 30 min at 37°C and the enzyme was subse-
quently heat-inactivated at 70°C for 30 min. In the following, the hexamers were
again amplified by PCR.
1Please note that instead of the originally described NN-monomer binding to the nucleotides gua-
nine and adenine, the improved NH-variant coding specifically for guanine was used.
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Figure 2.3: Scheme showing the hierarchical assembly of TALEN monomers by ligation-
independent cloning.
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Hexamer amplification 10 µl Herculase II reaction buffer (5x)
1 mM dNTPs (each)
200 mM Hex-F and Hex-R primers (each)
1 µl PlasmidSafe reaction
0.5 µl Herculase II Fusion DNA polymerase
ad 50 µl ddH2O
Cycle number Denature Anneal Extend hold
1 95°C, 2 min
2-36 95°C, 20 s 60°C, 20 s 72°C, 30 s
37 72°C, 3 min 4°C
The PCR reactions were completely loaded on a 2% gel and the corresponding
band of 700 bps is cut out using a scalpel. The DNA was extracted using the Nucle-
oSpin Gel and PCR Clean-up kit (Macherey-Nagel) according to the manufacturer’s
instructions. The concentration of the DNA was measured with a spectrophotome-
ter.
Golden Gate reaction II 1 µl NEBuffer 4 (10x)
15 units BsaI-HF
1 µml BSA (10x)
1 mM ATP
750 units T7 ligase
100 ng TALEN backbone 2
20 ng 3 different hexamers (each)3
ad 10 µl ddH2O
Cycle number Digest Ligate Inactivate Hold
1-20 37°C, 5 min 20°C, 5 min 80°C, 20 min 4°C
. .
The product was used to transform Stbl3 E.coli bacteria according to the protocol
described in section 2.2.2.4. The transformed bacteria were plated in three dilu-
tions on LB plates with ampicillin. Single clones were picked and the plasmid was
2TALEN backbone vectors coding for the last bound nucleotide were a gift from Feng Zhang (Ad-
dgene plasmids 32190, 32191, 32192)
3replace with water for control reaction
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isolated (see section 2.2.2.5) in order to preselect clones by enzymatic test digest
with AfeI (3.3, 2.8, 2.1 and 0.2 kbp). Clones with the expected digestion pattern
were sent for sequencing with the primers TALE-seq F1/F2/R1. Correct clones
were further expanded and DNA was extracted by maxi-preparation as described
insection 2.2.2.6.
2.2.3.2 Testing of TALENs with the T7 endonuclease I assay in NIH3T3 cells
In order to evaluate the ability of the TALENs to bind and cut the Lin28a locus in
cells a test performed. Therefore, NIH3T3 fibroblasts were seeded in a 6 well and
transfected with the TALEN vectors or a control plasmid using Lipofectamine2000
according to the manufacturer’s recommendations. After 24 hours the cells were
harvested and genomic DNA was extracted (section 2.2.2.7). The genomic region
flanking the targeted Lin28a locus was amplified generating a product of about
650 bp (seesection 2.2.2.1). The PCR-products were purified by spin columns and
the concentration was measured to set up the following hybridization reaction. 10
units of T7 endonuclease was added to the hybridized DNA and the reaction was
further incubated for 1.5 h at 37°C. The samples were loaded on a 2% agarose gel
for analysis. Since the T7 endonuclease recognizes non-perfectly matched DNA,
the restriction will take place when indel (insertion/deletion) mutations have oc-
curred. Since the frequency of those kind of mutations should dramatically increase
after several rounds of DNA breakage induced by TALENs, the appearance of two
defined cleavage products is expected. Indeed, both TALEN pairs designed for
Lin28a targeting resulted in indel mutations at the endogenous locus (2.4), sug-
gesting that the TALENs can effectively bind and cut their target sequence in cells.
Although both TALEN pairs showed similar activity in the T7 endonuclease assay,
the derivation of Lin28a KO mESC was subsequently only tried with the TALEN
pair 1+2 (see results figure 3.33).
Hybridization reaction 3 µl NEBuffer 2 (10x)
750 ng PCR product
ad 30 µl ddH2O
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Figure 2.4: The T7 endonuclease assay for the assessment of the restriction efficiency
of TALENs (a) Scheme showing the principle of this assay. Cells acquire indel mutations
after transfection with TALENs. The genomic DNA is amplified, denatured and hybridized
again. Hetero-duplex sites caused by the pairing of a WT strand with a DNA that acquired
an indel mutation are recognized and cut by the T7 endonuclease. The image was retrieved
from www.neb.com (b) T7 assay in NIH3T3 cells for 2 different Lin28a targeting TALEN pairs
24 hours after transfection. The agarose gel shows that restriction fragments of the expected
size were generated using both TALEN pairs.
Cycle number Annealing ΔT/s Hold
1 95°C, 3 min 3°C
2 85°C, 1 min 0.1°C
3 65°C, 1 min 0.1°C
4 55°C, 1 min 0.1°C
5 45°C, 1 min 0.1°C
6 35°C, 1 min 0.1°C
7 25°C, 1 min 2°C 8°C
2.2.3.3 Cloning of the Lin28a targeting construct
The targeting construct was generated for the insertion of a partially homologous
DNA fragment at the site of TALEN-mediated DNA restriction. Therefore, two ho-
mology arms flanking the TALEN targeted site were amplified from genomic DNA
45
2.2. Methods
of mESCs. Both homology arms were designed to cover together about 5000 bp of
the endogenous Lin28a locus, however one arm was significantly shorter than the
other (1,500 vs. 3,500 bp) in order to facilitate the subsequent PCR screening which
has to span at least one homology region (see figure 2.5). Cloning of large DNA
fragments by classical step by step restriction and ligation reaction is very chal-
lenging due to the need of unique restriction sites and also very time consuming.
Instead, ligation independent cloning (LIC) was used to assemble the four compo-
nents of the targeting vector (5’ and 3’ homology region, NeoR-cassette and vec-
tor backbone) in a single reaction without restriction endonucleases [171]. In this
method, about 14 nucleotide long homologous overlapping DNA sequences were
introduced into the PCR fragments via the primers. A exonuclease then chewed
back one strand of the DNA generating compatible overhangs that will allow di-
rectional assembly of several DNA pieces simultaneously. The chew back and as-
sembly was performed using the In-Fusion HD Cloning Kit from Clontech. After
assembly, the reaction was not ligated but the nicked plasmid DNA was directly
used to transform competent bacteria which will repair the DNA and amplify the
plasmid.
5’ HR for GGT ATC GAT AAG CTT GCT AGC GCT GAT GCC CCT GAA AGC AGG
5’ HR rev CGT TTG TTC GGA TCC GGT CGT CTG CTG AGC CCG TGG
NeoR for GGA TCC GAA CAA ACG ACC C
NeoR rev AAG CTT ACT TAC CAT GTC AGA TCC
3’ HR for ATG GTA AGT AAG CTT GTT CGA GCT TGC GAT TCA GC
3’ HR rev TAG TGG ATC CCC CGG TGA TTC TGC CTC CCA AGG GAC ATT T
46
2.2. Methods
Neo
R 
Stop
CMV-promoter
3’ homology5’ homology
HSV TK-promoter
DTA
AmpR
11,559 bp
2,472 bp
Stop
CMV-promoter
NeoR 
XmaIHindIII
AmpR
HSV TK-promoter
DTA
+
1,543 bp
5’ homology
3,524 bp
3’ homology
+
4,100 bp
In-Fusion reaction
NeoR for NeoR rev
5’ HR for 5’ HR rev 3’ HR for 3’ HR rev
HindIII / XbaI digest
Figure 2.5: Cloning strategy for the Lin28a targeting construct. The linearized vector is
combined in a so called In-Fusion reaction with the PCR-amplified 5’ and 3’ homology
region from the Lin28a endogenous locus and a neomycin resistance cassette harboring an
additional SV40 poly-A site. The partial overlaps of the fragments were introduced by the
primers and guided the directionality of the ligation.
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Figure 2.6: Workflow for the high-throughput sequencing of mRNAs and miRNAs.
2.2.4 Analysis of mRNA and miRNA expression changes in mESCs by
high-throughput sequencing
For a broader analysis of changes on RNA level the different mESC lines were
subjected to RNA and miRNA high-throughput sequencing (see figure 2.6). The
technical execution as well as the bioinformatic data analysis was performed in
collaboration with the lab of Prof. Joachim L. Schultze (Department for Genomics
& Immunoregulation, LIMES institute, Bonn). An expanded analysis of the com-
parison of Trim71fl/fl and Trim71-/- mESC data sets was included in the publication
from Mitschka et al., 2015 [172]
2.2.4.1 Generation of cDNA libraries for high-throughput sequencing
TRIzol extracted total RNA from different mESC genotypes was converted into
double stranded cDNA for subsequent high throughput sequencing the Illumina
TruSeq RNA Sample Preparation Kit v2 was used according to the manufacturer’s
recommendations. Therefore, mRNA was purified from 100 ng total RNA by poly-
T oligo coated magnetic beads with subsequent fragmentation using divalent cations
under elevated temperature. The first cDNA strand was generated with annealing
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of random hexamer primer in a SuperScriptII- guided RT reaction. Then, the sec-
ond strand was complemented using DNA Polymerase I and RNase H.
The remaining overhangs were enzymatically removed and the 3’ends of the
DNA adenylated to enable ligation of the Illumina PE adapter oligonucleotides.
DNA fragments with ligated adapter molecules were selectively enriched and am-
plified using Illumina PCR primer PE1.0 and PE2.0 in a 15 cycle PCR reaction.
cDNA fragments with about 200 bp in length were purified using SPRIBeads (Beck-
man-Coulter). Size-distribution of cDNA libraries was measured using the Agi-
lent high sensitivity DNA assay on a Bioanalyzer 2100 system (Agilent). cDNA
libraries were quantified using KAPA Library Quantification Kits (Kapa Biosys-
tems). After cluster generation on a cBot, a 200 bp paired-end run was performed
on a HiSeq1500.
2.2.4.2 RNA-seq preprocessing
After base calling and de-multipexing using CASAVA version 1.8 the 100 bp paired-
end reads were aligned to the murine reference genome mm10 from UCSC by
TopHat2 version v2.0.11 and Bowtie2 version 2.2.1 using the default parameters.
This annotation included 32600 unique transcript entries with genomic coordi-
nates. After mapping of the reads to the genome, we imported the data into Partek
Genomics Suite V6.6 (PGS) to calculate the number of reads mapped to each tran-
script against the RefSeq mm10 annotation download on April 2014. These raw
read counts were used as input to DESeq2 for calculation of normalized signal for
each transcript [173] using the default parameters. Please note that, although all
four analyzed mESC genotypes were sequenced simultaneously, in the subsequent
data analyses two normalizations were done: one including all four genotypes
and another one only comparing Trim71fl/fl with Trim71-/- mESC. This can lead
to slightly different values in the expression count of genes. After DESeq2 normal-
ization, the normalized read counts were imported back into PGS floored by setting
all read counts to at least a read count of 1 after the batch-correction. Subsequent
to flooring, all transcripts having a maximum over all group means lower than 10
were removed.
After dismissing the low expressed transcripts, the data with the normaliza-
tion for the Trim71fl/fl and Trim71-/- mESC samples comprised 13,558 transcripts.
For this analysis RNA-seq data can be accessed under GSE62398. On the other
hand, expression data including all four genotypes yielded significant expression
of 13,806 transcripts and data are not yet publicly available.
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2.2.4.3 miRNA sequencing
Sequencing of miRNAs was done performed to the manufacturer’s recommenda-
tions. In brief, 5x10 6 cells were harvested and total RNA including small RNAs
was isolated. Small RNA libraries were generated from 500 ng total RNA with
the NEBNext Multiplex Small RNA Library Prep Set (New England Biolabs). Af-
ter successful ligation of the 3’ adaptor to RNA molecules, the reverse transcrip-
tion primer was added before ligation of the 5’ adapter. Next, RNA was reverse
- transcribed using ProtoScript II Reverse Transcriptase. cDNA was amplified by
15 PCR cycles with high - fidelity LongAmp Taq 2X Master Mix and the respective
index primer. The indexed libraries with the size of miRNAs plus ligated adapters
were quantified on the Roche LightCycler 480 II qPCR instrument using the KAPA
Library Quantification Kit in triplicates, according to the manufacture’s protocol
(Kapa Biosystems, Woburn, MA, USA). After pooling of equimolar ratios of in-
dexed libraries these were purified on a pre-cast 6% Tris/Borate/EDTA polyacry-
lamide electrophoresis gel (Invitrogen). Generation of clonal clusters from single
molecules of the cDNA library was done with the TruSeq Cluster Kit (Illumina) on
a CBot station. Sequencing by synthesis was performed by using the TruSeq SBS
Kit on a HiSeq 1500 system (Illumina). Sequencing reads were retrieved as FASTQ
files.
2.2.4.4 miRNA preprocessing
After base calling, de-multiplexing and trimming using CASAVA version 1.8 and
FLICKR the 50 bp reads were aligned to the murine reference genome mm10 from
mirBase v20 87 by Bowtie2 version 2.2.1 using the default parameters. SAMtools
version 0.1.18 88 was then used to convert the SAM files into smaller BAM files. T
he annotation included 24 . 521 unique transcript entries with genomic coordinates.
After mapping of the reads to the genome, we imported them into Partek Genomics
Suite V6.6 (PGS). To calculate the number of reads mapped to each transcript we
generated a custom annotation file based on the BAM files using the integrated
function in PGS. The normalization and post-processing of the data was performed
the same way as described for RNA-seq processing. After dismissing the low ex-
pressed transcripts the data contained 592 miRNA transcripts. mi RNA-seq data
can be accessed under GSE62509.
50
2.2. Methods
2.2.4.5 Statistical and descriptive bioinformatics of transcriptome data
A one - way A N alysis Of V A riance (ANOVA) model was performed to calculate
the 1.000 most variable and the differentially expressed genes (transcripts) between
Trim71fl/fl and Trim71-/- mESCs using PGS. Differentially expressed genes were de-
fined by a fold change (FC) >1.5 or < - 1.5 and a p - value < 0.05. To visualize the
structure within the data we performed Principle Component Analysis (PCA) on
all genes and hierarchical clustering (HC) on the 1.000 most variable genes, with
default settings in PGS, based on p - values according to the expression values of
the samples across the conditions. In order to show whether the loss of Trim71
can be verified on the transcript level, read counts were visualized by IGV 89 map-
ping the aligned reads against the mouse genome (mm10). To identify the differ-
ences and similarities between Trim71fl/fl and Trim71-/- mESCs the differentially
expressed genes were visualized with SigmaPlot version 12.0 (Systat Software, San
Jose, CA) as a ratio - ranked (log2) plot. The expression of known important ES
transcription factors were visualized as a heatmap by Mayday 90. To link differen-
tially expressed genes to known biological functions we used the 166 most differ-
entially upregulated and 216 most downregulated genes in Trim71-/- compared to
Trim71fl/fl mESCs in order to generate and visualize a network based on GO - en-
richment analysis (GOEA) by using BiNGO [174], EnrichmentMap [175], and Word
Cloud [176] in Cytoscape [177].
2.2.4.6 Descriptive bioinformatics of miRNome
A one - way ANalysis Of VAriance (ANOVA) model was performed to calculate
the 100 most variable and the differentially expressed miRNAs between Trim71 fl/fl
and Trim71-/- mESCs using PGS. Among the 592 miRNA differentially expressed
miRNAs were defined by a fold change (FC) >1.5 or < - 1.5 and a p - value < 0.05.
To visualize the structure within the data we performed PCA on all miRNAs and
hierarchical clustering (HC) on the 100 most variable miRNAs, with default set-
tings in PGS, based on p - values according to the expression values of the samples
across the conditions. Me an ratios of differentially expressed miRNAs between
Trim71fl/fl and Trim71-/- mESCs were plotted against the maximum abundance.
Log2-transformed read counts of differentially expressed miRNAs were visualized
as a heatmap using MayDay. For tissue - related classification, we utilized miRNA-
seq data by Chiang et al . (2010)[178] who measured the relative miRNA expression
in various mouse tissues and developmental stages (ovary, testis, brain, newborn,
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ESC, E7.5, E9.5, and E12.5 embryos). miRNAs were further categorized as pro-
posed by Jouneau et. al. (2012) [179] by showing mainly expression (>50% of reads)
in one of the following categories: mESCs, gonads (ovary and testis), brain, other
somatic tissue (newborn, E12.5 , and E9.5). miRNAs not fulfilling these criteria e.g.
miRNAs with similar expression in all categories, were classified as ubiquitous and
not included in the analysis.
2.2.5 Eukaryotic cell culture and cell biological methods
2.2.5.1 Preparation and culture of mouse embryonic fibroblast (MEF) cells
MEFs were isolated from individually processed embryos at E12.5 to E14.5. After
dissection from the uterus and placenta, the head and internal organs of the em-
bryos were removed using forceps and the material was used for later genotyping.
The remaining parts were washed in PBS and crudely cut into smaller pieces. The
material was collected in a new falcon tube containing 5 ml trypsin/EDTA solu-
tion. The samples were incubated for 10-15 min at 37°C while occasional pipetting
of the solution facilitated cell dissociation. By adding 2 ml FBS the digest was ter-
minated. The mixture was let stand for additional 2 min to allow large pieces of
tissue to settle down. The upper phase was transferred to a new tube and the cells
were spun down for 5 min at 1,000 rpm. The supernatant was discarded and the
cell pellet was resuspended in MEF medium (see below). MEF cells from one em-
bryo were seeded on a 10 cm plates for further cultivation and expansion. When
the cells reached confluence they were split in a 1:5 ratio using trypsin. MEFs were
cultivated for 3-6 passages were frozen for long term storage when required. For in
vitro mutagenesis of the floxed Trim71 allele, cells were treated with 500 nM 4-OHT
or DMSO as vehicle control for 2 days. Conversion of the conditional allele was
subsequently checked by genotyping.
MEF medium 10% FBS
1% Non-Essential Amino Acid Solution (100x)
1% GlutaMAX (100x)
1% Penicillin-Streptomycin (100x)
0.1% 2-Mercaptoethanol (50 mM)
86.9% DMEM
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2.2.5.2 Generation of fetal radial glia-like neural stem cells
The isolation of fetal radial glia-like neural stem cells was performed according
to the protocol described by Pollard et al. (2006) [180]. In short, a breeding of
homozygously floxed Trim71 mice harboring the Rosa26-Cre-ERT2 allele was set
up and pregnant mice were sacrificed at 14.5 dpc. Fetal forebrains were prepared
in ice cold DMEM:F12 media and the cortices were subsequently pooled for cen-
trifugation for 5 min at 1,000 rpm. The supernatant was aspirated and the tissue
resuspended in 0.25% trypsin/0.53 mM EDTA in DMEM:F12 to enable tissue disso-
ciation. The samples were incubated for 30 min at 37°C before stopping the digest
by centrifugation. The cells were resuspended in NS-A medium (see below) in a
density of 3· 106 cells per 10 cm dish. The cells were incubated for another 5 days or
until the cells were forming floating neurospheres. Those cells were collected and
plated again on PO/Ln-coated dishes where they were further cultivated as adher-
ent cells. The medium was changed every other day and the cells were regularly
passaged by trypsin detachment and plated again on PO/Ln coated plastic dishes.
NS-A medium 80% EuroMed-N
18% DMEM:F12
1% N-2 Supplement (100x)
1% Penicillin-Streptomycin (100x)
2.2.5.3 Transfection of HEK293T cells wit calcium phosphate
The calcium phosphate method is a well established method for cell transfection
based on crystal formation of salt and DNA [181]. The HEK293T cells from an
exponentially growing culture were seeded the day before transfection so that they
would reach 40-60% confluence the next day. For a 10 cm plate 30 µg of plasmid
DNA was solved in 0.5 ml 0.25 M CaCl2 solution. While vortexing, 0.5 ml of HeBS
solution (see below) was added. The mixture was then added dropwise to the cells
and incubated for 6 hours at 37°C. Subsequently, the cells were washed once with
PBS and fresh medium was added. 24 or 48 hours after begin of transfection the
cells were harvested for further analysis.
HeBS 0.28 M NaCl
pH 7.05 0.05 M HEPES
1.5 mM Na2HPO4
ad 50 ml ddH2O
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2.2.5.4 Transfection of TCam-2 cells with siRNA
One day before transfection, 5·104 cells were plated per 12-well in 1 ml growth
medium. The next day, the medium was changed again and. 2 tubes per well
containing each 25 µl Opti-MEM I were prepared. In one of them 5 pmol siRNA
or miRNA mimic was solved, whereas in the second tube 1.5 µl Lipofectamine®
RNAiMAX was added and mixed by pipetting. Both solutions were combined
and after 15 min of incubation at RT, the transfection solution was added drop-
wise to the well. The medium was changed again after 6 hours incubation at 37°C.
Depending on the used oligos , the cells were further cultivated between 24 and 60
hours and then harvested for analysis.
Oligo name Targeted sequence
Renilla siRNA AAA CAT GCA GAA AAT GCT G
TRIM71 siRNA#1 CCG TGT GCG ACC AGA AAG TA
TRIM71 siRNA#2 CCA GAT CTG CTT GCT GTG CAA
2.2.5.5 mESC cultivation
Trim71 conditional mESCs were newly derived by crossing of animals homozygous
for the floxed Trim71 allele and the Rosa26-Cre-ERT2 allele. Blastocysts at stage E3.5
were washed out of the oviducts of pregnant females and digested with trypsin in
order to isolate the inner cell mass. The cells were freshly seeded and expanded on
irradiated MEFs in mESC medium with the addition of MEK inhibitor PD0325901
(1 µM). Different clones were cultivated individually. After further expansion, the
cells were weaned off the MEF cultivation. mESCs were cultivated feeder-free in
mESC cultivation medium (see below). The cells were seeded on gelatin-coated
plasticware (0.1% gelatin for 20 min). The medium was changed daily and cells
were split every other day. In order to induce the conversion of the floxed allele to
the knockout allele, cells were treated with 500 nM 4-hydroxytamoxifen or DMSO
as a solvent control for 48 hours. If not indicated differently the cells were further
cultivated for five days before performing experiments in order to rule out side
effects of drug treatment as reported elsewhere[182].
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mESC cultivation medium 15% FBS
1% Non-Essential Amino Acid Solution (100x)
1% GlutaMAX (100x)
1% Penicillin-Streptomycin (100x)
0.1% 2-Mercaptoethanol (50 mM)
0.2% LIF (homemade supernatant)
81.7% KnockOut DMEM
2.2.5.6 mESC differentiation procedures
Unbiased EB differentiation of mESCs For unbiased differentiation either the
EB model or the monolayer model was used. In the first approach, mESC were de-
tached from the dish using Accutase, washed in PBS and then seeded in a density
of 0.5-1·106 cells/ml in differentiation medium on non-adherent plastic. This leads
to the formation of so called embryoid bodies (EBs) which are spherical ESC aggre-
gates in suspension. The cells in the EB will differentiate into all three germ layers
(i.e. ectoderm, mesoderm, endoderm). The progress of differentiation depends on
the time span of incubation. Samples were taken at the indicated time points and
the EB were spun down and washed once in PBS before continuing with RNA or
protein extraction.
mESC differentiation medium 10% FBS
1% Non-Essential Amino Acid Solution (100x)
1% GlutaMAX (100x)
1% Penicillin-Streptomycin (100x)
0.1% 2-Mercaptoethanol (50 mM)
86.9% KnockOut DMEM
Because cells grown as EB are not easily dissociated, for some FACS experiments
cells were differentiated by seeding 1·105cells in mESC medium on an uncoated 6
cm dish. Next day the medium was replaced with mESC differentiation medium
which marks the time point 0. Afterwards the medium changed every other day.
Samples were taken by detachment of cells with Accutase®.
Neuroectodermal differentiation of mESCs stimulated by retinoic acid For in-
creasing the efficiency of the derivation of neuroectodermally committed cells mESCs
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were first cultivated as EBs for 4 days (see above). Then, cells were dissociated
using 2 mM EDTA in HBSS (plus 200 units DNAseI/ml). The cells were cen-
trifuged for 3 min at 1,000 rpm before plating them on poly-L-ornithin /laminin
(PLO/LN) coated plastic dishes in differentiation medium additionally containing
0.1 µM retinoic acid (RA). The medium was changed every other day. The cells
were harvested after another 4 days of incubation (in total day 8).
Neuroectodermal differentiation by monolayer culture in N2B27 medium As
an alternative protocol for neural differentiation, 1x104 cell/cm2 were seeded on
gelatin-coated tissue culture plastic in mESC cultivation medium. The next morn-
ing the medium was substituted for N2B27 medium (see below). The medium was
changed daily and cells were harvested at the indicated time points for subsequent
analysis.
N2B27 medium 0.5% GlutaMAX (100x)
1% N2 Supplement (100x)
2% B27 Supplement (50x)
50 mg/ml BSA (fraction V)
1% Penicillin-Streptomycin (100x)
47.5% Neurobasal medium
47.5% DMEM/F12
2.2.5.7 mESC transfection
For transfection of plasmid DNA Xfect mES reagent from ClonTech was used ac-
cording to the manufacturer’s instructions. In short, cells were seeded on gela-
tinized plasticware (5·105-1·106 per 6-well in 1 ml mES culture medium) and let
adhere for 5 hours. For each 6 well 5 μg plasmid was solved in 100 μl reaction
buffer and mixed with 2,5 μl transfection reagent in 100 μl reaction buffer. After
incubating the mix for 10 min at RT the lipid-DNA complexes were added to the
cells. Medium was changed again after 4 hours. Depending on the experiment cells
were harvested 24-48 hours after transfection.
For experiments performed with siRNAs as well as miRNA analogs and inhibitors,
transfections were performed with Lipofectamine® RNAiMAX reagent (Invitro-
gen). For this purpose, 2-5105 cells were seeded in a gelatinized 12-well the day
before transfection. The next day, 10 pmol of RNA was solved in 50 μl Opti-MEM
I. A second solution containing 3 μl Lipofectamine® RNAiMAX in 50 μl Opti-MEM
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I was prepared and incubated for 5 min at RT before mixing both solutions. Af-
ter further incubation for 20 min at RT, the mixture was added to the cells. The
medium was changed again after 6 hours. Cells were harvested for analysis about
48 hours post transfection.
2.2.5.8 Luciferase reporter assay
For the 3’UTR activity assays the psiCHECKTM-2 vector system from Promega was
used inserting the 3’UTR sequences of murine Tcf15 (NM_009328.2), Plxnb2 (NM_-
001159521.2), Foxj1 (NM_008240.3), Inhbb (NM_008381.3), Mras (NM_008624.3),
Nanos3 (NM_194059.2), Obscn (NM_199152.3), Prom1 (NM_008935.2) and Trim54
(NM_021447.2) using the restriction sites for XhoI and NotI (see section 2.2.2.2
for primer sequences). Dual-luciferase reporter constructs were transfected into
mESCs together with a Trim71 construct or a control plasmid, respectively. Trans-
fection was carried out using Xfect mES reagent from ClonTech in a 24-well plate
scale. The amount of total plasmid DNA per well was 750 ng that included 250
ng of firefly reporter DNA and 500 ng of Flag-Trim71 or eGFP as a control. For the
analysis of let-7 miRNA activity in mESCs the psiCHECK2-let-7 8x was used which
was a gift from Yukihide Tomari (Addgene plasmid # 20931) [183]. Luciferase ac-
tivities were measured 24 hours after transfection using the Dual Luciferase Assay
System (Promega) and the MicroLumatPlus LB96V (Berthold Technologies) accord-
ing to the manufacturer’s instructions. Results are mean ratios of Renilla to Firefly
activity normalized to the respective control condition. For some candidate RNAs
an effect ratio was determined as the normalized reporter signal without Trim71
and with maximal Trim71 expression (Trim71 knockout versus Trim71 overexpres-
sion).
RLU(x) =
Renilla(x)
Fire f ly(x)
norm. RLU(x) =
RLU(x)
RLU(vehicle(WT))
e f f ect ratio(x) =
norm. RLU(x(vehicle(KO))
norm. RLU(x(Trim71(KO))
2.2.5.9 Immunofluorescence staining
For immunofluorescence staining, cells were seeded on poly-l-lysine coated (100
µg/ml) cover slips the day before. The cells were fixed with 4% PFA for 15 min
and then carefully washed three times. Subsequently, the cells were permeabilized
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to enable antibody penetration using 0.2 Triton X-100/PBS for exactly 10 min. Af-
ter further washing the cover slips were incubated with 3% BSA/ PBS for 30 min
at RT in order to block unspecific epitopes. The primary antibodies were diluted
in blocking solution and incubated on the cover slips for either one hour at RT or
at 4°C overnight. The cover slips were washed with PBS before adding the fluo-
rescently labeled secondary antibodies corresponding to the species of the primary
antibodies. For visualization of the cell nuclei, DAPI (1 µg/ml) was added dur-
ing secondary antibody incubation. The cover slips were washed again and then
mounted on microscope slides using Fluoroshield to which DABCO (0.25% w/v)
was freshly added.
2.2.5.10 FACS staining
For staining of surface molecules, 1106 cells were detached using Accutase® and
incubated with the fluorescently labeled antibody in FACS buffer (2% FCS in PBS)
for 20 min at 4°C. Subsequently, the cells were washed twice in PBS and directly
analyzed by flow cytometry.
In contrast, for FACS analysis of intracellular antigens the cells were beforehand
permeabilized using the fixation and permeabilization/wash buffers from BioLe-
gend according to the product protocol. All following incubation and washing
steps were also performed in permeabilization/wash buffer. The cells were incu-
bated with the primary antibody for 30 min at 4°C and then washed twice before
incubation with the fluorescently labeled secondary antibody (30 min 4°C).
2.2.6 Protein biochemistry
2.2.6.1 Preparation of cell lysates and protein quantification
In order to perform protein extraction cells were detached and washed once in PBS.
The dry cell pellet was either frozen at -80°C or used for immediate protein prepa-
ration. Therefore, the pellet was resuspended in a small volume (20-100 μl) lysis
buffer (see below) containing freshly added protease inhibitors. The lysate was
incubate for 20 min on ice to ensure complete dissociation of protein complexes.
Then, the samples were centrifuged for 5 min at 13,000 rpm to separate the insol-
uble cellular components. The supernatant was transferred to a new cap and the
protein concentration was measured using the BCA assay. This method relies on
the change in color of Cu2+-complexes in the presence of cysteine residues. Using a
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standard dilution range of known protein content, the measured sample absorption
at a wavelength of 562 nm can be related to absolute protein concentrations.
Lysis buffer 10 mM HEPES
150 mM NaCl
10 mM KCl
2 mM MgCl2
0.5 mM EDTA
0.5% (v/v) Triton X-100
Protease inhibitors 20 µg/ml Antipain
10 µg/m Aprotinin
20 µg/ml Benzamidine
10 µg/m Leupeptin
1:1000 PMSF (saturated solution)
2.2.6.2 SDS-PAGE
SDS-PAGE is a method top separate proteins according to their molecular weight.
The use of SDS is essential for this technique since it eliminates the factors of pro-
tein structure and charge which might otherwise influence the migration behavior
of the proteins. A discontinuous SDS gel was used for all the studies. Thereby the
upper stacking gel with a low acrylamide concentration (5%) helps to congregate
the proteins in a precise band before reaching the lower phase, the separation gel,
where the actual size separation takes place. Depending on the size of the analyzed
proteins different acrylamide concentrations ranging from 8-12% were used for the
separation gel in order to optimize the resolution. For standard western blot anal-
ysis 20 μg of protein were mixed with Laemmli sample buffer and cooked for 5
min at 95°C before loading onto a SDS-PAGE gel. The gel was run in Tris-glycine
running buffer for 20 min at 80V and for another 80 min at 120V before proceeding
with the blotting.
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Stacking gel (5%) Resolving gel (8-12%)
4% 8% 10% 12%
Bidest. water 3.4 ml 2.3 ml 1.9 ml 1.6 ml
1.5 M Tris HCl (pH 8.8) - 1.3 ml 1.3 ml 1.3 ml
1 M Tris HCl (pH 6.8) 0.63 ml - - -
Acrylamide mix (30%) 0.83 ml 1.3 ml 1.7 ml 2.0 ml
SDS (10%) 50 µl 50 µl 50 µl 50 µl
APS (10%) 50 µl 50 µl 50 µl 50 µl
TEMED 5 µl 3 µl 2 µl 2 µl
Laemmli sample buffer (5x) 100 mM Tris HCl (pH 6.8)
20% Glycerol
4% (w/v) SDS
200 mM DTT
1 mg/ml Bromophenol blue
Tris-glycine running buffer (1x) 25 mM Tris
pH 8.3 192 mM Glycine
0.1% (w/v) SDS
2.2.6.3 Western blotting and immunodetection of proteins
Using the wet electroblotting technique, the size-separated proteins were trans-
ferred from the SDS gel to a nitrocellulose membrane on which immunodetection
of specific proteins can be performed. Therefore the gel was placed together with
the membrane in a sandwich of Whatman filter papers and sponge pads which was
pressed together by a support grid. This was put vertically in a transfer chamber
filled with transfer buffer (see below). The transfer was performed under constant
voltage of 80 V for 2 hours at 7°C. The nitrocellulose membrane was shortly washed
with water and then incubated for 1 hour in 3% BSA/TBST for blocking of unspe-
cific epitopes. The primary antibody was diluted in blocking buffer and incubated
for 2 hours at RT or at 4°C overnight. Subsequently, the blot was washed three
times for 5 min with TBST before incubation with the HRP-coupled secondary anti-
body matching to the species of the primary antibody. The membrane was washed
again three times. Then the ECL-substrate was pipetted on the membrane and a
chemoluminescence film was placed on top for signal detection. The exposure time
60
2.2. Methods
typically ranged between 0.5 to 30 min depending on the signal intensity. For re-
generation (stripping) of the membrane, the blot was incubated in stripping buffer
for 15 min at 150°C. Afterwards, the membrane was extensively washed, before
beginning again with blocking.
Transfer buffer (1x) 192 mM Glycine
25 mM Tris
20% (w/v) Methanol
0.002% (w/v) SDS
TBST (1x) 50 mM Tris
pH 7.6 150 mM NaCl
0.05% Tween-20
Stripping buffer (1x) 62.5 mM Tris HCl (pH 6.8)
2% (w/v) SDS
100 mM 2-Mercaptoethanol
2.2.6.4 Co-immunoprecipitation
Co-immunoprecipitation was performed in mESCs and HEK293T cells after over-
expression of tagged proteins. The cells were harvested 24 h after transfection and
protein lysates were prepared according to the description in 2.2.6.1. A BCA assay
was performed to measure protein concentration and the samples were adjusted
to final protein concentration of 1-2 μg/μl. 20 μg of the sample was used as input
control. Equal amounts of protein was mixed with equilibrated Protein A coupled
Dynabeads® (Life Technologies) for capturing IgG-fusion proteins, or with Anti-
FLAG® M2 Magnetic Beads (Sigma) for FLAG-tagged proteins, respectively. The
lysate-bead mixture was incubated for 2 h on a rotating wheel at 4°C. Then the
beads were washed five times with lysis buffer using a magnetic stand to separate
the beads from the liquid. For some experiments, lysates were additionally treated
with RNaseA. For RNA digest 200 µg/ml RNaseA was added to the first washing
solution and the lysates were incubated for 20 min at 37°C. After the final washing
step, the beads were resuspended in 1.5 x concentrated protein loading buffer and
cooked for 5 min at 95°C.
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3 Results
3.1 The generation of a new conditional mouse model for
Trim71
The role of Trim71 has been mostly investigated in the context of embryonic devel-
opment. Therefore, we used the characterization of Trim71 expression and function
during mouse embryonic development as a starting point for our investigation be-
fore exploring other systems. We analyzed the expression pattern of Trim71 mRNA
at different time points in wildtype embryos using whole mount in situ hybridiza-
tion staining. At the earliest investigated stage, E7.5, Trim71 was found to be ubiq-
uitously expressed (figure 3.1) in the whole embryo. At E8.5, Trim71 expression
became more restricted and was found to be especially high in the neural folds
which constitute the precursor structure of the central nervous system. At E9.5 and
E10.5, Trim71 expression was mainly found in the facial prominence, the neuroep-
itheleum, the branchial arches and the developing limb buds. Starting from E11.5
Trim71 expression generally decreased except for the mid-hindbrain region and the
limb buds. Taken together, Trim71 was abundantly expressed in early embryonic
development but became more restricted at later stages with longer lasting expres-
sion in the central nervous system and the developing limbs.
For the investigation of the full Trim71 knockout phenotype, mice bearing the
new Trim71 conditional allele were crossed with mice expressing the Cre recom-
binase under the control of the ubiquitously active PGK promoter [158], thereby
generating a Trim71 knockout allele (figure 3.2a). Trim71 heterozygous animals
were subsequently used for further breeding. The average number of born pubs
per litter was smaller in heterozygous intercrosses than in matings of the parental
strain (figure 3.2b). In addition, genotyping of the adult offspring revealed that 63%
of animals were again heterozygous for the mutated Trim71 allele and 37 % were
wildtype. We never found any living homozygous Trim71 mutant mice which led
us to conclude that homozygous Trim71 knockout animals did not survive until
birth. Therefore, embryos of heterozygous intercrosses were prepared and geno-
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E9.5E7.5 E8.5
E10.5 E11.5 E12.5
Figure 3.1: Trim71 is prominently expressed in the developing central nervous system
and the limb buds. Whole mount in situ hybridization analysis of wildtype embryos at the
indicated embryonic stages using a probe complementary to the Trim71 mRNA.
typed at several developmental stages. While at E7.5 Trim71 knockout embryos
were still found at the expected Mendelian ratio (about 25%), the number of ho-
mozygous Trim71 mutant embryos started to decrease from stage E9.5 (figure 3.2b).
We never found living embryos after E13.5, indicating that Trim71 deficiency led to
lethality during embryonic development with 100% penetrance. The morpholog-
ical analysis of embryos performed by Tobias Goller revealed that in E9.5 Trim71
mutant embryos the anterior neural tube did not close (figure 3.2d). Also at later
stages of development the neural folds failed to fuse resulting in an exencephalus
phenotype in all investigated Trim71 mutant embryos (figure 3.2d). In contrast,
the posterior neural tube closed properly. Furthermore, starting from E10.5 Trim71
mutant embryos additionally exhibited a general and severe growth retardation.
Notably, heterozygous Trim71 embryos did not display any visible abnormalities
during development (data not shown).
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Figure 3.2: Homozygous mutation of Trim71 leads to embryonic lethality in mice. (a)
Scheme of the Trim71 locus in wildtype, conditional and knockout state. (b) Average litter
size of heterozygous intercrosses is smaller than in control mouse breedings (mean+SEM;
n=10). (c) Genotyping statistics of embryos from heterozygous intercrosses. Numbers
above the bars indicate the number of analyzed animals. (d) Comparison of wildtype and
knockout Trim71 embryos at developmental stages E9.5 and E10.5. Homozygous Trim71
mutant embryos exhibit a neural tube closure defect and growth retardation. Upper panel
lateral view, lower panel dorsal view on headfolds (30 and 75 x magnification, respec-
tively). Embryos were dissected and pictures were taken by Tobias Goller. Figure modified
from Mitschka et al., 2015[172].
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Considering the severe phenotype of homozygous Trim71 knockout in mice lead-
ing to embryonic lethality, the question arose whether also heterozygously targeted
Trim71 mice display phenotypes. Indeed, we found that both adult male and fe-
male heterozygous mice weighed significantly less than their wildtype littermates
(figure 3.3a-b). The lower body weight correlated with a significant reduction of
the nose-rump-length of heterozygously targeted Trim71 mice (figure 3.3c). In or-
der to investigate the course of postnatal development, we monitored the weight
gain of newborn wildtype and heterozygous mice from week 4 to 15. Again, Trim71
heterozygous individuals from both sexes were in average 15% lighter than their
wildtype littermates at any given time point (figure 3.3d). This difference in weight
was also not restored in older mice, however this did not result in a reduced viabil-
ity of heterozygous mice in the course of one year (data not shown).
Next, we measured the weight of several organs relative to the body weight
of adult wildtype and heterozygous Trim71 mutant mice. The results for heart,
kidney and testis obtained from 10-14 week old male mice are depicted in fig-
ure 3.3e. Whereas kidney and heart showed a normal organ weight in relation
to the reduced body weight, the testes of male mice were significantly smaller in
Trim71 heterozygous males in comparison to their wildtype littermates. In par-
allel, samples from the different organs of adult wildtype and heterozygous mice
were taken to examine Trim71 mRNA expression by RT-qPCR. This analysis re-
vealed that Trim71 expression was undetectable in kidney and heart while there
were significant amounts of Trim71 mRNA in whole testes samples (figure 3.3f).
The amount of Trim71 mRNA detected in testes of Trim71 heterozygous males was
half of the amount found in wildtype animals, suggesting that both alleles need to
be functional to yield normal Trim71 mRNA expression. These finding supported
the notion that the reduced testis size observed in Trim71 heterozygous male mice
was indeed caused by organ intrinsic mechanisms.
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Figure 3.3: Heterozygous deletion of Trim71 leads to persistent growth retardation and
male Trim71 exhibit a reduced testis size. (b) Representative images of an adult male
wildtype mouse and its Trim71 heterozygous littermate (bar = 2 cm). Body weight (b) and
body length (c) of 10 week old males (mean+SEM; Student’s t-test; n=11-15; *** p<0.001).
Error bars represent SEM. (d) Growth curves for Trim71 wildtype (black) versus heterozy-
gous (orange) mice. Both male (left) and female (right) mice show a reduced body weight
(mean+SEM; n=3-15; *** p<0.001). (e) Relative organ weights of kidney, heart and testis in
Trim71 wildtype (black) versus heterozygous (orange) mice (Student’s t-test; n=15-16) (f)
Trim71 mRNA expression levels in testis, kidney and heart normalized to wildtype mESCs
(mean +SEM; n=3).
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3.2 In vitro mutagenesis of Trim71 as a versatile tool for
investigating protein functions
We and others have shown that Trim71 is abundantly expressed during embryonic
development with a temporally and spatially restricted expression pattern. How-
ever, the investigation of protein functions in the embryonic organism is difficult
and a complementary in vitro system is needed to answer basic cell biological ques-
tions. Mouse embryonic stem cells (mESCs) are the in vitro equivalent of the inner
cell mass (ICM) of an early blastocyst and they were shown to endogenously ex-
press high amounts of Trim71 [153, 152, 156]. Cultured mESCs retain the capacity
to form all cell types of the adult organism and are thus a very versatile tool for the
investigation of lineage determination and differentiation. To ascertain the impor-
tance of Trim71 for mESC functions and to identify key biological processes that
are controlled by Trim71, we established a genetic model for inducible Trim71 ab-
lation by generating mice carrying floxed Trim71 alleles plus the Cre-recombinase-
oestrogen-receptor-T2 (Rosa26 CreERT2) allele. Mice, homozygous for both alleles
were crossed and the blastocysts were extracted from the oviducts of pregnant fe-
male mice at embryonic stage E3.5. The blastocysts were digested with trypsin to
isolate the ICM (see figure 3.4a). These cells were propagated on feeder cells and
further expanded. The derived mESC clones were later on weaned off the feeder
culture and cultured on gelatinized plastic dishes.
The expression of the CreERT2transgene in Trim71fl/fl mESCs allowed the muta-
tion of the Trim71 allele in vitro. In this system, the treatment with the hormone-
like drug hydroxy-tamoxifen (4-OHT) induces the shuttling of the Cre recombi-
nase to the nucleus leading to the looping out of the loxP flanked exon four of the
Trim71 gene (figure 3.4b). The success of the deletion was subsequently monitored
by genotyping of the Trim71 genetic locus, revealing an efficient conversion of the
floxed allele to the knockout allele already after 48 hours of 4-OHT treatment (fig-
ure 3.4c). Accordingly, the expression of Trim71 mRNA was almost completely
lost when using a primer pair binding to exon four (figure 3.4d). Notably, we also
observed a reduction of the remaining 5’ mRNA by about 50% in comparison to
DMSO-treated control cells. This indicated a destabilization of the Trim71 mRNA
after deletion of exon four containing a part of the coding sequence as well as the
entire 3’UTR. In line with this, the Trim71 protein content decreased following 4-
OHT-treatment as assessed by western blot analysis and almost no Trim71 protein
could be detected after 48 hours of 4-OHT treatment (figure 3.4e).
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Figure 3.4: Derivation of conditional Trim71 mESCs from mouse blastocysts. (a) Mice
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the inner cell mass of E3.5 blastocysts was taken into culture. (b) Application of the drug
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2015 [172]
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This rapid loss of protein expression indicated a high Trim71 protein turnover in
undifferentiated mESCs. Taken together, our conditional mESCs system proved to
be suitable for fast and efficient in vitro deletion mutagenesis of the Trim71 gene.
3.2.1 Trim71 is not required for the maintenance of stemness and
proliferation in undifferentiated mESCs
When comparing undifferentiated Trim71fl/fl and Trim71-/- mESCs, no differences
were observed concerning the morphology in steady-state culture. Cells of both
genotypes were similarly able to form characteristic mESC colonies when grown
on gelatin-coated plastic dishes (see figure 3.5b). In order to further investigate
the stem cell qualities of Trim71-deficient cells, a SSEA-1 surface staining was per-
formed to measure the proportion of undifferentiated cells. We found that the fre-
quency of SSEA-1-positive cells was not significantly different in Trim71-deficient
mESCs and control cells (figure 3.5c). Furthermore, a RT-qPCR analysis of a set of
well-established stem cell transcription factors revealed equal marker expression
in Trim71fl/fl and Trim71-/- mESCs (figure 3.5d). Since another study had reported
that mESCs exhibit a decreased proliferation rate after Trim71 knockdown [153],
we also monitored the increase in cell number over time. However, in contrast to
the previously mentioned study, we did not detect an altered steady-state prolif-
eration of Trim71-/- mESCs in comparison to control cells (figure 3.5e). Thus, we
concluded that the maintenance of stemness including the proliferation capacity
was not impaired in Trim71-/- mESCs.
3.2.2 Trim71 deficiency enhances neural differentiation
As shown above, Trim71 is highly expressed in early stages of embryonic develop-
ment, however, Trim71 knockout phenotypes are only apparent at later stages of
development and defined regions. This suggests that Trim71 deficiency mostly af-
fects differentiation decisions in specific tissues. It was shown that Trim71 knockout
leads to premature differentiation of neural progenitor cells in vivo which is accom-
panied by a decreased proliferation [151]. Therefore, we hypothesized that Trim71
might likewise regulate the timing of differentiation after stimulation in vitro.
To test this assumption, cells were seeded in low density on gelatin-coated plas-
tic and subsequently the medium was substituted with serum-free N2B27 medium
without LIF to initiate neural differentiation in a monolayer culture. Samples were
taken for RT-qPCR analysis at regular intervals to monitor differentiation kinetics.
70
3.2. In vitro mutagenesis of Trim71 as a versatile tool for investigating protein
functions
4
Trim71
Sox2
Tubulin
    -     +      4-OHT  
mE
S T
rim
71
fl/f
l / 
    
Ro
sa
26
 C
reE
R
T2a
Trim71fl/fl Trim71-/-
b
d e
Oc
t3/
4
So
x2
    
My
c
Kl
f4
Re
x1
0.0
0.5
1.0
1.5
Trim71fl/fl Trim71 -/-
no
rm
. f
ol
d 
ex
pr
es
si
on
Growth kinetics
Trim71 fl/fl
Trim71 -/-
1 2 3
0
500
1000
1500
[days]
ce
ll 
nu
m
be
r (
x1
00
0)
c
0
20
40
60
80
100 n.s.
SS
EA
-1
 p
os
iti
ve
 c
el
ls
 in
 %
Tri
m7
1f
l/fl
Tri
m7
1-
/-
Figure 3.5: Trim71-deficient cells were able to maintain stemness. (a) WB showing com-
plete absence of Trim71 protein in 4-OHT treated cells which were still retaining expression
of the stem cell marker Sox2. (b) Trim71-deficient cells exhibited a mESC-typical morphol-
ogy (scale bar represents 200 µm).(c) Surface expression of the SSEA-1 was not significantly
altered upon Trim71 knockout (mean +SEM; Student’s t-test; n=5; n.s not significant). (d)
The mRNA expression of stemness factors was not altered in Trim71 knockout mESCs in
comparison to control cells. Values are normalized mean +SEM (n=3). (e) Analysis of
proliferation in Trim71fl/fl and Trim71-/- cells during four days of culture (representative
experiment with three technical replicates). The figure was modified from Mitschka et al.
2015 [172]
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Mitschka et al. 2015 [172]
We analyzed the expression of the transcription factors Sox1 and Pax6, which are
the earliest markers expressed in mouse and human neuroectoderm, respectively
[184, 185, 186]. Notably, the basal expression levels of both markers were compara-
ble in undifferentiated Trim71-deficient compared to control mESCs figure 3.6. In
control cells, both marker genes displayed a characteristic increase of expression
after induction of differentiation with a peak expression at day 3. However, we
found that the peak expression of Sox1 was higher in Trim71-/- cells than in con-
trol cells, while the expression kinetics were similar in both cell types at later time
points. Also for Pax6 the peak expression at day 3 was found to be elevated, but
in contrast to Sox1, the expression was steadily elevated and failed to decrease af-
terwards. These results indicated that the differentiation into the neuro-ectodermal
lineage was enhanced in Trim71-dificient mESCs
We also tested an alternative approach for induction of neural differentiation.
This time, cells were cultured for 4 days as embryonic bodies (EB) in the absence of
LIF and subsequently plated on poly-l-ornithine/laminin coated plastic in medium
supplemented with 0.1 µM retinoic acid (RA). After 8 days of differentiation the
cells were harvested and subjected to marker expression analysis by RT-qPCR.
In the panel of investigated neuroectodermal marker genes, Sox2 was the only
gene that showed equal expression in Trim71-deficient and control cells 3.7. Of
note, Sox2 is known to be continuously expressed from the undifferentiated ESC-
state to neuroectodermal differentiating cells, whereas it is downregulated in non-
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ectodermal differentiating cells [187, 188]. In contrast, the other markers were
specifically upregulated in neuro-ectodermally differentiating Trim71-/- cells. Also
the early markers Sox1 and Pax6 were significantly upregulated. The same holds
true for the transcription factor Pax3 and the metabolic protein BLBP of which
the expression was enhanced in Trim71-deficient cells. With respect to the neuro-
specific filament protein Nestin we have encountered the highest inter-assay vari-
ability of all tested markers. Nevertheless, a tendency for a higher expression in
Trim71-deficient cells was clearly detected.
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It must be taken into account that differentiation protocols are usually not effi-
cient enough to differentiate all cells of a sample preparation into the designated
cell lineage. Hence, working with these dynamic cell systems remains challenging.
Because it was proposed that Trim71 would help to maintain neural progenitor
cells in vivo [151], we next aimed to extract a late neural stem cell population from
conditional Trim71animals for propagation in vitro. Radial glia (RG)-like stem cells
from the neocortex of E14.5 embryos were extracted and further cultured in vitro
with addition of FGF2 and EGF. Due to the advanced differentiation state of these
cells, the expression of the Trim71 upstream-regulating miRNA let-7 was increased
in RG-like cells in comparison to undifferentiated mESCs (figure 3.8a). The op-
posite was true for the expression of the ESC-specific cell cycle regulating (ESCC)
miRNAs miR-294 and miR-302. The treatment of conditional Trim71 RG-like neu-
ral stem cells with 4-OHT resulted in efficient conversion of the Trim71 floxed allele
to the knockout allele (figure 3.8b). RG-like stem cells of both genotypes were mor-
phologically indistinguishable (figure 3.8c). However, WB analysis of Trim71 re-
vealed that neither floxed nor knockout RG-like cells expressed detectable amounts
of Trim71 protein (figure 3.8d). In line with this, the mRNA expression of Trim71
was only about 5% of the level detected in wildtype mESCs. Accordingly, Trim71-/-
RG-like cells were not affected by loss of Trim71 and protein expression of the neu-
ral marker genes Tuj-1 and Sox2 was unaltered.
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Figure 3.8: The expression of Trim71 is lost at later stages of embryonic neurodevelop-
ment. (a) Primary RG-like stem cells were isolated from Trim71fl/fl /Cre-ERT2 embryos at
stage E14.5. The expression of let-7a as well as cells the expression of ESCC miRNAs miR-
294 and miR-302a was analyzed in comparison to mESCs. (b) Genotyping PCR showing
the conversion of the floxed Trim71 allele to the deleted allele in RG-like stem cells after 48
hour treatment with 250 nM 4-OHT. DMSO treated cells and wild-type Trim71 cells with
Rosa26-CreERT2 background served as a control. Upper band: floxed allele; middle band:
knockout allele; lower band: wild-type allele. (c) No morphological changes were observed
after 4-OHT treatment. Scale bar represents 100 µm. (d) RG-like neural stem cells do not
express the Trim71 protein any longer, therefore the deletion has no effect on the protein
expression of typical neural stem cell markers such as Sox2, Tuj-1. (e) RT-qPCR confirming
massive downregulation of Trim71 mRNA in RG-like stem cells in comparison to mESCs
(mean+SEM, n=3). Figure modified from Mitschka et al. 2015 [172]
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3.2.3 Loss of Trim71 in undifferentiated mESCs leads to changes in
gene expression
Although we did not detect any impairments regarding the principal stem cell
characteristics of Trim71-deficient undifferentiated mESCs, we observed enhanced
neural differentiation after stimulation. Hence, we were interested whether mESCs
could be predisposed for neural differentiation. Two recently published studies
found that Trim71 might act as an RNA-binding protein (RBP) in mESCs [152, 70],
suggesting that Trim71 is directly or indirectly involved in expression regulation
of specific target genes. In order to obtain an overview of the changes in gene ex-
pression in Trim71-deficient mESCs in comparison to the parental cell line, we per-
formed a global transcriptome analysis in collaboration with the lab of J. L. Schultze
at the LIMES institute. For this purpose, Trim71 fl/fl and Trim71-/- were sorted
for the surface expression of the stemness marker SSEA-1 to remove any spon-
taneously differentiating cells in culture. The extracted total RNA was subjected to
cDNA synthesis with subsequent high-throughput sequencing. After alignment of
the sequences to the reference genome and data normalization 13,558 different gene
transcripts were found to be expressed above background level. A principal com-
ponent analysis (PCA) showed that the biological replicate samples of each geno-
type clustered together, whereas the Trim71-deficient and control mESCs showed
a clearly distinguishable global gene expression profile (figure 3.9a and b). Fur-
thermore, alignment of sequence reads from Trim71-/- mESCs to the genomic locus
of Trim71 verified the absence of transcripts originating from exon four (see fig-
ure 3.9c). Although there was remaining expression detected originating from the
other exons, the total Trim71 signal was reduced by almost 80% in comparison to
control cells. Thus, Trim71 was among the top five downregulated genes in our
data set, proving the accuracy and reliability of the RNA-seq analysis. By using
one-way ANOVA, we next identified differentially expressed (DE) genes with a
calculated fold change (FC) of ≤1.5 or ≥-1.5 and a p-value of p≤0.05. Applying
these criteria, we determined 166 up- and 216 downregulated genes in undifferen-
tiated Trim71 -/- mESCs, respectively (figure 3.9d and Appendix).
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Figure 3.9: Transcriptome analysis of Trim71fl/fl and Trim71-/- cells reveals changes in
the mRNA expression landscape. (a) Principal component analysis (PCA) of replicate
samples from Trim71fl/fl and Trim71-/- mESCs. (b) Dendrogram depicting the hierarchical
clustering of the top 1,000 differential z-transformed expression values. (c) Distribution of
sequencing reads across the genomic locus of Trim71 in one Trim71fl/fl and one Trim71-/-
mESC sample verified deletion of the fourth exon in 4-OHT treated cells. (d) Volcano plot
showing expression ratio and p-value of all analyzed genes. Red dots mark DE genes with
FC ≤1.5 and p≤0.05. Data analysis and figures were done by Thomas Ulas (AG Schultze).
Figure modified from Mitschka et al. 2015 [172]
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In order to predict which biological functions were majorly affected by the gene
expression changes observed in Trim71-/- mESCs, DE genes were subjected to gene
ontology - enrichment analysis (GOEA). This analysis lists the biological terms (GO
terms) used to describe a given selection of genes and identifies overrepresented
GO terms in comparison to the statistically expected outcome. The data were visu-
alized by connecting gene hubs according to their functional relation using differ-
ent Cytoscape plug-ins [174, 175, 176, 177], thus creating a network of Trim71 reg-
ulated genes (figure 3.10). In this network map two clusters of upregulated genes
that were implicated in ectodermal differentiation/development in general and the
central nervous system development in particular. Furthermore, a number of regu-
lated genes was associated with general cellular metabolism or negative regulation
of cell proliferation and survival. Finally, and in agreement with the observation
of reduced testis size in Trim71 heterozygous knockout mice, there was a cluster of
downregulated genes that was implicated in reproductive processes. Notably, there
were no gene annotations related to stem cell regulation or maintenance, which
corroborated our finding that stemness networks were intact in Trim71-deficient
mESCs.
In the following, the features of Trim71-mediated gene regulation were investi-
gated in more detail focusing on potential posttranscriptional mRNA regulation by
Trim71. In order to validate the RNA-seq results, the expression of some predicted
DE genes was independently analyzed by RT-qPCR. For this purpose, a selection of
representative up- and downregulated genes was chosen for further analysis (see
table 3.1). The selected candidate genes coded for proteins implied in diverse bio-
logical functions ranging from transcription factors to membrane receptors and sig-
naling proteins. Furthermore, the mRNA candidates also differed regarding their
3’UTR length and the presence or absence of putative miRNA target sites that were
predicted using the TargetScan 6.2 tool [32, 44, 189]. As a negative control, we
also included the Pou5f1 gene in our analysis which codes for the stemness-related
transcription factor Oct4 and was found to be unaltered in Trim71-defient mESCs.
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Figure 3.10: DE genes of Trim71-deficient mESCs were primarily implicated in tissue
morphogenesis, cellular metabolism and proliferation regulation. Visual representation
of gene ontology- enrichment analysis (GOEA) performed with DE genes from Trim71-/-
mESCs using BiNGO and EnrichmentMap. Red nodes and blue nodes mark up- and down-
regulated genes of enriched GO-terms, respectively. Color and size represent the corre-
sponding FDR-adjusted enrichment p-value (q-value). Overlap of genes between nodes
is indicated by edge thickness. Furthermore, clusters of similar biological functions were
marked in colored boxes (see legend). Data analysis and visualization was performed by
Thomas Ulas (AG Schultze). Figure modified from Mitschka et al. 2015 [172]
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Gene Function 3‘UTR1
Broadly conserved
miRNA
target sites2
Pou5f1
Transcription factor essential for early
embryogenesis [190] and embryonic stem cell
pluripotency [12]
264 bp none
Tcf15
Early transcriptional regulator of (mesodermal)
differentiation [191]
344 bp none
Plxnb2
Transmembrane receptor required for normal
differentiation and migration of neuronal cells
during brain corticogenesis and for normal
embryonic brain development [192, 193]
754 bp
miR-124ab/506
miR-137ab
miR-138ab
miR-192/215
Foxj1
Transcription factor that is involved in the
formation of motile cilia [194, 195], lung
development [196], postnatal neurogenesis [197]
1027 bp miR-141/200a
Inhbb
Protein subunit of inhibins and activins which act as
both a growth/differentiation factor and a hormone,
especially in the gonads [198]
1857 bp >5 sites
Mras
Membrane-anchored, intracellular signal transducer
regulating various processes [199, 200]
3266 bp >5 sites
Nanos3
RNA-binding protein regulating germ cell
maintenance[201, 159]
215 bp none
Obscn
Signaling and anchor protein involved in the
organization of myofibrils in striated muscle
[202, 203]
495 bp let-7/98/4458/4500
Prom1
Pentaspan transmembrane glycoprotein expressed
in adult stem cells and cancer cells; suppressor of
differentiation [204, 205]
1167 bp
miR30a-f/384
miR-203
Trim54
E3-ubiquitin ligase regulating titin kinase and
microtubule-dependent signaling pathways in
striated muscles [206]
149 bp none 3
Table 3.1: List of selected candidate genes which were unchanged, upregulated or down-
regulated in Trim71-/-mESCs. 1 Data were obtained from the respective reference tran-
scripts deposited on NCBI. 2 Indications according to annotations in TargetScan Release
6.2. 3 This 3’UTR was differently annotated in NCBI and TargetScan 6.2 [32, 44, 189]. Be-
sides, there were no references for miRNA binding sites.
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Figure 3.11: Validation of differentially expressed genes identified by RNA-seq analy-
sis. The mRNA expression of one unaltered, five up- and four downregulated genes were
measured by qRT-PCR relative to Gapdh. Expression levels were normalized to Trim71fl/fl
samples. Values are mean+SEM (Student’s t-test, n=4-11; * p<0.05, ** p<0.01). Figure mod-
ified from Mitschka et al. 2015 [172]
First, we could independently confirm differential gene expression in Trim71-/-
mESCs of all selected up- or downregulated candidate genes by RT-qPCR (fig-
ure 3.11). As previously mentioned, all DE genes were functionally unrelated to
mESC maintenance regulation but rather to embryonic development and differen-
tiation. Therefore, we asked the question whether the observed changes in gene
expression were indeed inherent to the entire stem cell population or if they reflect
a tendency towards spontaneous differentiation within the analyzed cell pool. To
answer this question, the protein products of one up- and one downregulated can-
didate gene were analyzed by FACS allowing for simultaneous staining of undiffer-
entiated cells via the marker protein SSEA-1. In this setting, Plexin-B2, which had
from all upregulated genes the highest basal mRNA expression in wildtype cells
(data not shown), showed homogenous staining on all SSEA-1 expressing cells. In
Trim71-/- mESCs, the MFI of Plexin-B2 was elevated in the entire cell population,
resulting in a right-shifted histogram peak (figure 3.12a). In contrast, CD133, the
protein product of the Prom1 gene, showed very low basal expression in wildtype
cells. This was even further decreased in Trim71-/- mESCs (figure 3.12a). Again,
there was no correlation between SSEA-1 surface expression and the expression of
CD133, suggesting that the observed effects were not due to spontaneously occur-
81
3.2. In vitro mutagenesis of Trim71 as a versatile tool for investigating protein
functions
ring cell differentiation of sub-populations within the mESCs culture. Moreover,
these analyses illustrated that the measured differences in mRNA expression led
to significant changes in protein output in intact undifferentiated Trim71-/- mESCs
(figure 3.12b).
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3.2.4 The repression of mRNA targets is mediated by Trim71 response
elements in the 3’UTR
Since we were further interested in the mechanism of Trim71-mediated gene regu-
lation, we tried to elucidate how Trim71 modulates the expression of the selected
candidate genes. Typically, RBPs regulate the expression of their target genes via
binding motifs in the 3’UTR of the mRNAs [68, 207]. However, the existence and
the characteristics of a putative Trim71 binding motif are not clarified yet. In order
to test whether the 3’UTR is necessary and sufficient to mediate Trim71 expression
regulation, the respective 3’UTRs of the selected candidate genes were cloned in
a reporter vector, downstream of the coding sequence of the Renilla luciferase en-
zyme. Thereby, the Renilla luciferase expression, which can be easily quantified
by light emission, reports about the regulation by RBPs and miRNAs binding to
the respective 3’UTR. The system can be internally normalized to the activity of
the Firefly luciferase, which is constitutively transcribed from the same plasmid
(figure 3.13a).
From the five upregulated genes three genes also showed a significantly en-
hanced reporter activity in Trim71-deficient mESCs (figure 3.13b), namely Plxnb2,
Foxj1 and Inhbb. Notably, the relative expression changes of the reporter constructs
and the endogenous mRNA expression were not directly proportionate (compare
to 3.11). For instance, Plxnb2 showed consistently the highest de-repression in the
reporter system but not the highest relative fold change on endogenous level in
Trim71-/- mESCs. On the other hand, neither the 3’UTR of the unaltered gene
Pou5f1 nor the four downregulated genes displayed any differences in reporter ex-
pression between Trim71-/- and control cells, arguing that Trim71-mediated down-
regulation was not mediated on posttranscriptional level.
Next, we wanted to explore the characteristics of Trim71-mediated mRNA sup-
pression in more detail. Therefore, we asked whether the enhanced reporter ac-
tivity of target 3’UTR in Trim71-/- mESCs can be restored upon reintroduction
of Trim71 cDNA. We transfected the reporter plasmids containing the different
3’UTRs together with flag-tagged Trim71 WT cDNA or a control plasmid in Trim71-
deficient and wildtype mESCs (figure 3.14a). Indeed, we found that the luciferase
reporter expression containing the 3’UTRs of Plxnb2, Foxj1 and Inhbb was de-
creased again upon Trim71 WT cDNA transfection in Trim71-/- mESCs. Moreover,
overexpression of Trim71 WT together with the Foxj1 or Inhbb 3’UTR reporters
further decreased reporter activity below basal control levels in wildtype mESCs
(figure 3.14a). This was not the case for the Plxnb2 3’UTR where Trim71 WT over-
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Figure 3.13: Trim71 regulated target genes via response elements located in the 3’UTR.
(a) Illustration showing the strategy of Renilla luciferase expression regulated by candi-
date mRNA 3’UTR. (b) Normalized RLU values of ten different candidate 3’UTRs (see
figure 3.11) relative to Trim71fl/fl levels. Values are depicted as mean+SEM normalized
to control cell level of 3 independent experiments (Student’s t-test with * p<0.05). Figure
modified from Mitschka et al. 2015 [172]
expression could not further repress Luciferase reporter expression. To account for
the full regulatory capacity of Trim71 on a specific candidate RNA, we established
the parameter of the effect ratio, which is calculated as the quotient of normalized
RLU values in Trim71-/- mESCs (no Trim71 present in the cell) and Trim71-/- mESCs
plus Trim71 WT overexpression (maximal Trim71 amount). A quotient of 1 means
that both values are equal and Trim71 does not influence target gene expression.
Values >1 indicate a Trim71-dependent repression and values <1 an enhancement
of reporter gene expression in the presence of Trim71. The plotted effect ratios
shown in figure 3.14b illustrate that the three 3’UTRs of Plxnb2, Foxj1 and Inhbb
are Trim71-dependently regulated, whereas this is not the case for Tcf15.
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Figure 3.14: Trim71 overexpression rescued reporter gene expression phenotype in
Trim71-/- mESCs. (a) Normalized RLU after transfection of reporter plasmids containing
different candidate gene 3’UTRs together with and without Trim71 WT cDNA in Trim71-
deficient and control cells. (b) Plotted effect ratios calculated from (a). (c) Measurement
of Foxj1 and Plxnb2 3’UTR-dependent reporter expression in correlation with increasing
amounts of transfected Trim71 WT cDNA. The amount of co-transfected reporter plasmid
was constant (0.5 µg).Values are means +SEM (ANOVA, Tukey’s test, n=3-6; n.s. not signif-
icant, * p<0.05, ** p<0.01, *** p<0.001).
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Next, we wanted to know whether the inhibitory function of Trim71 is corre-
lated with the amount of Trim71 protein present in the cell. Therefore, Trim71-
deficient and control cells were transfected with the Foxj1 or the Plxnb2 reporter
constructs together with increasing amounts of Trim71 WT cDNA. In both cases,
small amounts of transfected Trim71 cDNA led already to a substantial reduction
of reporter gene expression (figure 3.14c). Starting from 1 µg of transfected Trim71
plasmid per 0.5 µg of reporter plasmid, reporter expression was equal in Trim71fl/fl
and Trim71-/- mESCs, suggesting that the repression effect is maximal. Hence, re-
porter repression could not be further enhanced by increasing amounts of Trim71
plasmid in the cell (figure 3.14c). Moreover, this experiment recapitulated the pre-
vious finding that, whereas the Foxj1-3’UTR can be further repressed in wildtype
cells transfected with Trim71, this is not the case for Plxnb2. Taken together, we con-
firmed a clear dose-response relationship between the expression levels of Trim71
and its regulated target 3’UTRs.
3.2.5 Several protein domains of Trim71 are required for optimal target
binding and repression
Since there is very little known about the functional relevance of different Trim71
protein domains, we tried to establish which parts of Trim71 are required for tar-
get gene repression. Therefore, we generated different Trim71 deletion constructs
either lacking the putative RNA binding domain, the NHL domain, or the RBCC
domain. Furthermore, a double point mutation of the RING domain (C12L/C15A)
which was shown to disable the ubiquitin ligase activity [145] was included in the
analysis (figure ??a). For both tested 3’UTR reporter constructs only the transfec-
tion of Trim71 WT cDNA was able to rescue the relieve of reporter expression in
Trim71-/- mESCs (figure ??b). This suggested that more than one protein domain of
Trim71 was actively involved in mRNA target repression. It was especially surpris-
ing to find that the double point mutant of Trim71 was also not able to rescue the
Trim71-/- phenotype since the E3-ubiquitin ligase activity of Trim71 has not been
implicated in RBP function so far. Finally, the structurally related Trim-NHL pro-
tein Trim32 was not able to compensate for Trim71 deficiency, most likely due to
different binding specificities of its respective NHL domain.
All overexpression experiments shown so far were performed using N-terminally
flag-tagged Trim71 constructs. However, it was surprising to find that the overex-
pression of the same constructs tagged with a more bulky eGFP-tag showed par-
tially adverse effects on reporter gene expression. Figure 3.16 shows a compari-
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Figure 3.15: An intact Trim domain and the NHL domain of Trim71 were both required
for target gene repression. (a) Overview on different Trim71 constructs and Trim32 used
in this study. (b) Reporter gene assay using Trim71 wildtype (WT) and different Trim71
deletion mutants as well as Trim32 in Trim71fl/fl and Trim71-/- mESCs. Values are mean
+SEM (ANOVA, Tukey’s test; n=3-6; n.s. not significa* p<0.05, ** p<0.01, *** p<0.001)
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Figure 3.16: Both N- and C-terminus of Trim71 were important for the mRNA repressor
function. Luciferase assay performed in Trim71-/- and control mESCs after overexpression
of different Trim71 constructs N-terminally fused with a small flag- or a bulky eGFP-tag.
Values are mean +SEM (n=3-4).
son of different constructs either tagged with a short flag-tag (1 kDa) or a bulky
eGFP-tag (27 kDa) regarding Plxnb2 reporter gene expression. As shown before,
the overexpression of flag-tagged Trim71 WT normalizes reporter gene expression
in Trim71-deficient cells, whereas it remains unaltered in control cells. In contrast,
we found that the overexpression of eGFP-tagged Trim71 in control cells actually
de-repressed the Plxnb2 3’UTR reporter to a similar extent as the absence of Trim71
in mESCs. In Trim71-/- mESCs, the overexpression of eGFP-Trim71 WT even fur-
ther enhanced reporter expression. This was not the case after overexpression of the
RING domain mutant of Trim71 (3.16). The fact, that the eGFP-masked N-terminus
which is unlikely to directly interact with the target mRNA had such adverse ef-
fect on reporter gene expression suggests that the N-terminus is important for the
recruitment of effector proteins. Together with the previously shown experiment,
these results confirm that several protein domains of Trim71 are required for target
mRNA repression.
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All experiments presented so far did not exclude the possibility that miRNAs
are directly or indirectly involved in Trim71-dependent posttranscriptional expres-
sion regulation. All three verified targets (Inhbb, Plxnb2 and Foxj1) also contain
predicted miRNA binding sites. Hence, it is conceivable that Trim71 cooperates
with or modulates miRNA binding and function. To exclude the involvement of
miRNAs in Trim71 target gene regulation and to identify putative Trim71 bind-
ing sites within the candidate genes, 5’-end deleted fragments of the Plxnb2 and
Foxj1 test-3’UTRs were generated (figure 3.17a). According to the TargetScan 6.2
database [32], the murine Foxj1 3’UTR does contain only one broadly conserved
miRNA binding site for the miR-200a/141 which is located at the 5’end of the
mRNA and therefore only included in the full length Foxj1 3’UTR and in fragment
F1 (figure 3.17a left panel). In contrast, the Foxj1 3’UTR fragments F2 to F5 did not
contain any miRNA binding sites. By testing all deletion constructs of the Foxj1
3’UTR, we found that the fragments F1 to F4 showed Trim71-dependent regulatory
effects. Whereas fragments F1 and F2 were as effectively repressed by Trim71 as
the Foxj1 full length 3’UTR construct, the effect of the fragments F3 and F4 was
reduced to about half (figure 3.17c). The last fragment F5 showed no differential
expression in wildtype and Trim71-deficient mESCs. The step-wise decrease of the
effect ratios could indicate that several Trim71 response elements might be located
within the Foxj1 3’UTR.
We also investigated the Plxnb2 3’UTR which contains five predicted miRNA
binding sites, present in all but 3’-end located fragment F4 (figure 3.17a right panel).
We tested the different fragments in the luciferase reporter system and observed
that all deletion fragments showed enhanced luciferase expression in the Trim71-/-
mESCs in comparison to control cells. The effect could be rescued again upon
overexpression of Trim71 WT cDNA. Notably, there was even a decrease below
wildtype control level upon Trim71 overexpression in the last two fragments (fig-
ure 3.17b). However, the calculated effect ratios were similar for all deletion con-
structs and the full length Plxnb2 3’UTR (figure 3.17c).
This experiment allows the conclusion that miRNA binding was not to a prereq-
uisite for Trim71-mediated expression regulation. Moreover, in the case of Plxnb2
we could locate the Trim71 response element within the last 150 nt of the 3’UTR
which constitutes the shortest Trim71-regulated RNA identified so far.
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Figure 3.17: The repression of target 3’UTRs by Trim71 is independent from miRNA
binding. (a) Schematic of the full length and shorter fragments of the Foxj1 and Plxnb2
3’UTRs showing the location of predicted miRNA binding sites. (b) Reporter assay and
plotted effect ratios (c) with full length (grey shading) and fragments of the Foxj1 and
Plxnb2 3’UTRs. Values are mean+SEM (n=3-6).
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Figure 3.18: Trim71 dependent repression of the Plxnb2 mRNA required spatially sep-
arated binding elements. (a) Schematic showing the generation of four 40 nts fragments
from the 3’-end of the Plxnb2 3’UTR (b) Reporter assay and plotted effect ratios (c) of frag-
ment F4 (gray shading) and 40 nts subfragments. Values are mean+SEM (n=3-6).
We further subdivided the most ’3-end of the Plxnb2 mRNA into 4 40-mer frag-
ments (figure 3.18a) in order to localize the putative Trim71 response element more
precisely. However, none of the sub-fragments showed a comparable efficiency for
reporter expression regulation as the 150 nt F4 fragment (figure 3.18b). Surpris-
ingly, two non-adjacent fragments, F4b and F4d, showed a higher effect ratio than
1, however this was still considerably lower than for the whole F4 fragment (fig-
ure 3.18c). This indicated, that, as in the case with the Foxj1 3’UTR, different spa-
tially separated motif elements might be involved in the Trim71-mediated mRNA
repression.
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3.3 The role of Trim71 in miRNA biogenesis and expression
regulation
Next to the RBPs, miRNAs constitute a second option for posttranscriptional ex-
pression regulation. It is long since known that Trim71 itself is a conserved target
of miRNA regulation, especially by the miRNAs miR-125 and let-7 [59, 147, 208].
In order to test the correlation of Trim71 expression with let-7 miRNA abundance,
we performed expression analysis by RT-qPCR in different human cell lines. We
observed a strong inverse correlation between the expression of the miRNA let-7a
and the mRNA expression of Trim71 (figure 3.19a). This relationship was not linear
but exponential with a correlation coefficient of 0.92. In contrast, there was no re-
lationship between the expression of the miRNA let-7a and the mRNA expression
of the structurally related Trim-NHL protein Trim32 which has no predicted let-7a
binding sites [32](figure 3.19b).
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Figure 3.19: The expression of Trim71 and the miRNA let-7 is inversely correlated. The
relative expression of the miRNA let-7a and the Trim-NHL proteins Trim71 and Trim32
were measured relative to 18S rRNA in eight different human cell lines. The relative ex-
pression values of Trim71 (b) and Trim32 (c) were plotted against the expression of the
miRNA let-7a. For the Trim71-let-7 plot, an exponential decay regression curve was calcu-
lated with a correlation coefficient of 0.92.
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However, there is also accumulating evidence suggesting that Trim71 might not
only be a target of miRNA-mediated repression. A study published by Rybak et al.
demonstrated that Trim71 acts as a ubiquitin ligase for Ago proteins [145], thereby
decreasing the amount of available Ago proteins in the cell. Since Ago proteins
represent a bottleneck in the miRNA biogenesis pathway, the downregulation of
Ago proteins would have severe consequences for the whole miRNA expression
landscape in the cell. However, other studies did not confirm this observation [151,
153].
We tried to recapitulate some major findings supporting the idea of an involve-
ment of Trim71 in miRNA biogenesis. Trim71 was found to be localized in so called
P-bodies which are sites of mRNA storage and miRNA-mediated repression. All
proteins that take part in miRNA-mediated mRNA repression are present in P-
bodies, such as Ago proteins, GW182, decapping proteins and RNA helicases (re-
viewed in [209]). Indeed, after overexpression in human HEK293T cells, we found
TRIM71 to be exclusively localized to a series of discrete spots at the nuclear pe-
riphery which is characteristic for P-bodies (figure 3.20a). In order to specifically
prove the previously reported interaction of TRIM71 with AGO2, we overexpresed
flag-tagged TRIM71 constructs in HEK293T cells. Notably, we did not observe a
change in AGO2 protein content when Trim71 was present. However, we could
detect endogenous AGO2 protein in the IP-fraction which was co-purified together
with TRIM71 WT protein (figure 3.20b). The interaction with AGO2 was abrogated
when the E3 ubiquitin ligase mutant of Trim71 or a construct lacking the NHL
domain was overexpressed. This suggested that at least two different structural
features located at the N- as well as the C-terminus of TRIM71 were influencing the
ability to bind Ago2.
Although we and others have obtained similar results regarding the molecu-
lar interaction of Trim71 with Ago2 [145, 151, 152, 153, 154], the involvement of
Trim71 in Ago2 degradation is still controversially discussed. Using our Trim71
conditional mESC lines we had for the first time the chance to analyze the im-
pact of endogenously expressed Trim71 protein in a defined cell system. We have
performed WB analysis and observed similar Ago2 protein expression levels in
Trim71-deficient mESCs and control cells (figure 3.21a). However, we wanted to
exclude the possibility that a constitutive deficiency of Trim71 in mESCs initiated
compensatory transcriptional upregulation of Ago2 expression. Therefore, we also
performed RT-qPCR analysis, but again we found no difference in the Ago2 mRNA
expression levels between both mESC types (figure 3.21b). This led us to conclude
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Figure 3.20: Interaction of Trim71 with the RISC protein AGO2. (a) Immunofluores-
cence staining of overexpressed flag-TRIM71 (red) and nuclear stain with DAPI (blue)
in HEK293T cells. Scale bar represents 30 µm. (b) Representative AGO2 co-
immunoprecipiation experiment performed in HEK293T cells using overexpression of flag-
tagged TRIM71 WT and mutants.
that in undifferentiated mESCs Ago2 stability and turnover were not subject to ex-
pression regulation by Trim71.
3.3.1 Trim71 deficiency induces changes in the miRNA expression
landscape of mESCs
Nevertheless, we were still interested whether Trim71 might affect miRNA expres-
sion by other means than by Ago2 stability regulation. For this purpose, we per-
formed high-throughput sequencing of small RNAs and mapped the sequences to
all known miRNAs. Overall, 590 miRNAs were found to be expressed above back-
ground level in at least one of the two cell types. In total, we detected about 20%
more miRNA sequence counts in Trim71-/- mESCs in comparison to control cells.
Evidently, Trim71-/- mESCs did not have any general defects in the Ago2-controlled
miRNA biogenesis pathway. The PCA revealed that Trim71-/-cell samples clus-
tered together and they could be distinguished from Trim71fl/fl control samples
(figure 3.22a) DE miRNAs showed low inter-replicate variability (figure 3.22b).
Several members of the let-7 family as well as miR-21a were found among the
miRNAs that showed the highest mean upregulation. On the other hand several
miRNAs were found to be downregulated in Trim71 deficient mESCs in compar-
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Figure 3.21: Ago2 expression is not affected by Trim71 knockout in mESCs. (a) WB anal-
ysis of Ago2 in Trim71fl/fl and Trim71-/- mESCs. (b) Likewise, the mRNA expression of
Ago2 was not significantly altered (mean +SEM; n=5).
ison to control cells e.g. miR-127, miR-410 and miR-136. When plotting the mean
expression of all miRNAs in wildtype cells against their respective fold change in
Trim71-/- mESCs, we could prove that expression regulation was not only occur-
ring in low abundant miRNAs (figure 3.22c). When also taking the p-value into
account there were in total 31 DE miRNAs in Trim71-/- mESCs with a FC ≥1.5
and p≤0.05, 24 of which were downregulated and 7 upregulated (see Appendix).
In order to link the observed changes in miRNA expression to certain function-
alities, we grouped all expressed miRNAs as proposed by Chiang and colleagues
according to their dominant expression in certain developmental stages or tissues
[178] . We then counted the number of miRNAs that showed a higher expression in
either Trim71fl/fl or Trim71-/- mESCs and evaluated the relative differences in the
miRNA subgroups (figure 3.23). Indeed, most ESC-specific miRNAs were higher
expressed in Trim71fl/fl cells. Although the individual effects of specific miRNAs
were usually not very pronounced this might indicate a decreased stability of stem
cell maintenance in Trim71-/-mESCs. On the other hand, brain-specific miRNAs
were in average higher expressed in Trim71-/- mESCs going in line with the upreg-
ulation of mRNAs involved in neural development (figure 3.10). Most strikingly,
the vast majority of gonadal miRNAs, i.e. those species which were annotated to be
characteristic for ovaries and testes, were also higher expressed in Trim71-deficient
mESCs. The table in figure 3.23 shows some examples of miRNAs belonging to the
different categories and a brief description of their described functions.
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Figure 3.22: Differential expression of miRNAs in Trim71fl/fl and Trim71-/- mESCs. (a)
Principal component analysis (PCA) of technical replicates from Trim71-deficient and con-
trol mESCs revealed genotype specific changes in the miRNA profile. (b) Trim71fl/fl and
Trim71-/-replicate samples were clustered according to the expression profiles of the top
100 differentially expressed miRNAs. (c) Expression values of miRNAs in Trim71fl/fl con-
trol cells were plotted against their respective fold changes in Trim71-/- mESCs, demon-
strating that not only low abundance miRNAs show an altered expression. The data anal-
ysis was performed by Thomas Ulas (AG Schultze). Figure modified from Mitschka et al.
2015 [172]
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Tissue miRNA FC Functions
ESC
miR-20b -1.28
promotes breast cancer, modulates ERK, STAT3 and BMP signaling
[210, 211, 212]
miR-18b -1,51
inhibits melanoma cell proliferation by targeting the p53 regulator
Mdm2 [213], expression correlates with malignancy of HCC [214]
Gonads
miR-881 1.53 no information available
miR-184 1.86
highly expressed in testis (function unknown) and brain, governs
NPC proliferation and differentiation [215, 216]
miR-743a
miR-743b
2.40
1.83
downregulated by oxidative stress in the brain [217]
Somatic
miR-410 -4.88
overexpressed in gliomas and neuroblastomas,
positive regulator of proliferation via MET [218, 219]
miR-136 -4.15
tumor suppressor in glioma [220], tumor promoter in lung cancer
[221], positive regulator of keratinocyte proliferation [222]
miR-127 -3.04
regulates proliferation, upregulated in senescent fibroblasts [223],
modulates fetal lung development [224]
miR-9 1.56
regulation of neural differentiation [225]
downregulated in breast cancer [226]and renal cancer [227]
Neural
miR-200a 1.41
establishment of epithelial phenotype via regulation of adhesion
molecules [228], regulates cell cycle exit in NPCs [229],
downregulated in different cancers [228, 230]
miR-128 1.54 drives differentiating neural progenitors to neuronal cell fate [231]
miR-132-5p 1.79 regulates neurite outgrowth [232] and dendritic plasticity [233]
Figure 3.23: Loss of Trim71 increased expression of tissue-specific miRNA at the expense
of ESC miRNAs. Based on the miRNA annotation by Chiang et al. (2010) [178] ESC, go-
nadal, somatic and brain-specific miRNAs were grouped to the genotype which exhibits
higher expression and results were depicted in a pie chart. N indicates the total number
of miRNAs that showed higher expression in the respective group. Data analysis was per-
formed by Thomas Ulas (AG Schultze). Figure modified from Mitschka et al. (2015) [172].
Table with representative miRNAs belonging to the different categories depicted above
with their functional associations.
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3.3.2 Trim71 deficiency leads to elevated let-7 miRNA expression
As shown in 3.22c, several members of the let-7 miRNA family were found to be
upregulated in Trim71-deficeint mESCs. In contrast to the miRNAs analyzed in
figure 3.23, let-7 miRNAs are not tissue-specifically expressed but their expression
is generally considered to be restricted to all differentiated cell types [234, 58]. Pre-
vious studies have analyzed let-7 expression in the context with Trim71 [145, 153,
154], however no consistent hypothesis has been developed so far and we decided
to analyze this miRNA in more detail.
10 highly similar miRNAs belong to the let-7 miRNA family (let-7a-g, let-7i, miR-
98 and miR-202) originating from 13 and 14 genes in humans and mice, respectively
[60]. Using the RNA-seq data we compared the expression of the individual let-7
members in wildtype and Trim71-deficient undifferentiated mESCs (figure 3.24a).
We noticed that the basal expression of individual let-7 miRNAs strongly varied
already in control cells: let-7f, let-7g and let-7i showed the highest basal expression
whereas let-7b,-7d and -7e exhibited a very low expression and miR-202 was not
detectable. Despite very different baseline expression levels, we observed a sub-
stantial increase of expression across all let-7 members in Trim71-/- mESCs which
was in average 2.06 (∓0.23) fold in comparison to control cell levels. Hence, the
total let-7 content was doubled in Trim71-/- mESCs figure 3.24a). Since it has been
proposed that ESCC miRNAs of the miR-290 family can partially counteract let-7
in mESCs [49], we were examining the relative abundance of those miRNAs as
well. In contrast to let-7, the basal expression levels of the ESC-specific miR-290
miRNAs were very high. However, we found that Trim71 deficiency did not af-
fect the expression of single miR-290 members or overall expression (figure 3.24b).
This illustrated that Trim71-deficiency specifically led to an upregulation of let-7
miRNAs.
In order to independently confirm the upregulation of mature let-7 miRNAs, we
performed RT-qPCR analysis of different miRNAs in Trim71-/- and control mESCs.
Again we found a significantly elevated expression of the let-7 family members
let-7a and let-7g, but not for miR-294, miR-302a and miR-125a, which were investi-
gated as well (figure 3.25a). Next, we measured the levels of mature let-7a, Trim71
mRNA and Trim71 protein at different time points after begin of 4-OHT treatment.
Because of the high Trim71 turnover we observed a substantial reduction of both
Trim71 mRNA and protein after 24 hours of 4-OHT treatment (figure 3.25b). At
this early time point, let-7a was already found to be upregulated, which speaks for
a direct involvement of Trim71 in let-7 expression regulation rather than for indi-
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Figure 3.24: High-throughput sequencing of miRNAs confirmed a selective upregulation
of let-7 miRNAs but not of ESCC miRNAs in Trim71-/- mESCs. Sequence counts in Trim71
knockout and control mESCs attributed to the family members of the let-7 family (a) and
the miR-290 family (b). Values are mean +SEM (n=5-6).
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rect effects caused by other targets. Last, we could show that let-7a and let-7g levels
could be restored again after reintroduction of Trim71 WT cDNA. Moreover, over-
expression of Trim71 WT in wildytpe cells further reduced let-7 expression below
baseline level (figure 3.25c), highlighting that Trim71 levels influenced let-7 expres-
sion already in steady-state in undifferentiated mESCs.
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Figure 3.25: Trim71 deficiency in undifferentiated mESCs leads to higher let-7 expres-
sion in steady-state culture. (a) RT-qPCR analysis of the expression of different miRNAs in
Trim71fl/fl and Trim71-/- mESCs. (b) Reduction of Trim71 mRNA and protein immediately
gradually leads to increased expression of let-7. Values are depicted as mean +SEM (Stu-
dent’s t-test; n=3; *** p<0.001). (c) Trim71 overexpression in Trim71-/- and control mESCs
reduced the expression of let-7a and let-7g (mean +SEM, n=3).
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3.3.3 Let-7 miRNA processing is affected by Trim71 deficiency in
mESCs
The maturation of miRNAs to the final 21 nt single stranded RNA is a multi-step
process involving many different processing enzymes and regulatory proteins (fig-
ure 3.26a). Hence, any impacts on let-7 processing could lead to an elevated ma-
ture miRNA expression. In order to identify at which level Trim71 might regulate
let-7 expression, we comparatively measured the levels of pri-, pre- and mature
miRNAs for the miRNA let-7a-1 by RT-qPCR. It was found that only the mature let-
7a miRNA but not its pri- and pre- form were significantly elevated (figure 3.26b).
Thus, we could exclude that the Trim71 repression effect on let-7 miRNAs was me-
diated by transcriptional regulation. Furthermore, the primary processing of the
pri-let-7 transcript by the Dgcr8/Drosha enzyme complex was also unaffected (fig-
ure 3.26b). Taken together, this finding suggested that Trim71 could be either in-
volved in a late step of precursor miRNA processing, or could decrease the stability
of the mature let-7 miRNAs.
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Figure 3.26: Unaltered transcription and primary processing of let-7 miRNAs in Trim71-/-
mESCs. (a) Schematic showing miRNA biogenesis from the primary transcript to precursor
and mature miRNA. (b) RT-qPCR of pri-,pre- and mature let-7a-1. Values are mean + SEM
(Student’s t-test; n=3-10; ** p<0.01).
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For distinguishing between miRNA processing and stability regulation, we took
advantage of the RNA-seq data which record expression of all 21-mers independent
of their functional relevance. Naturally, all mature miRNAs have a by-product, a
second less conserved 21 nt RNA strand which is also referred to as the passenger
strand. This passenger strand is the partial complement of the mature miRNA and
is separated from the active guide strand during loading into the RISC complex.
The passenger strand is usually rapidly degraded after strand separation [235]. If
Trim71 were to decrease the stability of mature let-7 miRNAs, this would require
a direct or indirect recognition of the mature (guide strand) sequences which are
indeed very similar between the different let-7 family members. On the other hand,
the passenger strands are very different to the guide strand and also show more
variability among the let-7 members. Hence, it is unlikely that miRNA stability
regulation would also affect the passenger strand, too. In contrast, any impact
on the prior processing step from the pre-miRNA would equally affect both RNA
strands.
In order to investigate this aspect, we picked the two let-7 family member let-7a
and let-7f to investigate their guide and passenger strand expression. Both miRNAs
are coded by two distinct genes resulting in an identical 5p strand (guide) miRNA,
but different 3’ (passenger) miRNAs. The pre-miRNAs with the annotated 5p and
3p strand as well as the terminal loop sequence is depicted in figure 3.27a. As
expected, the sequence counts for the respective 5p guide strand were dramati-
cally higher than for the corresponding 3p passenger strands. However, for both
miRNAs we observed a similar upregulation of guide and passenger strand counts
in Trim71-/- mESCs (figure 3.27b). This experiment led us to conclude that Trim71
affects pre-miRNA processing instead of let-7 miRNA stability.
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Figure 3.27: Trim71 deficiency led to an equal increase of guide and passenger strands of
let-7 miRNAs. (a) let-7a and let-7f can be generated from two different precursor miRNAs
that differ in their respective loop sequence and the 3p-strand. (b) miRNA-seq of wild-
type and Trim71-deficient cells revealed a comparable increase in both the functional guide
strands as well as the passenger strands. n.d. not detectable.
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3.3.4 Trim71 interacts with the let-7 regulatory protein Lin28
The functional analysis of Trim71-dependent let-7 expression regulation revealed
a striking resemblance to the effects described for another developmental regula-
tory protein: lin-28/Lin28/LIN28 (lineage abnormal 28). In the model organism
C. elegans it acts upstream of the miRNA let-7 in the heterochronic pathway and
this regulatory relationship is highly conserved across species [146, 59]. In mam-
mals, two different Lin28 paralogs, Lin28a and Lin28b, which have different ex-
pression patterns but share similar molecular functionality, have been identified
[63, 89, 236, 237]. Lin28 binds to the let-7 pre-miRNAs and sequesters them from
the Dicer complex and also indirectly mediates their degradation. In this role,
Lin28 is an established posttranscriptional regulator of let-7 expression in stem cells
[62, 63, 66, 238].
In order to explore the molecular connection between Trim71-dependent let-7
regulation and Lin28 protein function, we first investigated whether these proteins
physically interact in mESCs. For this purpose, flag-tagged Lin28a was overex-
pressed in wildtype mESCs. 24 hours post transfection the cells were lysed and
flag-tagged proteins were enriched by immunoprecipitation using magnetic beads
coated with antibodies raised against the flag-tag. This resulted in an enrichment of
flag-tagged Lin28a in the IP fraction (figure 3.28a). Indeed, we found that Trim71
was co-purified in the IP-fraction together with Lin28a. As a positive control we
stained for the poly(A)-binding protein (PABP) which was previously shown to
co-precipitate together with Lin28a [90]. However, as both Lin28a and Trim71
are RBPs, a co-precipitation could be the result of coincidental binding to com-
mon mRNA targets. In order to exclude this possibility, we treated a part of the
lysates with RNaseA to degrade any RNAs that might act as molecular linker. Af-
ter RNaseA treatment, PABP binding to Lin28a was abolished, whereas Trim71 was
equally detected in RNaseA-treated and untreated fractions (figure 3.28b). This
suggested that Trim71 binding to Lin28a was protein-mediated and that RNA bind-
ing was not a prerequisite for the protein interaction.
Lin28 possesses two RNA-binding domains (RBDs): an N-terminal cold-shock
domain (CSD) followed by two tandem Cys-Cys-His-Cys -type zinc-binding mo-
tifs (CCHCx2) which are connected by a flexible linker sequence. Several studies
had shown that both RBDs are required for efficient pre-let-7 binding and sup-
pression [64, 66, 239]. In order to identify the interaction site of Trim71 with Lin28a,
different constructs were cloned lacking specific protein domains. Furthermore, we
also included a Lin28a cDNA introducing two point mutations which were shown
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Figure 3.28: RNA-independent protein interaction of Trim71 with Lin28a. (a) Flag-tagged
Lin28a was overexpressed in wildtype mESCs and immunoprecipated from the total lysate.
Trim71 as well as the known interactor PABP were specifically found in the Lin28a enriched
sample. The grey star marks the antibody light chain. (b) Similar procedure as in (a) but
IP-fractions were additionally treated with or without RNaseA to eliminate RNA-mediated
binding of proteins.
to impede let-7 suppressive activity [90]. Trim71 interacted with similar efficiency
with the Lin28a WT protein as well as with a Lin28a construct lacking the CCHC
domains and the double point mutant which is able to bind but not suppress pre-
let-7 miRNAs (figure 3.29a). However, Trim71 binding was nearly completely abol-
ished upon deletion of the CSD of Lin28a. A similar binding pattern was observed
for the known interactor PABP (figure 3.29a). Thus we concluded that the 74 amino
acid long CSD of Lin28a is required and sufficient for the interaction with Trim71.
Lin28 is a multifunctional protein as it was proposed to likewise interact with
mRNAs as well as miRNA precursors (reviewed in [240]). Likewise, Lin28a was de-
scribed to be localized to various subcellular compartments [90]. In order to further
strengthen the claim of a relevant interaction of Trim71 and Lin28a we performed
microscopic co-localization analysis. Since ESCs have a very low cytoplasm to nu-
cleus ratio which hinders the discrimination of specific cytoplasmic compartments,
the colocalization analysis was performed in HEK293T cells. Flag-tagged Trim71
and mRFP-tagged Lin28a were co-overexpressed and cells were subsequently sub-
jected to immunofluorescence staining. Indeed, we found a rather broad subcel-
lular localization pattern of Lin28a in both nucleus and cytoplasm. On the other
hand, Trim71 was majorly found in precise perinuclear speckles formerly identified
as P-bodies [145] (compare also 3.20). We found overlapping fluorescence signals
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Figure 3.29: The interaction of Trim71 with Lin28a is mediated by the cold-shock domain
of Lin28a. (a) Different Lin28a deletion and mutation constructs were overexpressed in
wildtype mESCs. Trim71 could be co-precipitated with any construct containing an in-
tact cold shock domain (CSD). PABP was used as a positive control and showed similar
binding characteristics. (b) Co-localization of Trim71 and Lin28a in perinuclear P-bodies.
Immunofluorescence staining of overexpressed mRFP-Lin28a (red) and flag-Trim71 (green)
together with DAPI nuclear stain (blue) in HEK293T cells. Scale bar represents 20 µm.
of both proteins in these structures, which might be part of the interaction platform
for Trim71 and Lin28 (figure 3.29b)..
In our analysis of the mRNA repression activity of Trim71 we found that the E3-
ligase mutant of Trim71 was not able to repress specific target genes. Therefore,
we wondered whether the activity of Trim71 to regulate let-7 miRNA expression is
similarly dependent on this enzymatic function. To answer this question, we over-
expressed Trim71 WT, the double point mutant of the RING domain (C12L/C15A)
or a control plasmid in wildtype mESCs. We found that 48 hours post transfection
the levels of mature let-7a and let-7g were decreased in both Trim71 WT and Trim71
E3-ligase mutant overexpressing cells in comparison to the control transfected cells
(figure 3.30a).
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In order to show that protein binding of LIN28A to TRIM71 is also not impaired
when using the E3-ligase mutant we performed a co-precipitation experiment in
HEK293T cells. Surprisingly, quantification of the relative protein enrichment of
TRIM71 WT and E3-ligase mutant revealed that the binding to LIN28A was even
stronger for the Trim71 E3-ligase mutant in comparison to TRIM71 WT protein (fig-
ure 3.30b). Accordingly, we found that mostly the lower-running, non-ubiquitinated,
pool of the overexpressed TRIM71 WT protein was bound to LIN28A in the IP-
fraction. Conversely, TRIM71 binding with AGO2 was decreased by mutation of
the RING domain (figure 3.30c and figure 3.20b). This result implied that the pool of
Trim71 protein that is regulating mRNAs is distinct from the Trim71 pool regulating
let-7 miRNA expression and that the balance between both functions is regulated
by auto-ubiquitination of Trim71/TRIM71.
3.3.5 Trim71 cooperates with both Lin28 paralogs in mice and humans
As mentioned earlier the genome of mammals codes for two highly similar Lin28
paralogs. all analyses so far have been performed using the Lin28a isoform because
it is the predominantly expressed variant in mESCs. However, depending on the
cell type, the Lin28b variant can substitute its function. Therefore, we were inter-
ested whether Trim71 is likewise able to cooperate with the Lin28b variant when
present. Figure 3.31a shows a comparative structural overview of the Lin28a and
Lin28b isoforms in mice and humans which share 97 and 87 % identity on amino
acid level, respectively. In contrast to Lin28a, Lin28b possesses an additional C-
terminal extension which harbors an additional nuclear localization signal (NLS)
[66]. Notably, it was found that both paralogs are able to shuttle between nucleus
and cytoplasm, indicating that other sequences, presumably in the linker region,
can also serve as NLS [66].
First, we screened a panel of different human cell lines for their endogenous ex-
pression levels of TRIM71, LIN28A and LIN28B by RT-qPCR and WB. We found
that a number of embryonic carcinoma cell lines, i.e. NCCIT, 2102EP and NTera-2,
indeed co-expressed all three proteins (figure 3.31b and c). Furthermore, the hepato-
cellular carcinoma cell line HepG2 as well as the seminoma cell line TCam-2 were
found to express TRIM71 together with LIN28B. Notably, there were two cell lines,
JKT-1 and Jurkat T-cells which did not express significant levels of any of the in-
vestigated proteins (figure 3.31b and c). Taken together, we concluded that Trim71
expression always coincides with expression of at least one Lin28 isoform, thus
enabling a functional cooperation of both proteins in these cell types.
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Figure 3.30: Lin28a preferentially associates with non-ubiquitinated Trim71. (a) Overex-
pression of Trim71 WT or the point mutant of Trim71 in wildtype mESCs and measurement
of let-7a and let-7g levels 48 hours post transfection by RT-qPCR (ANOVA, Tukey’s test;
n=3; * p<0.05, ** p<0.01). (b) Representative WB of Lin28-IP with Trim71 in HEK293T cells
and quantification of relative enrichment relative to Trim71 WT construct (n=2). (c) Same
as in (b) with AGO2-IP in HEK293T cells (n=2).
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Figure 3.31: TRIM71 is frequently co-expressed with LIN28A or LIN28B in human cell
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Figure 3.32: Interaction of Trim71 and Lin28b contributes to Trim71 dependent let-7 reg-
ulation. (a) Representative WB showing co-immunoprecipitation of TRIM71 with LIN28B
in HEK293T. (b) Diagram showing relative expression of mature let-7a in different human
and murine cell lines after overexpression of TRIM71/Trim71 (n=2-7).
To further investigate into cooperativity of TRIM71 with LIN28B, we performed
immunoprecipitati of TRIM71 and LIN28B in HEK293T cells. After overexpres-
sion and precipitation flag-tagged Trim71 constructs, we could specifically enrich
LIN28B together with Trim71 WT protein (figure 3.32a). However, when we in-
stead used a TRIM71 variant lacking the NHL domain the interaction was abol-
ished. This proved that Lin28b/LIN28B is like Lin28a/LIN28A able to interact
with Trim71. For a functional validation of the cooperativity, we overexpressed
either Trim71/TRIM71 WT or a control vector into two human and two murine cell
lines and measured let-7a levels by RT-qPCR. Whereas overexpression of Trim71
led to a relative reduction of mature let-7a in mESCs and in HEK293T cells this was
not the case for the NIH3T3 fibroblasts and the Jurkat T cell lines (figure 3.32b). In
contrast to Hek293T cells, which are positive or LIN28B, Jurkat T-cells do not ex-
press any LIN28 isoform (see 3.31). The same holds true for the NIH3T3 fibroblasts
[241] which did also not display a decrease in let-7 content upon Trim71 overexpres-
sion. In contrast, let-7a was reduced after overexpression in mESCs which express
Lin28a and to a lesser extent Lin28b. This experiment unambiguously showed that
the ability of Trim71 to regulate let-7 levels is mediated by Lin28a proteins which
need to be co-expressed in the same cell.
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3.3.6 Homozygous gene targeting of the Lin28a locus assisted by
TALENs in mESCs
In order to further support the hypothesis of cooperativity between Trim71 and
Lin28a with regard to let-7 expression regulation in mESCs, we wanted to test
whether Trim71 can still regulate let-7 in the absence of Lin28a. Therefore, we gen-
erated a double mutant mESC line which was deficient in both Trim71 and Lin28a.
This required the mutation of both Lin28a alleles in the background of the Trim71
conditional allele mESCs. The Lin28a gene is located on chromosome 4 and consists
of four exons, all of which contain coding sequences (see figure 3.33a). The clas-
sical strategy of homologous recombination is very suitable to introduce defined
mutations but has very low success rate. Instead, we performed an approach of
in vitro mutagenesis using transcription activator-like effector nucleases (TALENs)
for site-specific genome editing. We transfected a Lin28a-specific TALEN pair to-
gether with a targeting construct introducing a stop site and a neomycin resistance
cassette flanked by homology regions (figure 3.33b). The insertion of the neomycin
resistance cassette increased the number of positive clones after positive selection
and also facilitates screening by PCR, since wildtype and targeted alleles were eas-
ily distinguishable.
The transfection of the Lin28a targeting construct alone yielded about double as
many mESC clones as the transfection of the TALEN pair which can be considered
as the background level (figure 3.34a). The number of G-418-resistant clones was
again doubled when cotransfecting the targeting vector together with the TALEN
pair, showing that the efficiency of genome integration was increased. Individ-
ual G-418-resistant mESC clones were picked and screened by PCR (figure 3.34b).
Out of 48 picked mESC clones, the genotypes of 36 could be determined by PCR
screening. Of those, more than 50% showed the expected band for the targeted
allele which indicated that there was at least one site-specific integration event (fig-
ure 3.34c). Moreover, 17% of all analyzed mESC clones did not show a correspond-
ing wildtype allele signal, indicating that both alleles underwent homozygous re-
combination. Thus, TALEN-assisted mutagenesis dramatically increased the effi-
ciency and accuracy of gene targeting. As a proof for the success of the Lin28a tar-
geting mutagenesis, three clones identified as Lin28WT/WT (wildtype), Lin28WT/KO
(heterozygous) and Lin28KO/KO (knockout) were analyzed by WB for Lin28a pro-
tein expression. As expected, the Lin28a knockout cell clone exhibited no Lin28a
protein signal, while the heterozygous clone had a slightly reduced Lin28a amount
in comparison to the wildtype clone (figure 3.34d).
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PCR verification strategy
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Figure 3.33: Strategy for the generation of TALEN-assisted mutagenesis of the Lin28a
genomic locus. (a) Genome organization and mRNA splicing of Lin28a. (b) A TALEN
pair was designed to bind to sequence within the first exon of Lin28a in close proximity of
the start codon. Integration of the targeting construct via homologous recombination will
disrupt translation and furthermore lead to the expression of an antibiotic resistance gene.
The screening for recombined clones was done with a PCR using a set of three primers
generating PCR products of different lengths.
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Figure 3.34: Generation of Lin28a knockout mESC lines by TALEN-assisted mutagenesis.
(a) Co-transfection of TALENs together with the targeting construct markedly increases the
number of G-418 resistant clones. (b) Representative genotyping PCR on Lin28a wildtype
and targeted locus. Red box marks a homozygously targeted clone. (c) Statistical analysis
of targeting efficiency showing that more than 50% of the clones had integrated at least one
copy of the partially homologous donor DNA (n=36). (d) WB analysis verifies the absence
of Lin28a protein in a homozygously targeted mESC clone.
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For all further analyses we used one Lin28a homozygously targeted mESC clone
and compared it the parental Trim71fl/fl clone. Additional Cre activation by 4-OHT
treatment allowed the generation of four different mESCs genotypes originating
from just one parental Trim71fl/fl mESC line (figure 3.35a). For convenience, the
different mESC genotypes are in the following just called wildtype (Trim71fl/fl,
Lin28a+/+), Lin28a KO (Trim71fl/fl, Lin28a-/-), Trim71 KO (Trim71-/-, Lin28a+/+)
and Trim71/Lin28a dKO ((Trim71-/-, Lin28a-/-). Figure 3.35b illustrates that the
conversion of the Trim71 allele after 4-OHT treatment works very efficiently also
in the Lin28a-deficient mESC background. Whereas we could detect remaining
Lin28a mRNA, there was no evidence for intact Lin28a protein in Lin28a KO mESCs
(figure 3.35b and c). Interestingly, we found that the mRNA expression of Trim71
in Lin28a KO mESCs was significantly increased in comparison to wildtype cells
(figure 3.35c). However, this increase did not yield changes in Trim71 protein ex-
pression. Because we were furthermore interested whether the Lin28a paralog,
Lin28b, would be affected by compensatory feedback regulation, we also moni-
tored Lin28b protein expression by WB analysis. However, in contrast to previous
publications, neither Trim71 nor Lin28a deficiency resulted in increased expression
of Lin28b [78, 155] (figure 3.35b and c).
As there are until now no data available describing complete Lin28a deficiency
in mESCs, we first had to verify that stemness was not impaired of Lin28a deficient
mESCs. All knockout mESC lines were morphologically indistinguishable from the
parental mESC line (figure 3.36a). Furthermore, we measured the mRNA expres-
sion of Oct4 and Nanog by RT-qPCR and found no significant differences between
the different mESC lines. Taken together, we did not observe any impairments in
stem cell maintenance, arguing that, like Trim71, Lin28a is not an essential compo-
nent of the mESC-regulating network.
Next, we measured the levels of pre- and mature let-7a and let-7g in the differ-
ent knockout mESC lines. We found that the pre-let-7 levels were unaltered in all
knockout cells (figure 3.37a and b). In contrst to that, the levels of mature let-7a and
let-7g were dramatically increased in Lin28a KO cells in about the range that has
been previously reported after efficient Lin28a knockdown in mESCs [242]. This
increase was more pronounced than the relative let-7 increase observed in Trim71
KO cells, indicating that Trim71 is mostly a modulating Lin28a function. Also the
Trim71/Lin28a dKO cell line had significantly more mature let-7 than wildtype
control cells. However, in comparison to Lin28a single KO cells, there was no ad-
ditional effect on let-7 expression in Trim71/Lin28a dKO mESCs (figure 3.37a and
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Figure 3.35: The generation of Trim71/Lin28 double knockout mESCs. (a) Scheme show-
ing the derivation of different knockout mESC lines. WB (b) and RT-qPCR analysis (c)
confirming Trim71 deletion in the background of Lin28a knockout mESCs after application
of tamoxifen. In contrast, Lin28b expression is not significantly affected. Expression was
calculated relative to Gapdh and values are depicted as means +SEM (ANOVA, Tukey’s
test; n=3-9; *** p<0.001).
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Figure 3.36: Lin28 and Trim71-deficient mESCs shown no deficiency in the maintenance
of stemness. (a) Bright field microscopic images of different stem cells grown on gelatin.
Scale bar represents 200 µm. (b) mRNA expression of the stemness genes Oct4 and Nanog
relative to WT cell levels. Values are depicted as means +SEM (ANOVA, Tukey’s test; n=5-
6; n.s. not significant).
b). In order to analyze the impact of the knockout-induced let-7 overexpression
on potential target genes, we performed a reporter assay with a Renilla luciferase
construct containing 8 let-7 binding sites in its 3’UTR [183] (figure 3.37c). In Trim71
KO mESCs the let-7 responsive reporter gene was slightly, but nevertheless signifi-
cantly, repressed in comparison to wildtype control cells (figure 3.37d). However,
in accordance with the stronger increase of let-7 expression, the reporter repres-
sion was more pronounced in Lin28a KO cells. In comparison to the Lin28a single
KO, the downregulation of the let-7-reporter was similar in Trim71/Lin28a dKO
mESCs, again highlighting that Trim71 effects are mdiated by Lin28a function in
mESCs.
The binding of Lin28a to let-7 precursors is mediated by two critical structural
characteristics of the pre-miRNA. On the one hand, Lin28 proteins can recognize
and bind to a GGAG RNA motif in the pre-let-7 loop [243, 239]. On the other
hand, a guanine-rich bulge in the dsRNA adjacent to the Dicer cleavage site was
proposed to play a role in target specificity [243]. The GGAG RNA sequence was
also identified as a consensus motif for mRNA binding and is majorly depending
on the CSD of Lin28a [77, 78]. Other miRNAs also have conserved GGAG motifs
in their terminal loop sequence e.g. miR-107, -143, -200c, -324 and -363. These
miRNA were proposed to respond to Lin28a knockdown in a similar fashion like
let-7 [64]. Thus, we tested two of those miRNAs (miR-107 and miR-143) and one
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Figure 3.37: Both Trim71 and Lin28a deficiency result in de-repression of let-7 target
genes in mESCs. RT-qPCR analysis of precursor and mature let-7a (a) and let-7g (b) rel-
ative to the reference U6 snRNA. Values are means +SEM, n=2-7. (c) Principle of reporter
assay with 8 let-7 response elements in the 3’UTR of a Renilla luciferase cDNA. (d) Relative
repression of a let-7 responsive reporter construct as shown in (c) which was transfected
in different knockout mESC lines. Results are mean +SEM of 4 independent experiments
(ANOVA, Tukey’s test; n.s. not significant, * p<0.05, ** p< 0.001).
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Figure 3.38: The GGAG sequence in the stem loop of miRNA precursors alone is not
sufficient for Lin28a and Trim71-dependent repression. (a) Several miRNAs share a con-
served GGAG sequence in their terminal loop (highlighted in green) of the miRNA pre-
cursor. The respective mature miRNAs are marked in orange. (b)The expression levels
of GGAG-containing miRNAs miR-107 and miR-143 as well as the unrelated miR-16 were
unaltered in Trim71 and Lin28a knockout conditions. Values are relative expression to U6
snRNA and are depicted as means +SEM, n=4-11 (ANOVA, Tukey’s test).
control miRNA lacking the GGAG motif (miR-16) for changes in expression in the
different knockout mESC lines (figure 3.38a). However, none of the investigated
miRNAs were significantly elevated in Trim71 or Lin28a KO cell lines (figure 3.38b),
indicating that miRNA regulation is not only dependent on the sequence motif
located at terminal loop but that other structural features also play an important
role.
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To obtain a complete overview of the global mRNA expression changes in the
different knockout mESC lines, we performed another RNA-seq analysis of all four
genotypes in collaboration with the group of J. L. Schultze (LIMES institute, Bonn).
In comparison to the Trim71 knockout mESCs, the amount of DE genes was sub-
stantially higher in Lin28a KO and in Trim71/Lin28a dKO mESCs (2.5% in com-
parison to 12.9% and 10.5% of all genes, respectively) (figure 3.39a). This suggested
that Lin28a has a broader target mRNA spectrum. However, we were most of all
interested whether Trim71 and Lin28a also cooperate in mRNA target regulation.
Figure 3.39b illustrates the overlap of DE genes that were either significantly up-
regulated or downregulated in the different KO mESC lines. In general, there was
a striking overlap of DE genes between Lin28a KO and Trim71/Lin28a dKO mESC
lines. For further analysis we concentrated on the DE genes in Trim71 KO mESCs
and evaluated those in the context of the other mutant mESC lines. We found
that among the significantly downregulated genes in Trim71 KO mESCs very few
genes showed concomitant regulation in Lin28a KO cells (figure 3.39c). In contrast,
when analyzing the genes that were identified as upregulated in the Trim71 KO
mESCs, we found that the majority of those (52%) were actually also upregulated
in the Lin28a KO mESCs. From those about 90% were likewise significantly overex-
pressed in the Trim71/Lin28a dKO mESCs. In contrast, fewer than expected genes
were counterregulated in this group (figure 3.39c). This suggested that Trim71
specifically cooperated with Lin28a in target gene suppression, whereas the up-
regulation of target genes was specific to Trim71 and Lin28a, respectively.
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3.4 The role of Trim71 in germ cell development
3.4.1 Trim71 expression is restricted to spermatogonial stem cells
(SSCs) in testes
The role of Trim71 in adult tissues and organs is still unknown, however, sev-
eral studies have shown endogenous expression of Trim71 in mESCs. Intriguingly,
there is a significant overlap of proteins which are important for ESCs as well as for
gonadal stem cells [244, 245]. In fact, one study has shown that Trim71 is expressed
in the testes of adult mice [145]. We wanted to validate theses findings and hypoth-
esized that Trim71 expression could originate from the stem cell niche in mouse
testis - the spermatogonial stem cells (SSCs). In order to prove this, we dissected
the testes of 12 week old mice and prepared a cell suspension of the seminifer-
ous tubules. SSCs were enriched by CD90.2 (also known as Thy1.2)-FITC antibody
staining with subsequent magnetic activated cell sorting (MACS) using anti-FITC
antibody coupled microbeads. Both positive and negative fractions were collected.
Using this method we could enrich the fraction of CD90.2 positive cells about five-
fold (from 2.4 % to 13.2 %) (figure 3.40a and b). We performed RT-qPCR and WB
with the whole cell population as well as with positive and negatively enriched cell
populations. We found that the Trim71 mRNA signal was increased about fourfold
in the CD90.2 enriched population in relation to the whole cell population (fig-
ure 3.40c). This reflects quite accurately the increase in the amount of SSCs in com-
parison to the initial cell pool. As a positive control, we also measured Lin28a and
Sall4 mRNA expression which are established marker genes for SSCs [86, 246, 247].
Both genes were elevated to a similar extent as Trim71 in the enriched cell popula-
tion. In contrast, Lin28b mRNA which was reported to be transiently expressed in
postmitotic spermatids as well as in interstitial Leydig cells was slightly decreased
in CD90.2-positive SSCs [248]. In accordance with the mRNA expression data, we
found that Trim71 and Lin28a protein signals were higher in CD90.2 positively se-
lected cells whereas this was not the case for Lin28b (figure 3.40d).
In order to further prove that Trim71 must be primarily originate from undiffer-
entiated spermatogonia we recorded the expression of SSC marker genes during
postnatal development and early spermatogonia differentiation. The pool of adult
SSCs is established after birth by the transient population of gonocytes. In the male
germline, the gonocytes are quiescent until shortly after birth when they start to
migrate into the seminiferous tubule basement membrane (figure 3.41a). From this
point they are referred to as SSCs. Concomitantly, the cell pool is expanded by
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Figure 3.40: CD90.2 positive spermatogonia express Trim71. (a) CD90.2-positive cells were
enriched from testicular cells using MACS, resulting in a 4-fold enrichment of CD90.2 pos-
itive cells (b). (c) RT-qPCR analysis of Trim71 and spermatogonial marker genes before
and after CD90.2 MACS. (d) WB analysis confirms Trim71 expression in positively-selected
cells.
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re-entering of the cell cycle. This expansion of the SSCs results in a characteristic
increase of SSC marker expression at around 1 to 2 weeks after birth. At this time
the first SSCs start to differentiate to give rise to the first wave of spermatogenesis.
Therefore, the number of undifferentiated SSCs decreases again and is stabilized
thereafter to maintain a stem cell pool throughout life. In order to analyze Trim71
expression during postnatal development we took samples of testes of wildtype
mice from day 0 (day of birth) to 8 weeks (adult). We analyzed the tissue sam-
ples for expression of Trim71, Lin28a and Lin28b as well as Sall4 (figure 3.41b-e).
We found a peak expression of Trim71 between days 7 and 14. This was similar
for the SSC markers Lin28a and Sall4. In comparison, Lin28b peak expression was
delayed, with its peak expression between days 14 and 21 (figure 3.41d) with the
beginning of spermatogonia differentiation. These results were confirmed on pro-
tein level using WB (figure 3.41f). Taken together, these results strengthened the
hypothesis that Trim71 expression in testes originates from undifferentiated SSCs.
3.4.2 Trim71 deficiency results in infertility in male and female mice
In order to analyze the requirement of Trim71 expression in the gonads, Trim71
conditional mice were used to generate germline-specific adult Trim71 knockout
mice. For this purpose homozygously floxed Trim71 females were crossed with
Trim71 heterozygous males which additionally expressed the Cre recombinase un-
der the control of the endogenous Nanos3 promoter (figure 3.42a). Endogenous
Nanos3 expression is restricted to primordial germ cells (PGCs) as early as E7.25
and and remains expressed throughout spermatogenesis [159, 201, 250]. This cross-
ing scheme yielded 25% germ-line-specific Trim71 knockout animals which are at
the same time heterozygous for Trim71 in all other tissues (figure 3.42a). For a
first functional evaluation of the Trim71 effect, adult Trim71fl/-/Nanos3 Cre mice
were crossed with wildtype mice. However, neither homozygously targeted males
nor females were able produce offspring in the course of several weeks. This sug-
gested that Trim71 deficiency results in complete infertility in both sexes. The mice
were sacrificed and the reproductive organs were prepared. Macroscopic analysis
revealed that both ovaries and testes were drastically reduced in size indicating
severe defects in the germline of Trim71-deficient mice (figure 3.42b and c).
As the weight of the testis correlates with sperm count in mice and thus has a
predictive value for fertility [251, 252] we measured the testis weight of adult mice
also including mice with additional genotypes of the parental strains. Whereas all
the wildtypic allele combinations (wildtype and floxed alleles) had similar testes to
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Figure 3.41: Trim71 expression in mouse testis during postnatal development. (a)
Schematic overview of pre- and postnatal development of male germ cells. Modified from
Culty et al. (2009) [249]. RT-qPCR analysis of Trim71 (b) as well as Lin28a (c), Lin28b (d)
and Sall4 (e) at indicated time points after birth. Data are means +SD normalized to day 0
(n=3). (f) WB showing peak expression of Trim71 between days 7 to 14 after birth.
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Figure 3.42: Mouse breeding strategy for the generation of germline-specific Trim71
knockout mice. (a) Heterozygous males additionally carrying the Nanos3 Cre allele were
crossed with homozygously floxed Trim71 females. Grey indicates WT (wildtype and
floxed), orange heterozygous and red homozygous Trim71 mutation. The star represents
the germline (ovary and testis) in adult males and females. (b-c) Representative images
of Trim71 ovaries (b) and testes (c) of Trim71/Nanos3-Cre animals. Scale bar represents 2
mm.
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Figure 3.43: Trim71 expression levels are critical for normal testis development. (a)
Testis weight ratios of different genotypes of Trim71/Nanso3 intercrosses. Values are mean
+SEM. Numbers above columns indicate the number of analyzed individuals.(b) Summary
of (a) and statistical analysis testis size from animals wildtype (WT), heterozygous (HET)
and knockout (KO) for Trim71 (ANOVA, Tukey’s test; n=9-27; *** p<0.001).
body weight ratios, the Nanos3-Cre-containing mice displayed a tendency towards
smaller testes (figure 3.43a). This might be explained by the fact that the Cre cDNA
substitutes the endogenous Nanos3 cDNA and thus the Cre-positive mice are by
definition heterozygous for Nanos3. Notably, this effect was in the range of Trim71
heterozygous testes which is in congruence with the general observations made in
heterozygous Trim71 males (see figure 3.43b). Surprisingly, we found that the com-
bined effect of Trim71 and Nanos3 heterozygocity had a remarkable effect on testes
size leading to a weight reduction of more than 50%. Complete knockout of Trim71
led to drastically reduced testis size (figure 3.43a and b). We also found one male
mouse that had transferred a floxed allele from a Nanos3 carrying parental mouse.
This is only possible when Trim71 recombination rates were not 100%. Taken to-
gether, this analysis showed that Trim71 is essential for a proper development of
the mouse testis.
For further analysis of the male germ cell compartment, the expression of SSC
markers was analyzed by RT-qPCR and WB. For this purpose, the before men-
tioned categories of wildtype (WT), heterozygous (HET) and knockout (KO) an-
imals were analyzed. In germ cell KO animals the expression of Trim71 was re-
duced by about 90%, arguing that the recombination rates were generally high,
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Figure 3.44: Trim71-deficient adult testes lack SSCs. (a) RT-qPCR analysis of wildtype
(WT) heterozygous (HET) and knockout (KO) testis for markers genes of spermatogene-
sis. Values are mean +SEM (ANOVA, Tukey’s test; n=3-7; ** p<0.05, *** p<0.001) (b) WB
analysis reveals absence of SSC marker expression in Trim71-deficient testes.
but not complete (figure 3.44a). Nevertheless, there was a strong downregula-
tion of the analyzed SSC marker genes Sall4, Lin28a and Oct4. Furthermore, in
Trim71 heterozygous animals there was also a tendency for downregulation of the
same SSC markers, coinciding with the already reduced testis size in heterozygous
males. The marker gene Lin28b which is expressed in both Leydig cells and matur-
ing spermatocytes showed a downregulation in the knockout but no alteration in
the heterozygous animals arguing that organ integrity is generally still preserved
in testes of heterozygous animals. These results were highly congruent with the
protein analyses from testis tissue that revealed strong downregulation of Lin28a,
Lin28b and the germ cell marker Ddx4 in Trim71 deficient testes (figure 3.44b).
Next, we wanted to investigate if Trim71 expression is required for initial PGC
specification during embryonic development. In order to exclude that at the begin-
ning of germ cell specification the expression of the Nanos3-driven Cre expression
is not yet sufficient for Trim71 deletion, Trim71 heterozygous animals were mated
to yield complete Trim71 knockout embryos. Embryos at stages E8.5 and E8.75
were dissected and the alkaline phosphatase (AP)-positive PGCs were stained. At
stage E8.5 PGCs were detected in close proximity to the allantois in both Trim71-
deficient and wildytpe embryos (figure 3.45). We found similar numbers of AP-
positive PGCs in Trim71-deficient and control embryos and in both groups PGCs
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Figure 3.45: Trim71 deficiency does not impair PGC specification during embryogene-
sis. Alkaline phosphatase staining in Trim71 wildtype and knockout embryos. Alkaline
phosphatase-positive PGCs (white arrows) in posterior hindgut pieces from E8.5 (dorsal
view) and E8.75 (lateral view) sibling embryos from a Trim71+/- mating.
started to migrate along the hindgut at E8.75. These results suggested that Trim71
deficiency elicited the loss of PGCs at later stages of germ cell development.
During the migration and after the arrival of the PGCs at the genital ridges, the
germ cell founder population strongly increases in numbers. Because proliferation
is an important process in PGC development and Trim71 has been formerly im-
plicated in proliferation regulation, we wanted to investigate this specific aspect
in more detail. However, the assessment of absolute cell numbers is difficult in
vivo. Hence, we used an in vitro cell model to analyze the impact of Trim71 knock-
down on proliferation. We could show before that the human seminoma cell line
TCam-2 endogenously expresses Trim71 (figure 3.31). Knockdown of Trim71 using
two different siRNA oligos resulted in a long lasting decrease of cell proliferation
(figure 3.46a and b). Concomitantly, we observed an increase in expression of the
negative regulators of cell proliferation p53, p27 and p21 (figure 3.46c). Therefore, it
can be assumed that Trim71 might be also important for the expansion of the germ
cell pool during embryogenesis.
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Figure 3.46: Trim71 is a positive regulator of proliferation in the seminoma cell line
TCam-2. (a) Bright field microscopy of Trim71 and control siRNA treated TCam-2 cells
four days after transfection. Scale bar represents 200 µm. (b) Normalized cell numbers
in the time course of 7 days post transfection. The graph shows one representative ex-
periment with three technical replicates. (c) Expression analysis of proliferation regulators
seven days after siRNA treatment by WB.
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4 Discussion
Developmental biology has tremendously profited from extensive studies that were
performed using simple model organisms. The reason for this is the high degree
of conservation of genes involved in developmental processes. Despite the un-
deniably large differences regarding morphology, complexity and environmental
adaptation of the investigated organisms, numerous studies have pointed out that
key developmental regulators are consistently maintained during evolution from
the nematode to human [253]. While the investigation of developmental pheno-
types were often the key for elucidating gene functions, most of these genes have
later on been shown to be likewise involved in other biological contexts and condi-
tions. Trim71 is a prime example for genetic conservation, since homologs of this
gene can be found in all common animal model systems, including the nematode,
fruitfly, zebrafish and the mouse. Human Trim71 shares more than 90% identity
on protein level with its mouse homolog, and 41.2% identity with the nematode
homolog lin-41 [254].
In the year 2000, the nematode homolog of Trim71, lin-41, was identified as a
downstream target of the miRNA let-7 and an essential component of the hete-
rochronic pathway [147]. 15 years after the initial discovery of lin-41/Trim71 we
are now introducing the first Trim71 conditional mouse line which allows advanced
analysis of Trim71 functions both in vivo and in vitro.
We started with the phenotypic analysis of the Trim71 full knockout mouse which
was generated with the help of a new conditional targeting allele. We found that
homozygous deletion of Trim71 caused the death of all homozygous animals be-
fore E13.5 [131, 255, 151]. Furthermore, starting at day E9.5, the mutant embryos
displayed severe growth deficits. We could show that Trim71 plays an essential
role in embryonic neurodevelopment because Trim71 deficient mice exhibit a neu-
ral tube closure defect leading to an exencephalus phenotype. The gathered in-
formation suggest that Trim71 is essential for normal embryonic development and
in particular for the development of the central nervous system. Taken together,
our phenotypic analysis of Trim71 deficiency using the new Trim71 conditional
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mouse line further supports published data using other Trim71 knockout alleles
[131, 151, 255]. This is remarkable considering the different structure of Trim71 tar-
geting constructs used. While our new Trim71 conditional allele enables the dele-
tion of the last of four exons, coding for a part of the coiled coil region and the NHL
domain of Trim71, other gene trap insertion mutations disrupt the Trim71 gene al-
ready after the first exon [131, 255]. This suggests that the NHL domain, which is
affected in all reported mouse alleles, is essential for Trim71 protein function.
Apart from the embryonic phenotype of Trim71 mutant mice, we noticed that
also Trim71 heterozygously targeted adult mice displayed specific defects, which
has not been reported so far. Usually heterozygous deletion phenotypes are com-
paratively rare, because reduction of the mRNA/protein amount by half is usually
well tolerable. However, in Trim71 heterozygous mice both male and female mice
displayed a growth retardation resulting in a reduced body weight and length.
This is very characteristic for metabolic defects and cannot be sufficiently explained
with the currently known expression pattern of Trim71 in the adult organism [131].
Database studies have shown that both the haploinsufficency phenotype in mice as
well as the functional association of a gene with early development morphogene-
sis predisposes a gene to be haploinsufficient in humans, too [256, 257]. Whereas
it is quite likely that homozygous mutations of Trim71 would lead to the death
of the embryo during early development also in humans, single loss-of-function
mutation carriers might exist. Currently, there are only 13 haploinsufficient genes
known that cause growth retardation in humans [256] and thus Trim71 might be a
so far unknown disease gene.
4.1 Trim71 negatively regulates differentiation in mESCs by
suppression of pro-differentiation mRNAs and miRNAs
In comparison to the description of the embryonic Trim71 knockout phenotype, the
data concerning the molecular function of Trim71 are less consistent. The NHL do-
main of Trim71 has been proposed to act as an RNA-binding domain (RBD) which
enables the protein to function as a posttranscriptional regulator of target gene ex-
pression [152, 70, 156]. Independently of that, Trim71 has also been implicated in
miRNA biology [145, 155].
All available studies so far either worked with RNAi-mediated knockdown or
overexpression of Trim71 but both methods are very prone to generate artifacts.
Therefore, there was a strong demand for establishing a defined knockout cell sys-
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tem for Trim71, in order to solve fundamental issues raised in the last years of
research on Trim71. Mouse embryonic stem cells (mESCs) are especially suitable
as a model system because Trim71 is endogenously expressed in mESCs, where it
was shown to belong to a pool of stem cell-specific RNA-binding proteins (RBPs)
[70, 153, 152, 156]. Moreover, there have been controversial discussions whether or
not Tim71 is actually required for mESC maintenance [153, 156].
Therefore, we derived mESC lines form Trim71fl/fl- Rosa26-Cre-ERT2 mice to con-
trol Trim71 allele conversion in vitro. The major advantage of this in vitro mutagen-
esis system in comparison to individual knockout mESC clones is that it enables the
comparison of Trim71 knockout mESCs with their cognate parental cell line. This
is specifically important in the light of recent evidence for substantial inter-clone
differences of human and mouse ESCs, for example regarding epigenetic marks
[258, 259].
Notably, the mutagenesis of Trim71 in undifferentiated mESCs did not result
in spontaneous differentiation and cell proliferation was not impaired. In order
to obtain an unbiased overview on the mRNA and miRNA expression profile of
Trim71-deficient and control cells, we performed high-throughput sequencing in
collaboration with the group of J. L. Schultze (LIMES Institute, Bonn). Significantly,
there were very few differentially expressed (DE) genes known to be involved
in stemness regulation, which corroborates our evaluation of a normal stemness
phenotype in Trim71-/- mESCs (see also the extended analysis in Mitschka et al.
[172]). While the RNA-seq analysis revealed that some of the DE genes in TRim71-
deficient mESCs were functionally associated with the regulation of proliferation
and apoptosis, this seems not to be the primary function of Trim71 in mESCs,
which proliferated normally in the absence of Trim71. In contrast, we clearly found
diminished proliferation in the cancer cell line TCam-2 after Trim71 knockdown.
Similar effects might play a role once differentiation is initiated and the levels of
ESC-specific cell cycle regulating (ESCC) miRNAs decrease which were shown to
actively support proliferation in mESCs [50]. In summary, Trim71 is not essential
for mESC proliferation but this does not exclude the involvement of Trim71 in pro-
liferation regulation in other contexts.
While the stemness network was clearly intact in Trim71-deficient mESCs, we
found that many pro-differentiation genes were deregulated. Especially genes as-
sociated with neurodevelopment were affected. In addition, we could demonstrate
that the measured changes in gene expression were not due to spontaneous dif-
ferentiation but instead inherent in the whole cell population. Using two different
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approaches, we could show that neural differentiation was enhanced in Trim71-
deficient cells when mESCs were stimulated in vitro. This is very much in line with
the prevalent phenotype in the mouse embryo lacking Trim71 expression, where
a premature differentiation of neural precursor cells has been observed ([151] and
Tobias Goller, unpublished data). It is tempting to speculate that an accelerated
differentiation of neural precursor cells might be the cause of the malformations in
Trim71 knockout embryos. Although there are studies performed on other genetic
mutations that imply a connection between the neural differentiation behavior of
mESCs in vitro and a neural tube closure defect in vivo [260, 261, 262], this needs to
be further investigated in the case of Trim71.
The neuroectodermal priming of Trim71-/- mESCs clearly suggests that Trim71
might in general control neural differentiation. We found that Trim71 expression in
the neuroepitheleum is steadily decreasing in vivo and this might be necessary to
limit differentiation until the appropriate time point. Pro-differentiation mRNAs
are constantly transcribed at low and medium levels in undifferentiated mESCs
and RBPs like Trim71 are needed to suppress their protein expression posttran-
scriptionally. In line with this, an interesting study which had employed C. elegans
as a model system has shown that Trim71 overexpression enhances the ability of
neurons to regenerate axons [154]. Although we and others have not found Trim71
expression in neuronal stem cells, a very recent publication found that Trim71 be-
comes re-expressed in the postnatal brain in the ependymal stem cell niche [255].
Therefore, the controlled manipulation of Trim71 expression levels might help to
increase the plasticity and connectivity of neuronal circuits after brain injury.
Concomitantly with the de-repression of pro-differentiation mRNAs in Trim71-
deficient mESCs, we also found that the expression of neuro-specific miRNAs was
enhanced in Trim71-deficient mESCs in comparison to wildtype cells. Among the
upregulated miRNAs were the brain-specific miRNAs miR-9 and miR-124 which
were shown to affect the neural lineage differentiation in vitro [263]. Furthermore,
miR-9 target genes were have been shown to regulate neural progenitor prolifera-
tion, migration and differentiation also in vivo [264, 265]. Overexpression of miR-9
has been demonstrated to reduce the number of proliferating neural precursor cells
in zebrafish [266], chicken [267] and mouse [268] embryos. In addition, Lim et al.
showed that the overexpression of miR-124 in Hela cells shifts the mRNA expres-
sion profile towards that of brain [269]. The relevance of these two miRNAs for the
instructive fate determination is further highlighted by the study of Yoo and col-
leagues who found that overexpression of these two miRNAs can convert human
134
4.1. Trim71 negatively regulates differentiation in mESCs by suppression of
pro-differentiation mRNAs and miRNAs
Pluripotent cells Somatic cells
Stemness 
factors
Lineage-specific 
differentiation 
inhibitors, 
e.g. Trim71
Wildtype
Trim71 KO
a b
time
di
ffe
re
nt
ia
tio
n 
m
ar
ke
rs
Trim71 expression
Figure 4.1: Spatio-temporal control of cell fate differentiation by Trim71 (a) Stemness-
maintaining and differentiation-regulating factors guide lineage-specific mESC differentia-
tion. (b) Enhanced neural differentiation in Trim71-deficeint mESC is casued by premature
de-repression of pro-differentiation mRNAs and miRNAs.
fibroblasts into neuronal cells, a process that can be further facilitated by the addi-
tion of neuro-specific transcription factors [267]. Therefore, we speculate that the
overexpresison of miRNAs that are relevant for neural commitment and differenti-
ation might contribute to the functional phenotype seen in Trim71-deficient mESCs
upon induction of differentiation.
Our analysis of undifferentiated mESCs showed that stemness-supporting and
differentiation-limiting factors constitute distinct regulatory levels of stem cell main-
tenance (figure 4.1a). Therefore, activation of pro-differentiation mRNAs and miR-
NAs alone is not sufficient to induce differentiation. Furthermore, Trim71 seems
to be a lineage specific differentiation inhibitor, which implies that several such
regulators are acting together to guide lineage-specific cell fate determination. Al-
though it cannot be excluded that those safeguards might additionally help to stabi-
lize the undifferentiated cell state in mESCs, their actual importance becomes only
apparent after downregulation of the stemness maintaining factors upon differen-
tiation-inducing signaling (figure 4.1b). Further unraveling this second line of con-
trol will certainly help to understand the dynamics of cell commitment and is likely
essential for the clinical application of stem cell therapy.
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4.2 Trim71 decreases the stability of target mRNAs
Our unbiased mRNA sequencing identified both significantly down- and upreg-
ulated genes in Trim71-/- mESCs, together accounting for about 2.5-2.8% of the
mESC transcriptome (depending on data normalization). Independent verifica-
tion of the RNA-seq results performed on a group of candidate genes showed that
the screening was highly reliable in identifying Trim71-mediated gene regulation
targets. However, only some of the significantly upregulated genes in Trim71-/-
mESCs were indeed targeted on posttranscriptional level in a Trim71-dependent
manner. Hence, the other differentially regulated genes, especially the downregu-
lated genes in Trim71-/- mESCs, must be the result of alternative Trim71-dependent
mechanisms and indirect effects. Although the number of investigated genes needs
to be further increased, these results support the notion that Trim71 primarily acts
as a suppressor of mRNA stability. Trim71 might thus act as an adapter between
specifically bound mRNAs and the mRNA-degrading machinery. Whether Trim71
might additionally influence mRNA translation efficiency of target mRNAs needs
to be further investigated.
The characteristics of target repression were investigated in more detail using
the 3’UTRs of two responsive genes: Plxnb2 and Foxj1. Significantly, both genes
are also implicated in developmental processes. As a transcriptional regulator of
motile cilia, Foxj1 regulates the commitment of cileated cells via modulation of
cellular responses to Sonic hedgehog signaling in different tissues e.g. the airway
epithelium [196] and the neural tube [270]. Foxj1 deficient mice exhibit defects
in postnatal neurogenesis due to alterations in proliferation and differentiation of
neural progenitor cells [197, 271]. Furthermore, Foxj1 was shown to be differen-
tially regulated in different types of cancer [272, 273]. Plxnb2, on the other hand, is
a transmembrane receptor for semaphorins that participates in axon guidance and
cell migration. During development, Plxnb2 is expressed in the central nervous
system but its mRNA expression becomes restricted to the subventricular zone of
the brain and the vascular system in adults [192, 274].
By investigating these two candidate genes, we could gain valuable insights
into the mechanism of Trim71-dependent mRNA repression. The NHL domain
of Trim71 serves as the RNA-binding element [152] and seems to confer binding
specificity, since overexpression of the structurally related Trim32 did not yield re-
pression of Trim71 target genes. However, we found that the NHL domain alone
is not sufficient for target gene repression. The N-terminal domains of Trim71 reg-
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ulate target gene repression as well, either by modulating the binding of Trim71
to target mRNAs or by coupling these to downstream effector molecules. In ad-
dition, we found that the N-terminal coupling of a bulky eGFP-tag altered Trim71
protein functions, as cells overexpressing this N-terminally-masked Trim71 behave
like Trim71-/- mESCs regarding mRNA suppression. This N-terminally-masked
Trim71 protein is likely to compete with the endogenously expressed functional
Trim71 for binding to response elements located in the 3’UTR of target mRNAs
which results in de-repression.
We also identified a function of the intrinsic E3-ligase activity for target gene
repression, since a RING domain mutant of Trim71 did not result in target mRNA
regulation. Since it was shown that Trim71 can modify itself by auto-ubiquitination
[145, 151] this suggests that the enzymatic activity of Trim71 intrinsically regu-
lates its own function, e.g. target mRNA binding. Significantly, none of the cur-
rently proposed ubiquitination targets could be independently verified by others
[145, 151, 155] which raises the question if the E3-ligase activity of Trim71 is rather
a mean of self-regulation instead of needed for classical protein degradation. A
similar mechanism has been identified for the TRIM-NHL protein Trim32, where
it was found that exogenous signaling causes phosphorylation of Trim32, which
in turn induces auto-ubiquitination. Ubiquitinated and non-modified Trim32 were
shown to preferentially associate with separate protein complexes and also local-
ize differently within the cells [275]. In line with this, unbiased mass spectrometric
analysis performed in steady state mESCs and embryonic carcinoma cells has al-
ready provided evidence for both conserved phosphorylation and ubiquitination
of Trim71 [276].
We could exclude the necessity of miRNA binding sites within the 3’UTRs for
Trim71-dependent repression. However, it needs to be further investigated whether
the entire miRNA protein machinery is likewise dispensable for the repression.
For both analyzed candidate genes, Plxnb2 and Foxj1, several spatially separated
Trim71 response elements were located apart from each other in the 3’UTR. By con-
secutive shortening of the 3’UTR we detected a step-wise decrease of reporter gene
repression. This result is compatible with several interpretations: First, a number
of short Trim71 binding sequences could be located within the 3’UTR and only the
cooperative binding yields the full repression effect. Second, other mRBPs could be
involved, which either function in a complex together with Trim71 or act in cis on
binding to the mRNA. A similar mechanism has been recently proposed by Loedige
and colleagues who found that the Trim-NHL protein Brat associates together with
137
4.3. Trim71 as a new regulator of let-7 biogenesis in mESCs
Pumilio and Nanos, each of them binding to distinct sequence elements within the
target mRNAs [141].
Until today the precise sequence requirements for Trim71 are still unknown and
thus the identification of the consensus binding site will be a main research topic for
the future. It must be highlighted that most mRBPs have very short binding sites
which can also be degenerated and are thus difficult to identify. Methods like PAR-
CLIP offer the possibility to catch RPBs in action and identify the bound mRNAs
by subsequent sequencing.
4.3 Trim71 as a new regulator of let-7 biogenesis in mESCs
Apart from RBPs, miRNAs represent a second common cellular mechanism for
posttranscriptional expression regulation. Several Trim-NHL proteins across dif-
ferent species have been proposed to regulate miRNA activity and biogenesis, i.e.
NHL-2 [144], Mei-P26 [142] and Trim32 [143]. Trim71 was first associated with
miRNA biology in a study which proposed Trim71 to be the mediator of Ago2
degradation, the bottleneck-protein of miRNA biogenesis and function [145]. In
order to prove their hypothesis, the authors chose let-7 as a candidate miRNA
and could show that let-7 expression was inversely proportional to Trim71 levels.
However, several studies trying to recapitulate these results could not find Trim71-
dependent downregulation of Ago2 [151, 152, 153]. In parallel with the present
study another publication came out which identified Lin28b as a binding partner
and ubiquitination substrate of Trim71. In line with this, they stated that Trim71
would actually be inducing let-7 expression [155]. Taken together, there has been
an inconclusive debate on whether Trim71 affects miRNA expression and function,
and if so, by which mechanism.
The studies published so far were either performing transient overexpression of
Trim71 likely generating an unphysiological excess of protein in the cell, or siRNA-
mediated knockdown, which on the other hand largely depends on Ago2 function-
ality. Both methodologies could thus produce undesired side effects which might
not reflect the behavior of Trim71 in a normal cellular environment. Taking ad-
vantage of the new genetic mESC model for conditional Trim71 mutagenesis as
well as by acquiring additional cell line data, we were able to shed light on this
issue. We found that Trim71 deficiency leads to partial de-repression of mature let-
7 miRNAs in mESCs. In congruence with others, we found that Trim71 associates
with the RISC protein Ago2 in P-bodies [145, 151, 152, 153]. However, Ago2 protein
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levels were completely unaffected in Trim71-deficient cells, arguing that Trim71 is
not regulating Ago2 stability or turnover in mESCs. Nevertheless, some miRNAs
still showed differential expression in Trim71 knockout mESCs, but this might be
mostly due to an altered transcriptional regulation. However, in the specific case
of let-7 miRNAs, we could find an increase of let-7 abundance in Trim71-deficient
mESCs while let-7 transcription was unaffected.
As an alternative mechanism to Ago2 protein regulation, we propose the func-
tional cooperation of Trim71 with Lin28 proteins for the efficient repression of let-7
maturation. The mechanism of let-7 miRNA repression by the stem cell protein
Lin28 is a well accepted and thoroughly investigated aspect of miRNA research
[236, 238, 239, 277]. Lin28 proteins have a high affinity for the conserved loop
region of pre- and pri-let-7 miRNAs which allows Lin28 to compete with Dicer
for pre-let-7 binding [238, 239]. Apart from sequestration, Lin28 can furthermore
actively reduce the pool of available pre-let-7 miRNA by recruitment of the en-
donucleases Tut-4 and Tut-7, which modify precursor miRNAs by attaching sev-
eral uridine residues [64, 238]. Poly-uridylated pre-miRNAs are then recognized
and degraded by the endonuclease Dis3l2 [65, 242]. The Lin28b isoform might ad-
ditionally sequester pri-let-7 in the nucleus [66]. The discovery of this mechanism
solved an apparent paradox in stem cell research: The transcription rate of let-7
sequences is permanently high in undifferentiated ESCs while at the same time the
levels of mature let-7 miRNAs are relatively low. Therefore, we identified Trim71
as a new modulator of the bistable switch of let-7 and Lin28 which regulates the
balance between stemness and differentiation (figure 4.2).
We have mapped the region of interaction with Trim71 to cold-shock domain
(CSD) of Lin28a which exhibits 84% identity at the amino acid level (Uniprot [278])
to closely related paralog Lin28b. Therefore, we were not surprised to also find an
interaction between Trim71 and Lin28b. Both paralogs are found in the cytoplasm
and the nucleus and the repertoire of bound mRNAs and miRNAs is in great part
overlapping [63, 77, 89, 236, 237]. Because Trim71 is a strictly cytoplasmatic protein,
the association of Trim71 is restricted to the cytoplasmic fraction of Lin28 proteins.
In congruence with other studies we find that the expression of the Lin28 paralogs
is cell type-dependent.
We found a striking pattern of coexpression of Trim71 with either Lin28a or
Lin28b.This is likely the result of common transcriptional and posttranscriptional
expression regulation. For instance, it was found that the transcription of both
genes is majorly regulated by the transcription factor c-Myc [279, 280, 281]. Fur-
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thermore, both genes are subject to posttranscriptional regulation by the miRNAs
let-7 and miR-125 [208, 277]. Hence, there is a abundant expression of Trim71 and
Lin28 in undifferentiated mESCs which declines upon induction of differentiation
[70]. Both proteins are also strongly expressed during embryonic development
[131, 151, 237, 282, 283]. The same applies for germline cells, which are positive
for both Trim71 and Lin28a [86, 145, 248, 284].
Lin28a knockout results in postnatal death of the majority of homozygous off-
spring and the surviving animals display severe dwarfism [82]. Furthermore, also
Lin28b was shown to be important for pre- and postnatal growth [81] similarly to
Trim71 heterozygous knockout mice. Interestingly, a combined knockout of Lin28a
and Lin28b results in embryonic death of all animals by E12.5. The affected ani-
mals also exhibit a retardation in growth and some additionally display a neural
tube closure defect [81]. Very recently, Lin28a deficiency was also found to reduce
neural progenitor proliferation in the developing brain [285]. Taken together, the
described Lin28a/b deficiency phenotypes show striking similarities to the phe-
notype of Trim71 mutant mice and further corroborate a functional cooperation of
Trim71 and Lin28 proteins.
Nevertheless, the question arises as to why there would be the need for an ad-
ditional regulator of the let-7 biogenesis pathway apart from Lin28. The concept
of Lin28 mediated let-7 repression still lacks an essential component: the switch
that deactivates Lin28a repression once differentiation is induced. Up to this day,
there is no mechanism known that would modulate the ability of Lin28 to bind to
pre-let-7 or to deliver it to the degradation pathway. Our data indicate that the
release of the interaction of Trim71 and Lin28a does partially release this repres-
sion of let-7 maturation, yet without inducing differentiation. In undifferentiated
mESCs, opposing miR-290 miRNAs were shown to keep let-7 function in check
[49]. As mentioned before, Trim71, as an E3-ubiquitin ligase, is able to mediate
auto-ubiquitination. Again we found a relationship between the modification-state
of Trim71 and its activity regulation. Whereas the E3-ligase mutant of Trim71 was
not able to efficiently repress target mRNAs, the opposite was the case for Lin28
binding. The relative abundance of the modified versus the non-modified Trim71
could be decisive for let-7 repression activity and thereby the timing of differentia-
tion (figure 4.2).
In the future, it will be of great interest to investigate by which mechanism Trim71
enhances the Lin28-dependent let-7 repression. One plausible option would be that
the binding of Trim71 directly increases the affinity of Lin28a for the let-7 precur-
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Figure 4.2: Trim71 fine-tunes the balance between let-7 and Lin28 for the regulation of
stem cell differentiation.
sors. However, Lin28a was shown to bind to pre-let-7 in vitro with high affinity in
the absence of Trim71 [62, 64, 286] which refutes this theory of affinity regulation.
Alternatively, Trim71 could facilitate the recruitment of the TUTase to the pre-let-
7/Lin28a complex. Finally, there is the possibility that Trim71 majorly affects the
protein localization of Lin28 by acting as a molecular anchor to the P-bodies. Lin28
proteins can potentially localize to ER complexes, P-bodies, stress granules and
the nucleus [77, 90]. Since the pool of available Lin28 protein is limited, a factor
that influences the localization would have tremendous influence on target repres-
sion. Further evidence supporting this argument may lie in the finding that also the
mRNA target spectrum of Trim71 and Lin28a partially overlap. In line with this,
the overlapping targets would not be bona fide Trim71 targets but rather Lin28 re-
sponsive targets that are less occupied in the absence of Trim71. It is still unknown
how cells balance the various effector functions of miRNA and mRNA regulation
by Lin28. The investigation of the precise mechanism will be important to the field
and will contribute to the understanding of both let-7 biogenesis regulation and
mRNA suppression.
Along with certain transcription factors, overexpression of Lin28a can induce re-
programming of fibroblasts to iPSCs. This phenomenon was explained by the abil-
ity of Lin28a to suppress let-7 biogenesis [3] since the molecular inhibition of let-7
had a similar effect as Lin28a overexpression and both strongly enhanced repro-
gramming efficiencies [49, 156]. A study from Worringer and colleagues aiming
to identify the major let-7 target proteins (apart from Lin28) that would mediate
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this effect, found that the RBP Trim71 alone was able to enhance reprogramming
efficiency to a similar extent as let-7 inhibition [156]. The authors attributed this
effect to the ability of Trim71 to regulate other downstream mRNA targets by post-
transcriptional mechanism. However, in the light of the present study, it seems
worthwhile to speculate that Trim71 also directly helps to overcome the let-7 bar-
rier to facilitate reprogramming. Because Trim71 and Lin28a are endogenous let-7
target genes, this would further shift the balance towards more efficient let-7 re-
pression. As a consequence, Trim71 reprogramming effects would be mediated
both upstream and downstream of let-7.
It will be of specific importance to investigate into processes that were already
known to be modulated by the Lin28/let-7 axis in the context of Trim71. One of
them is the role of Trim71 in cancer. Many cancers were shown to downregulate
let-7 miRNAs which is generally linked to phenotypic de-differentiation. Among
the tumors that have shown responsiveness to let-7 and Lin28a expression levels
are lung cancer [287], breast cancer [288], ovarian cancer [289] and hepatocellular
carcinoma [89], the latter being the first tumor model where Trim71 was already
being correlated with tumor-promoting function [280].
4.4 Germ cell development critically depends on Trim71
protein expression
Trim71 is receiving more and more attention in the scientific community in recent
years, but there is still a large backlog concerning the role of Trim71 in adult tis-
sues or organs. Until now only two studies have described Trim71 expression in
adult tissues or organs in mammals, namely in ependymal cells of the brain and in
testes of mice [145, 255]. However, these previous studies had only descriptive and
generic character and did not contribute any functional data.
Using the new conditional Trim71 knockout allele, we were now able to gener-
ate a tissue-specific adult Trim71 knockout mouse. In a first approach, we decided
to target the germ cell niche which seemed a promising candidate for several rea-
sons: First, Rybak et al. had detected Trim71 mRNA in adult testes of mice [145]
- a finding that we could recapitulate. We found Trim71 expression in the small
population of spermatogonial stem cells (SSCs) which represent the stem cell niche
of the male reproductive organ in which self-renewal and differentiation is tightly
controlled. Second, we noticed that Trim71 heterozygous male mice had already
20% smaller testes than wildtype littermates. This led us to conclude that the level
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of Trim71 expression might be critical for proper organ development. Furthermore,
germ cells show striking similarities to ESCs, the model in which most functional
research on Trim71 has been performed so far. We and others have investigated
the role of Trim71 with regard to pluripotency regulation in mESCs [152, 153]. By
definition, pluripotency marks the ability of cells to give rise to all cells of the adult
body. Sperm and egg cells are the precursor cells of a new organism and can thus be
considered as the real biological equivalent of generation-spanning pluripotency.
The similarity is further illustrated by the finding that primordial germ cell (PGC)-
derived embryonic germ cells are the only cells apart from ESCs that can prolif-
erate indefinitely in culture without undergoing malignant transformation. After
re-transplantation into a blastocyst, embryonic germ cells can also contribute to all
embryonic tissues [290, 291, 292]. Last, several marker genes are unique for both
undifferentiated ESCs and PGCs, such as Oct4[293], Nanog [294], Lin28a [86, 247],
Sall4 [295], Dppa3 [296] and Iftm3 [296].
By crossing conditional Trim71 mice with mice carrying the Cre recombinase un-
der the control of the Nanos3 promoter, we could generate adult germline-specific
Trim71 knockout mice. Nanos3 is an RBP that is exclusively expressed in PGCs as
early as E7.25 and throughout spermatogenesis [159, 201, 250]. We found that ho-
mozygous deletion of Trim71 in the germline leads to infertility of male and female
mice. Both ovaries and testes were drastically reduced in size and SSC marker
expression analysis in Trim71 knockout testes revealed the absence of germ cells
in adult mice. The fact that both sexes were equally affected in germline-specific
Trim71 knockout mice suggests that Trim71 expression might be relevant in an
early step of germ cell development. Divergent gene expression in PGCs of male
and female embryos can be first observed at E10.5 and the cell fate is considered
irreversible at E13.5 (reviewed in [297]). At this time point, female germ cells start
entering meiosis while male germ cells do not undergo meiosis until after birth.
Due to the lack of adult germ cells we tested whether PGCs are actually specified
in the embryo. The fact that we found similar numbers of PGCs in wildtype and
Trim71 knockout animals at E8.5 suggests that initial PGC specification does not
require Trim71. Moreover, we have observed directed cell migration to the genital
ridges, which excludes that the migration behavior or chemokine sensing are the
primary cause of the defect. Thus it seems likely that Trim71 knockout PGCs would
subsequently arrive at the genital ridge at around E10.5. The evidence presented
here would therefore suggest that Trim71 deficiency leads to the loss of PGCs in
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the time frame between E10.5 and E13.5. However, this hypothesis requires further
experimental validation.
Right before and after arrival at the genital ridges, the population of PGCs in-
creases drastically from about 250 to 25,000 cells in wildtype embryos [298]. It has
preciously been proposed that siRNA-mediated downregulation of Trim71 could
lead to decreased proliferation by upregulation of the gene Cdkn1a [153]. The pro-
tein product of Cdkn1a, p21, is a negative regulator of cell proliferation. Indeed, we
found that Trim71 knockdown in TCam-2 cells, a germ cell derived seminoma cell
line, reduced proliferation and likewise elevated the protein expression of the cell
cycle regulators p21, p27 and p53. This is contrast to the Trim71-/- mESCs which
do not a exhibit deficits in proliferation, suggesting that this function of Trim71 is
cell context-dependent. It was shown that Dicer mutants of the germline also ex-
hibit deficits in PGC proliferation, however this does not ablate the whole pool of
germ cells [299]. Hence, it seems worthwhile to speculate that PGC proliferation
regulation alone would not sufficiently explain the drastic phenotype of Trim71
mutation. Last, we found that a great part of differentially expressed miRNAs in
Trim71-deficient mESCs are considered as germ cell-specific. Throughout germ cell
development, factors are required that actively suppress the somatic cell fate. The
most prominent is the Prdm1 protein that is involved in the suppression of somatic
program by repressing the expression of Hox genes [100, 300] at the transcriptional
level. Germ cell-specific RBPs like Nanos3 further assist the suppression of so-
matic genes at the posttranscriptional level. In fact, the evidence gathered so far
regarding the Trim71 deficiency phenotype shows striking resemblance to Nanos3
deficiency in mice. Moreover, we found Nanos3 among the significantly down-
regulated genes in undifferentiated Trim71-/- mESCs. In Nanos3 knockout mice,
the PGC population progressively shrinks due to somatic differentiation as well as
apoptosis [159]. Furthermore, the Trim71 homolog in drosophila, Brat, was found
to cooperatively bind and repress target mRNAs together with the RBPs Nanos and
Pumilio [141]. Both Pumilio and Nanos proteins are highly conserved and are also
involved in germline development [301, 302, 303]. In the transgenic Nanos3 Cre
mouse line that we used for germline targeting of Trim71, the Nanos3 coding se-
quence is substituted with the Cre gene on one allele. Due to this, Cre-positive mice
are concurrently heterozygous for Nanos3. Like for Trim71, Nanos3 heterozygocity
already slightly reduced testis size in comparison to wildtype animals. However,
when both genes were present in the heterozygous state, the size of testes was
dramatically reduced, speaking for a functional cooperation of both proteins in a
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common pathway. Besides Nanos3, also the RBPs Tiar and Dnd1 have also been
shown to cause loss of PGCs during development [304, 305]. Our global expression
analysis performed in mESCs showed that Trim71 is actively involved in the sup-
pression of somatic neural cell fates and Trim71 knockout led to the upregulation
of pro-differentiation genes. The resulting overexpression of neural lineage deter-
mining genes might very well interfere with proper germ cell identity. Moreover,
we found that some of the significantly downregulated genes in Trim71 deficient
mESCs were functionally associated with reproductive processes and fertility.
In parallel with the present study, two independent studies found that the nema-
tode homolog of Trim71, lin-41, is required for normal oocyte maturation [306, 307].
In lin-41 deficient nematodes, oocytes precursor cells spontaneously differentiated
and the authors proposed that this might be due to insufficient suppression of so-
matic lineage-specific markers such as Hox genes [306]. However, in stark contrast
to our own observations in Trim71 germline knockout mice, the male germline was
not affected in Trim71 mutant nematodes.
In addition, the expression regulation of the miRNA let-7 also plays an important
role in gem cell development because germ cell specifiers such as Prdm1 are direct
targets of let-7 miRNA-mediated suppression [284]. Hence, deficiency in the let-7
master regulator, Lin28a, reduces the germ cell pool, however, the phenotype is not
as drastic as seen for Trim71 knockout animals [86].
To improve the understanding of the processes governing germ cell biology is
generally of great interest since it might pave the way for new therapeutic applica-
tions in the fields of reproductive medicine and cancer treatment. Testicular cancer,
which in the majority of cases has a germ cell origin, is the most common cancer
in men between 20 and 39 years of age [308]. Although the chances of success-
ful treatment for this type of cancer have greatly improved in the last years, this
achievement is partially overshadowed by a drastically rising overall prevalence of
germ cell tumors, especially in the western world [309, 310]. The reasons for this
are still unknown. In the present study, we found that a number of human embry-
onic carcinoma and a seminoma cell lines (both germ cell-derived) were positive
for Trim71 expression and it seems likely that many clinical tumors are likewise ex-
pressing Trim71. As mentioned before, the knockdown of Trim71 caused a decrease
in cell proliferation of the seminoma cell line TCam-2. The development of a com-
pound that acts as an inhibitor for Trim71 could thus be of great therapeutic value.
A major drawback of most applied chemotherapies is that they directly target very
central components of common pro-proliferation pathways. The fact that Trim71
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has a very restricted expression pattern in the adult organism can be considered as
an advantage, since it minimizes the expected side effects caused by the treatment
with a Trim71 inhibitory drug.
On the other hand, infertility is a worldwide problem, affecting up to 15% of the
reproductive-aged couples [311]. It is estimated that 40% of the cases can be at-
tributed to the man, 40% to the woman and the remaining 20% might be caused
by combined problems of both partners or are unexplained [312]. In most cases the
genetic causes of the infertility are unknown. Trim71 may be considered as a rele-
vant gene that might help to understand cases of genetically caused infertility. In
addition, changes in lifestyle, especially in the western world, have delayed family
planing resulting in reduced fecundity due to the increase in age. This is why there
is an increasing demand to fight age-related decline of natural fertility, and in the
same line to further improve assisted reproductive technologies. Hence, it is impor-
tant to catalog genes that directly affect fertility. The fact that testis size in mice was
already affected in Trim71 heterozygous mice suggests that also humans with het-
erozygous mutations in the Trim71 gene might be categorized as subfertile. Only
when the mechanisms underlying the maintenance and differentiation regulation
of germ cells are sufficiently understood, effective treatment can be developed.
In summary, this study unraveled important aspects of Trim71 functions in the
regulation of cell fate determination in both embryonic stem cells and the devel-
oping germline. Trim71 could be established as a suppressor of alternative gene
expression states which is not essential for stem cell maintenance but for proper
spatio-temporal control of cell lineage differentiation.
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5 Summary
The formation of complex tissues and organs from a limited set of stem and progen-
itor cells requires precise regulation of the balance between stem cell maintenance
and differentiation. In the present study we introduce Trim71 as a novel regula-
tor of this balance. Trim71 heterozygous mice exhibit lifelong growth retardation,
while complete deficiency of Trim71 causes defects in neural tube closure and em-
bryonic lethality. To unravel the molecular processes regulated by Trim71, we de-
rived mESC lines in which the Trim71 gene can be conditionally mutated in vitro.
Interestingly, Trim71 knockout mESCs display no deficits in the maintenance of
stemness in steady-state conditions. However, upon induction of differentiation a
premature upregulation of neural marker gene expression can be observed, which
is in accordance with the already described phenotype of the Trim71 knockout mice
[151]. High-throughput sequencing of mRNAs and miRNAs in Trim71-deficient
and control mESCs revealed that neuroectodermal priming already occurred in
undifferentiated mESCs. While genes associated with stemness regulation were
majorly unaffected, Trim71 deficiency led to an upregulation of both mRNAs and
miRNAs involved in neuroectodermal development. We could show that Trim71
reduces the stability of specific target mRNAs via response elements located in their
respective 3’UTRs.
Furthermore, we found that Trim71 is involved in a feedback mechanism regulat-
ing the expression of the pro-differentiation miRNA let-7. We propose that Trim71
cooperates with the stem cell protein Lin28 to facilitate repression of let-7 miRNA
maturation in undifferentiated mESCs. We observed co-localization and physical
interaction of Trim71 with Lin28 and found functional cooperation of both proteins
in different cell types which led to the repression of let-7 maturation. These results
suggested that Lin28 was necessary and sufficient for the function of the Trim71
protein as a let-7 repressor, and this was confirmed by ablating the Lin28 gene in
mESCs using TALEN-based genome engineering. Importantly, Trim71 and Lin28
are both relevant targets of let-7 and are downregulated once differentiation is in-
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duced. Therefore, our data establish a role of Trim71 as an important regulator of
the bistable let-7/Lin28 switch in mESCs.
Last, we were interested to investigate the role of Trim71 in the adult organism.
For this purpose, we used the conditional Trim71 allele to generate a germ cell-
specific Trim71 knockout mouse. Deletion of Trim71 in the germline leads to infer-
tility of both male and female mice. Whereas initial germ cell fate determination
seems not to be impaired in Trim71 knockout mice, we found that Trim71 is essen-
tial for the survival of these cells during embryonic development. Moreover, we
showed that Trim71 expression is retained in the spermatogonial stem cell popula-
tion of the testis in adult mice.
Taken together, the acquired data reveal important aspects of Trim71 functional-
ity that might further the understanding of cell fate programming and maintenance
in both normal and pathophysiological conditions.
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Appendix
i
Upregulated genes in Trim71-/- mESCs
Rank Gene FC p-value Rank Gene FC p-value
1 Gm364 6,01 0,0016 31 2610528J11Rik 2,31 0,0176
2 Foxj1 4,50 0,0364 32 Bend5 2,27 0,0334
3 Rsad2 4,30 0,0093 33 Rapgef3 2,24 0,0268
4 Ccr4 4,15 0,0012 34 Slco4a1 2,23 0,0004
5 Slc6a1 4,09 0,0095 35 Zbtb7c 2,20 0,0088
6 Nfia 4,03 0,0223 36 Hopx 2,15 0,0093
7 Nrg2 3,72 0,0290 37 Wdr78 2,14 0,0474
8 Adrb1 3,65 0,0287 38 E030030I06Rik 2,13 0,0280
9 Vsig2 3,53 0,0118 39 Tcf15 2,11 0,0171
10 Pifo 3,37 0,0037 40 Kifc3 2,08 0,0559
11 Nkx6-3 3,30 0,0280 41 Gbx2 2,07 0,0448
12 Pglyrp1 3,29 0,0147 42 Gpx2 2,07 0,0001
13 Esam 3,16 0,0365 43 Cdkl4 2,06 0,0452
14 9030617O03Rik 3,03 0,0037 44 Zc3h12a 2,02 0,0024
15 Ntn1 2,99 0,0029 45 Plek2 2,00 0,0064
16 Ndufb2 2,98 0,0145 46 Plxnb2 2,00 0,0243
17 Id1 2,95 0,0426 47 Vwa1 2,00 0,0140
18 Emp1 2,91 0,0127 48 Trim7 2,00 0,0305
19 Tex13 2,90 0,0091 49 Urah 1,99 0,0162
20 Insc 2,83 0,0393 50 Ankrd34a 1,99 0,0204
21 Hist3h2ba 2,63 0,0083 51 Krt17 1,97 0,0283
22 Pdzd3 2,61 0,0385 52 Rsg1 1,96 0,0589
23 Inhbb 2,57 0,0004 53 Il34 1,96 0,0231
24 Mras 2,47 0,0002 54 Ndufab1 1,96 0,0517
25 Tsix 2,47 0,0433 55 Lmna 1,96 0,0281
26 Cdx2 2,45 0,0411 56 Efna3 1,95 0,0546
27 Slc52a3 2,42 0,0095 57 Ccdc28b 1,95 0,0403
28 Fah 2,35 0,0018 58 H2afj 1,95 0,0229
29 Cdh4 2,31 0,0180 59 Pqlc1 1,93 0,0005
30 Robo4 2,31 0,0112 60 Epha2 1,92 0,0241
Table 5.2: List of upregulated genes in Trim71-/- mESCs. Genes with a higher sequence
count than 20 and a p-value ≤0.05 were listed in decreasing order of the their respective
mean fold change. Genes that were selected for further analysis are marked in bold.
ii
Downregulated genes in Trim71-/- mESCs
Rank Gene FC p-value Rank Gene FC p-value
1 Trim71 -4.44 0.0006 31 Myl9 -2.15 0.0257
2 Aurkc -4.04 0.0110 32 Saa2 -2.14 0.0492
3 Gm13139 -3.99 0.0027 33 Obox6 -2.14 0.0235
4 Lrrc15 -3.43 0.0104 34 Trim54 -2.13 0.0050
5 Ctrb1 -3.19 0.0181 35 Letm2 -2.12 0.0341
6 Gm21293 -2.93 0.0138 36 AU041133 -2.11 0.0196
7 Gm21304 -2.93 0.0138 37 Parp10 -2.11 0.0113
8 Gm6763 -2.93 0.0138 38 Nrsn1 -2.10 0.0283
9 Gm8764 -2.93 0.0138 39 Ccdc170 -2.08 0.0111
10 Col26a1 -2.87 0.0060 40 Nuggc -2.07 0.0391
11 Ror1 -2.87 0.0335 41 Usp29 -2.06 0.0086
12 Ceacam10 -2.85 0.0005 42 Clgn -2.05 0.0088
13 Myh13 -2.77 0.0177 43 Itih5 -2.04 0.0377
14 Zscan4b -2.76 0.0335 44 Hrc -2.03 0.0032
15 Obscn -2.75 0.0008 45 Nlrp4c -2.01 0.0249
16 Epx -2.60 0.0119 46 Hdac9 -2.01 0,0002
17 Gm13152 -2.60 0.0249 47 Lrrn1 -2.01 0.0155
18 Atp10a -2.55 0.0150 48 Tsga10 -2.00 0.0127
19 Gm5662 -2.50 0.0067 49 Adcyap1r1 -1.99 0.0110
20 Dcdc2a -2.40 0.0099 50 Pm20d2 -1.99 0.0060
21 Prom1 -2.31 0.0303 51 Thbd -1.97 0.0443
22 Serpina3m -2.30 0.0482 52 Tnnc2 -1.95 0.0129
23 Spic -2.26 0.0356 53 Klhl13 -1.95 0.0045
24 Peril -2.23 0.0346 54 Cep85l -1.95 0.0012
25 Slc11a1 -2.23 0.0225 55 Nexn -1.94 0.0364
26 Sema3e -2.21 0.0064 56 Pla2g5 -1.93 0.0157
27 Slco4c1 -2.21 0.0402 57 Pcdh19 -1.92 0.0074
28 Wnk3 -2.21 0.0265 58 Lrmp -1.92 0.0324
29 Meg3 -2.19 0.0273 59 Igtp -1.92 0.0312
30 Igsf10 -2.19 0.0407 60 Fam13c -1.92 0.0045
Table 5.3: List of downregulated genes in Trim71-/- mESCs. Genes with a higher sequence
count than 20 and a p-value ≤0.05 were listed in increasing order of the their respective
mean fold change. Genes that were selected for further analysis are marked in bold.
iii
Upregulated miRNAs in Trim71-/- mESCs
Rank Gene FC p-value
1 mmu-miR-743a-3p 2,35 0,0078
2 mmu-let-7e-5p 2,27 0,0130
3 mmu-miR-132-5p 1,88 0,0088
4 mmu-miR-378a-5p 1,72 0,0065
5 mmu-miR-200c-3p 1,60 0,0019
6 mmu-miR-145a-3p 1,55 0,0248
7 mmu-miR-24-2-5p 1,51 0,0185
Downregulated miRNAs in Trim71-/- mESCs
Rank mmu-miR-378a-5p FC p-value
1 mmu-miR-377-3p -3,78 0,0202
2 mmu-miR-410-3p -3,71 0,0433
3 mmu-miR-410-5p -3,51 0,0090
4 mmu-miR-323-3p -3,26 0,0113
5 mmu-miR-136-3p -3,20 0,0284
6 mmu-miR-376b-3p -3,19 0,0064
7 mmu-miR-300-3p -2,82 0,0486
8 mmu-miR-127-3p -2,63 0,0482
9 mmu-miR-127-5p -2,58 0,0448
10 mmu-miR-485-3p -2,53 0,0140
11 mmu-miR-433-3p -2,36 0,0129
12 mmu-miR-434-3p -2,29 0,0318
13 mmu-miR-466d-5p -2,26 0,0196
14 mmu-miR-409-3p -2,26 0,0385
15 mmu-miR-369-5p -2,26 0,0156
16 mmu-miR-3475-3p -2,24 0,0359
17 mmu-miR-1934-5p -2,19 0,0488
18 mmu-miR-6240 -2,01 0,0036
19 mmu-miR-673-3p -1,99 0,0371
20 mmu-miR-466a-5p -1,79 0,0165
21 mmu-miR-129-1-3p -1,69 0,0486
22 mmu-miR-669-3p -1,62 0,0313
23 mmu-miR-155-3p -1,60 0,0221
24 mmu-miR-3068-5p -1,57 0,0373
Table 5.4: List of significantly up- and downregulated miRNAs in Trim71-/- mESCs.
miRNAs with a higher sequence count than 10 and a p-value ≤0.05 were listed accord-
ing to their respective mean fold change.
iv
